
<html lang="en"     class="pb-page"  data-request-id="49fb96f0-d62e-4ac8-b6f4-0e99647c47e2"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2010.53.issue-9;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm100348u;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 (LFA-1): Structure−Activity Relationships Leading to the Identification of 6-((5S,9R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (BMS-688521)" /></meta><meta name="dc.Creator" content="Scott H.  Watterson" /></meta><meta name="dc.Creator" content="Zili  Xiao" /></meta><meta name="dc.Creator" content="Dharmpal S.  Dodd" /></meta><meta name="dc.Creator" content="David R.  Tortolani" /></meta><meta name="dc.Creator" content="Wayne  Vaccaro" /></meta><meta name="dc.Creator" content="Dominique  Potin" /></meta><meta name="dc.Creator" content="Michele  Launay" /></meta><meta name="dc.Creator" content="Dawn K.  Stetsko" /></meta><meta name="dc.Creator" content="Stacey  Skala" /></meta><meta name="dc.Creator" content="Patric M.  Davis" /></meta><meta name="dc.Creator" content="Deborah  Lee" /></meta><meta name="dc.Creator" content="Xiaoxia  Yang" /></meta><meta name="dc.Creator" content="Kim W.  McIntyre" /></meta><meta name="dc.Creator" content="Praveen  Balimane" /></meta><meta name="dc.Creator" content="Karishma  Patel" /></meta><meta name="dc.Creator" content="Zheng  Yang" /></meta><meta name="dc.Creator" content="Punit  Marathe" /></meta><meta name="dc.Creator" content="Pathanjali  Kadiyala" /></meta><meta name="dc.Creator" content="Andrew J.  Tebben" /></meta><meta name="dc.Creator" content="Steven  Sheriff" /></meta><meta name="dc.Creator" content="ChiehYing Y.  Chang" /></meta><meta name="dc.Creator" content="Theresa  Ziemba" /></meta><meta name="dc.Creator" content="Huiping  Zhang" /></meta><meta name="dc.Creator" content="Bang-Chi  Chen" /></meta><meta name="dc.Creator" content="Albert J.  DelMonte" /></meta><meta name="dc.Creator" content="Nelly  Aranibar" /></meta><meta name="dc.Creator" content="Murray  McKinnon" /></meta><meta name="dc.Creator" content="Joel C.  Barrish" /></meta><meta name="dc.Creator" content="Suzanne J.  Suchard" /></meta><meta name="dc.Creator" content="T. G.  Murali Dhar" /></meta><meta name="dc.Description" content="Leukocyte function-associated antigen-1 (LFA-1), also known as CD11a/CD18 or αLβ2, belongs to the β2 integrin subfamily and is constitutively expressed on all leukocytes. The major ligands of LFA-1..." /></meta><meta name="Description" content="Leukocyte function-associated antigen-1 (LFA-1), also known as CD11a/CD18 or αLβ2, belongs to the β2 integrin subfamily and is constitutively expressed on all leukocytes. The major ligands of LFA-1..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 20, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100348u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100348u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100348u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100348u" /></link>
        
    
    

<title>Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 (LFA-1): Structure−Activity Relationships Leading to the Identification of 6-((5S,9R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (BMS-688521) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100348u" /></meta><meta property="og:title" content="Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 (LFA-1): Structure−Activity Relationships Leading to the Identification of 6-((5S,9R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (BMS-688521)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0016.jpeg" /></meta><meta property="og:description" content="Leukocyte function-associated antigen-1 (LFA-1), also known as CD11a/CD18 or αLβ2, belongs to the β2 integrin subfamily and is constitutively expressed on all leukocytes. The major ligands of LFA-1 include three intercellular adhesion molecules 1, 2, and 3 (ICAM 1, 2, and 3). The interactions between LFA-1 and the ICAMs are critical for cell adhesion, and preclinical animal studies and clinical data from the humanized anti-LFA-1 antibody efalizumab have provided proof-of-concept for LFA-1 as an immunological target. This article will detail the structure−activity relationships (SAR) leading to a novel second generation series of highly potent spirocyclic hydantoin antagonists of LFA-1. With significantly enhanced in vitro and ex vivo potency relative to our first clinical compound (1), as well as demonstrated in vivo activity and an acceptable pharmacokinetic and safety profile, 6-((5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro-[4.4]nonan-7-yl)nicotinic acid (2e) was selected to advance into clinical trials." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100348u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100348u">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100348u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100348u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100348u&amp;href=/doi/10.1021/jm100348u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3814-3830</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100243n" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901664a" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 (LFA-1): Structure−Activity Relationships Leading to the Identification of 6-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (BMS-688521)<a class="ref internalNav" href="#acc1" aria-label=""></a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+H.++Watterson">Scott H. Watterson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zili++Xiao">Zili Xiao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dharmpal+S.++Dodd">Dharmpal S. Dodd</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+R.++Tortolani">David R. Tortolani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wayne++Vaccaro">Wayne Vaccaro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dominique++Potin">Dominique Potin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michele++Launay">Michele Launay</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dawn+K.++Stetsko">Dawn K. Stetsko</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stacey++Skala">Stacey Skala</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patric+M.++Davis">Patric M. Davis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deborah++Lee">Deborah Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoxia++Yang">Xiaoxia Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kim+W.++McIntyre">Kim W. McIntyre</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Praveen++Balimane">Praveen Balimane</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karishma++Patel">Karishma Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zheng++Yang">Zheng Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Punit++Marathe">Punit Marathe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pathanjali++Kadiyala">Pathanjali Kadiyala</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+J.++Tebben">Andrew J. Tebben</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Sheriff">Steven Sheriff</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=ChiehYing+Y.++Chang">ChiehYing Y. Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Theresa++Ziemba">Theresa Ziemba</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huiping++Zhang">Huiping Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bang-Chi++Chen">Bang-Chi Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Albert+J.++DelMonte">Albert J. DelMonte</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nelly++Aranibar">Nelly Aranibar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Murray++McKinnon">Murray McKinnon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel+C.++Barrish">Joel C. Barrish</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne+J.++Suchard">Suzanne J. Suchard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=T.+G.++Murali+Dhar">T. G. Murali Dhar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="affa"><span class="aff-symbol">‡</span> <span class="aff-text">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div><div class="aff-info" id="affb"><span class="aff-symbol">§</span> <span class="aff-text">Cerep, 19 Avenue du Quebec, 91951 Courtaboeuf cedex, France</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 609-252-6778. Fax: 609-252-7410. E-mail: <a href="/cdn-cgi/l/email-protection#b4c7d7dbc0c09ac3d5c0c0d1c6c7dbdaf4d6d9c79ad7dbd9"><span class="__cf_email__" data-cfemail="0d7e6e627979237a6c7979687f7e62634d6f607e236e6260">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100348u&amp;href=/doi/10.1021%2Fjm100348u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3814–3830</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 20, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 March 2010</li><li><span class="item_label"><b>Published</b> online</span>20 April 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100348u" title="DOI URL">https://doi.org/10.1021/jm100348u</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3814%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DScott%2BH.%2BWatterson%252C%2BZili%2BXiao%252C%2BDharmpal%2BS.%2BDodd%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D9%26contentID%3Djm100348u%26title%3DSmall%2BMolecule%2BAntagonist%2Bof%2BLeukocyte%2BFunction%2BAssociated%2BAntigen-1%2B%2528LFA-1%2529%253A%2BStructure%25E2%2588%2592Activity%2BRelationships%2BLeading%2Bto%2Bthe%2BIdentification%2Bof%2B6-%2528%25285S%252C9R%2529-9-%25284-Cyanophenyl%2529-3-%25283%252C5-dichlorophenyl%2529-1-methyl-2%252C4-dioxo-1%252C3%252C7-triazaspiro%255B4.4%255Dnonan-7-yl%2529nicotinic%2BAcid%2B%2528BMS-688521%2529%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3830%26publicationDate%3DMay%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100348u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3348</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">36</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100348u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 (LFA-1): Structure−Activity Relationships Leading to the Identification of 6-((5S,9R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (BMS-688521)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;H. Watterson&quot;},{&quot;first_name&quot;:&quot;Zili&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Dharmpal&quot;,&quot;last_name&quot;:&quot;S. Dodd&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;R. Tortolani&quot;},{&quot;first_name&quot;:&quot;Wayne&quot;,&quot;last_name&quot;:&quot;Vaccaro&quot;},{&quot;first_name&quot;:&quot;Dominique&quot;,&quot;last_name&quot;:&quot;Potin&quot;},{&quot;first_name&quot;:&quot;Michele&quot;,&quot;last_name&quot;:&quot;Launay&quot;},{&quot;first_name&quot;:&quot;Dawn&quot;,&quot;last_name&quot;:&quot;K. Stetsko&quot;},{&quot;first_name&quot;:&quot;Stacey&quot;,&quot;last_name&quot;:&quot;Skala&quot;},{&quot;first_name&quot;:&quot;Patric&quot;,&quot;last_name&quot;:&quot;M. Davis&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Xiaoxia&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Kim&quot;,&quot;last_name&quot;:&quot;W. McIntyre&quot;},{&quot;first_name&quot;:&quot;Praveen&quot;,&quot;last_name&quot;:&quot;Balimane&quot;},{&quot;first_name&quot;:&quot;Karishma&quot;,&quot;last_name&quot;:&quot;Patel&quot;},{&quot;first_name&quot;:&quot;Zheng&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Punit&quot;,&quot;last_name&quot;:&quot;Marathe&quot;},{&quot;first_name&quot;:&quot;Pathanjali&quot;,&quot;last_name&quot;:&quot;Kadiyala&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;J. Tebben&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Sheriff&quot;},{&quot;first_name&quot;:&quot;ChiehYing&quot;,&quot;last_name&quot;:&quot;Y. Chang&quot;},{&quot;first_name&quot;:&quot;Theresa&quot;,&quot;last_name&quot;:&quot;Ziemba&quot;},{&quot;first_name&quot;:&quot;Huiping&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Bang-Chi&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Albert&quot;,&quot;last_name&quot;:&quot;J. DelMonte&quot;},{&quot;first_name&quot;:&quot;Nelly&quot;,&quot;last_name&quot;:&quot;Aranibar&quot;},{&quot;first_name&quot;:&quot;Murray&quot;,&quot;last_name&quot;:&quot;McKinnon&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;C. Barrish&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;J. Suchard&quot;},{&quot;first_name&quot;:&quot;T.&quot;,&quot;last_name&quot;:&quot;G. Murali Dhar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;3814-3830&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100348u&quot;},&quot;abstract&quot;:&quot;Leukocyte function-associated antigen-1 (LFA-1), also known as CD11a/CD18 or αLβ2, belongs to the β2 integrin subfamily and is constitutively expressed on all leukocytes. The major ligands of LFA-1 include three intercellular adhesion molecules 1, 2, and 3 (ICAM 1, 2, and 3). The interactions between LFA-1 and the ICAMs are critical for cell adhesion, and preclinical animal studies and clinical data from the humanized anti-LFA-1 antibody efalizumab have provided proof-of-concept for LFA-1 as an immunological target. This article will detail the structure−activity relationships (SAR) leading to a novel second generation series of highly potent spirocyclic hydantoin antagonists of LFA-1. With significantly enhanced in vitro and ex vivo potency relative to our first clinical compound (1), as well as demonstrated in vivo activity and an acceptable pharmacokinetic and safety profile, 6-((5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro-[4.4]nonan-7-yl)nicotinic acid (2e) was sel&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100348u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100348u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100348u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100348u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100348u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100348u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100348u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100348u&amp;href=/doi/10.1021/jm100348u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100348u" /></input><a href="/doi/pdf/10.1021/jm100348u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100348u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100348u%26sid%3Dliteratum%253Aachs%26pmid%3D20405922%26genre%3Darticle%26aulast%3DWatterson%26date%3D2010%26atitle%3DSmall%2BMolecule%2BAntagonist%2Bof%2BLeukocyte%2BFunction%2BAssociated%2BAntigen-1%2B%2528LFA-1%2529%253A%2BStructure%25E2%2588%2592Activity%2BRelationships%2BLeading%2Bto%2Bthe%2BIdentification%2Bof%2B6-%2528%25285S%252C9R%2529-9-%25284-Cyanophenyl%2529-3-%25283%252C5-dichlorophenyl%2529-1-methyl-2%252C4-dioxo-1%252C3%252C7-triazaspiro%255B4.4%255Dnonan-7-yl%2529nicotinic%2BAcid%2B%2528BMS-688521%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D9%26spage%3D3814%26epage%3D3830%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=290865" title="Nitrogen">Nitrogen</a>,</li><li><a href="/action/doSearch?ConceptID=291305" title="Cell physiology">Cell physiology</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Leukocyte function-associated antigen-1 (LFA-1), also known as CD11a/CD18 or α<sub>L</sub>β<sub>2</sub>, belongs to the β<sub>2</sub> integrin subfamily and is constitutively expressed on all leukocytes. The major ligands of LFA-1 include three intercellular adhesion molecules 1, 2, and 3 (ICAM 1, 2, and 3). The interactions between LFA-1 and the ICAMs are critical for cell adhesion, and preclinical animal studies and clinical data from the humanized anti-LFA-1 antibody efalizumab have provided proof-of-concept for LFA-1 as an immunological target. This article will detail the structure−activity relationships (SAR) leading to a novel second generation series of highly potent spirocyclic hydantoin antagonists of LFA-1. With significantly enhanced in vitro and ex vivo potency relative to our first clinical compound (<b>1</b>), as well as demonstrated in vivo activity and an acceptable pharmacokinetic and safety profile, 6-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro-[4.4]nonan-7-yl)nicotinic acid (<b>2e</b>) was selected to advance into clinical trials.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span>†</span> </h4><p class="last">PDB ID code <db-link db-identifier="3M6F" db-name="pdb">3M6F</db-link>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56021" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56021" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Integrins are a family of α/β heterodimeric receptors that mediate cell−cell and cell−extracellular interactions.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Leukocyte function-associated antigen-1 (LFA-1<a class="ref internalNav" href="#fn2" aria-label="a">a</a><div class="NLM_fn" id="fn2">a<p class="last">Abbreviations: LFA-1, leukocyte function associated antigen-1; ICAM, intercellular adhesion molecules; IDAS, I-Domain allosteric site; HUVEC, human umbilical vein endothelial cells; MLR, mixed lymphocyte reaction; b.END3, mouse brain endothelial cell line; SFC, super critical fluid chromatography; hERG, human ether-a-go-go-related gene; BAL, bronchoalveolar lavage; OVA, ovalvumin; PBMC, human peripheral blood mononuclear cells; APC, antigen presenting cell.</p></div>), also known as CD11a/CD18 or α<sub>L</sub>β<sub>2</sub>, belongs to the β<sub>2</sub> integrin subfamily and is constitutively expressed on all leukocyctes.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The major ligands of LFA-1 include three members of the immunoglobulin super gene family, intercellular adhesion molecules 1, 2, and 3 (ICAM 1, 2, and 3). In particular, the interaction between LFA-1 and ICAM-1 promotes tight adhesion between many cell types including endothelial cells as well as other leukocytes and plays a critical role in immunological functions including leukocyte recruitment and T-cell costimulation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">LFA-1 is expressed in a low affinity state on unactivated cells and switches to a high affinity state following cell activation.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> LFA-1 is composed of two subunits, an α<sub>L</sub>-subunit and a β<sub>2</sub>-subunit. The α<sub>L</sub>-subunit contains a seven-bladed propeller region in which there is a 200 amino acid inserted domain at the N-terminus referred to as the I-Domain.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The I-Domain consists of a central β-sheet surrounded by α-helices and two noninteracting binding sites. The MIDAS or metal-ion-dependent adhesion site is the site that directly interacts with ICAM. On the opposing end of the I-Domain is the IDAS or I-Domain allosteric site that indirectly affects the conformation of the MIDAS site to regulate the affinity of LFA-1. Specifically, a change in the IDAS site, from a closed to an open conformation, results in high affinity LFA-1/ICAM-1 interactions.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The β<sub>2</sub>-subunit contains an I-like domain, which is believed to serve a regulatory role and does not participate directly with the binding of ICAM.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">In vivo studies with anti-LFA-1 antibodies or with LFA-1 deficient mice have demonstrated that LFA-1 plays a critical role in leukocyte extravasation in recruitment models.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Additionally, preclinical and clinical data from the humanized anti-LFA-1 antibody efalizumab, which was approved by the FDA in 2003 for the treatment of moderate to severe psoriasis, has provided proof-of-concept for this target.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> As a consequence, the LFA-1/ICAM-1 interaction has emerged as an attractive target for the treatment of immunological disorders such as psoriasis, rheumatoid arthritis, and solid organ transplantation.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a></div><div class="NLM_p">As a result of the strong preclinical and clinical validation, there has been an intense effort to identify orally active small molecules that induce a targeted disruption of the LFA-1/ICAM-1 interaction as potential therapeutic agents. In this effort, our group<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and others<a onclick="showRef(event, 'ref5 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref7">(5, 7)</a> have disclosed several diverse chemical series of compounds. NMR and X-ray crystallographic studies have established that many of these series bind to the IDAS site (I-Domain allosteric site) of the I-Domain located on the α<sub>L</sub> subunit.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> It has been reported that small molecule antagonists binding to the IDAS site prevent the conformational changes necessary for the conversion of the I-Domain from the low affinity, closed conformation to the high affinity, open conformation, consequently precluding the binding of ICAM.<a onclick="showRef(event, 'cit2a'); return false;" href="javascript:void(0);" class="ref cit2a">(2a)</a></div><div class="NLM_p">In an earlier report, we disclosed the structure−activity relationships (SAR) leading to a novel spirocyclic hydantoin antagonist (<b>1</b>, BMS-587101; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) of the LFA-1/ICAM-1 interaction.<a onclick="showRef(event, 'cit6b'); return false;" href="javascript:void(0);" class="ref cit6b">(6b)</a> Compound <b>1</b> inhibited LFA-1-mediated adhesion of human T-cells to human umbilical vein endothelial cells (HUVEC) and mouse T-cell adhesion to a mouse brain endothelial cell line (b.END3). It has been reported<a onclick="showRef(event, 'cit6b ref9'); return false;" href="javascript:void(0);" class="ref cit6b ref9">(6b, 9)</a> that small molecule LFA-1 antagonists exhibit a significant disconnect with regard to inhibition of human LFA-1 vs rodent LFA-1, and to that end, <b>1</b> exhibited an approximately 8-fold decrease in potency. Additionally, in support of the role of LFA-1 in T-cell activation, <b>1</b> successfully blocked human T-cell proliferation in a mixed lymphocyte reaction (MLR) assay. Previously, we demonstrated that <b>1</b> was efficacious in combination with CTLA-4Ig in a mouse heart-to-ear transplant model.<a onclick="showRef(event, 'cit6b'); return false;" href="javascript:void(0);" class="ref cit6b">(6b)</a> Recently, we reported that <b>1</b> was able to robustly inhibit disease in two preclinical models of rheumatoid arthritis, a mouse antibody-induced arthritis (AIA) model and a mouse collagen-induced arthritis (CIA) model, even though <b>1</b> is ∼8-fold less potent against mouse LFA-1.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> On the basis of its in vitro potency, in vivo activity, pharmacokinetic profile, and clean safety profile, compound <b>1</b> was advanced into the clinic.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0017.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Having identified our first successful antagonist of LFA-1, we turned our attention to developing a next generation of spirocyclic hydantoins with enhanced potency. In this article, we outline the SAR leading to the identification of compound <b>2e</b> (BMS-688521;<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which demonstrated significantly improved potency relative to compound <b>1</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic pathways utilized in the preparation of the spirocyclic hydantoins discussed in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> are outlined in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>−<a class="ref internalNav" href="#sch9" aria-label="9">9</a>. The spirocyclic hydantoin core, 4-((5<i>S</i>,9<i>R</i>)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-9-yl)benzonitrile (<b>6</b>), was prepared as outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.<a onclick="showRef(event, 'cit6b ref11'); return false;" href="javascript:void(0);" class="ref cit6b ref11">(6b, 11)</a> Knoevenagel condensation of <b>3</b> with 4-cyanobenzaldehyde gave the thermodynamically more stable benzylidene hydantoin <b>4</b>, which crystallized out of the reaction mixture as a single diastereomer having the desired <i>E</i> double bond stereochemistry. A subsequent azomethine ylide cycloaddition step with commercially available <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzylamine afforded compound <b>5</b> as a single diasteromer. <i>N</i>-Debenzylation utilizing modified Von Braun conditions afforded the des-benzyl analogue, which was separated into its individual enantiomers using a Chiralpak-AD column under supercritical fluid chromatography (SFC) conditions to give <b>6</b>. The intermediate <b>6</b> was determined to have >99% enatiomer excess, with the spirocyclic carbon assigned as (<i>S</i>) and the carbon bearing the 4-cyanophenyl residue assigned as (<i>R</i>), and was used as an intermediate for the preparation of all compounds discussed in this article.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) sarcosine ethyl ester, NaOH, THF/H<sub>2</sub>O, 96%; (b) 4-cyanobenzaldehyde, β-alanine, AcOH, reflux, 35% or 4-cyanobenzaldehyde, pyrrolidine/EtOH, 78 °C 18 h, 85%; (c) <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzylamine, THF, TFA, 0 °C to RT, 18 h, 70%; (d) 1,2-dichloroethane, 1-chloroethyl chloroformate, 5 °C, to RT, 18 h, MeOH, reflux, 3 h, 50−85%; (e) Chiralpak-AD column, CO<sub>2</sub>/MeOH, ∼100% desired enantiomer (>99% ee).</p></p></figure><div class="NLM_p">Analogues <b>2a</b>−<b>d</b> and <b>2k</b> were prepared as outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Spirocyclic hydantoin <b>6</b> and 2-bromopyidine were heated at 100 °C in dimethylformamide in the presence of potassium carbonate to give <b>2a</b>. Analogues <b>2b</b>, <b>2d</b>, and <b>2k</b> were prepared via a Buchwald coupling<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> with either the appropriate bromo- or chloropyridine. A Chan−Lam coupling<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> between 4-cyanoboronic acid and <b>6</b> afforded <b>2c</b>. Analogue <b>2e</b> was prepared as depicted in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> 6-Nicotinic acid was protected as a <i>tert</i>-butyl ester (<b>7</b>) in 70% yield. Heating of <b>7</b> with intermediate <b>6</b> at 112 °C in dimethylacetamide in the presence of diisopropylethylamine afforded <i>tert</i>-butyl ester <b>8</b> in 77% yield. The ester was subsequently hydrolyzed with trifluoroacetic acid to give <b>2e</b> in 86% yield. The carboxylic acid isostere, tetrazole <b>2f</b>, was prepared as outlined in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 25%; (b) <b>6</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, biphenyl-2-yldicyclohexylphosphine, <i>t</i>-BuOK, DMA, 85 °C, 41%; (c) <b>6</b>, Cu(OAc)<sub>2</sub>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 100 °C, 14%; (d) <b>6</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, biphenyl-2-yldicyclohexylphosphine, <i>t</i>-BuOK, DMA, 85 °C, 8%; (e) <b>6</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, DIPEA, 90 °C, 33%.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SOCl<sub>2</sub>; <i>t</i>-BuOH, CH<sub>2</sub>Cl<sub>2</sub>, Et<sub>3</sub>N, DMAP, 70%; (b) <b>6</b>, DIPEA, DMA, 112 °C, 77%; (c) TFA, DCM, 86%.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaN<sub>3</sub>, Et<sub>3</sub>N, AcOH, 130 °C, 30%; (b) Ph<sub>3</sub>CCl, NaOH, CHCl<sub>3</sub>, 39%; (c) <b>6</b>, DIPEA, 118 °C, 12%; (d) TFA, MeOH.</p></p></figure><div class="NLM_p">Analogues <b>2g−i</b> and <b>2p−t</b> were prepared as outlined in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a> for the preparation of <b>2h</b>. Spirocyclic hydantoin intermediate <b>6</b> was heated in either dimethylformamide or dimethylacetamide with the appropriate chloro-, bromo-, or methylsulfone-substituted heteroaryl substrate, additionally substituted with a methyl or ethyl ester, at 95−110 °C to provide the intermediate esters in yields ranging from 28 to 97%.  Subsequent hydrolysis of the ester with 1.0 M aqueous potassium hydroxide and 1,2-propanediol in a mixture of tetrahydrofuran and water afforded the desired analogues in yields ranging from 8 to 70%.  The chloro-, bromo-, and methylsulfone-substituted heteroaryl substrates were commercially available, prepared as described in the literature, or synthesized as depicted in Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>6</b>, DIPEA, DMF, 100 °C, 86%; (b) 1 M aq KOH, 1,2-propanediol, THF, H<sub>2</sub>O, 28%.</p></p></figure><div class="NLM_p">Analogues <b>2o</b>, <b>2u</b>, and <b>2v</b> were prepared as shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a> for the preparation of <b>2o</b>. Spirocyclic hydantoin intermediate <b>6</b> was heated in either dimethylformamide or dimethylacetamide with the appropriate chloro-substituted heteroaryl substrate, additionally substituted with a methyl or ethyl ester, at 100−110 °C to provide the intermediate esters in yields ranging from 31 to 81%. Subsequent hydrolysis of the ester with either lithium iodide or lithium chloride in dimethylformamide, dimethylacetamide, or <i>N</i>-methyl-2-pyrrolidinone at 115−140 °C afforded the desired analogues in yields ranging from 39 to 86%. The chloro- and bromo-heteroaryl substrates were commercially available, prepared as described in the literature, or synthesized as depicted in Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>6</b>, DIPEA, DMF, 100 °C, 81%; (b) LiI, DMA, 140 °C, 42%.</p></p></figure><div class="NLM_p">Analogues <b>2j</b> was prepared as outlined in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>. Spirocyclic hydantoin intermediate <b>6</b> was heated neat with commercially available methyl 2-chloroisonicotinate at 96 °C  to give the intermediate ester (<b>15</b>) in 37% yield.  Subsequent hydrolysis of the ester with lithium iodide in dimethylacetamide at 140 °C afforded <b>2j</b> in 86% yield.  Compound <b>2n</b> was prepared as depicted in Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>6</b>, neat, 96 °C, 37%; (b) LiI, DMA, 140 °C, 86%.</p></p></figure><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) neat, 108 °C, 72%; (b) DMF, reflux, 55%; (c) POCl<sub>3</sub>, 128 °C; (d) NaOH (25% aq), 98%; (e) SOCl<sub>2</sub>; <i>t</i>-BuOH, DMAP, Et<sub>3</sub>N, 10% (f) <b>6</b>, DIPEA, DMA, 112 °C, 50%; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 76%.</p></p></figure><div class="NLM_p last"><figure id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0009.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 9. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>, MeOH, reflux; (b) POCl<sub>3</sub>; (c) urea, 100 °C, 40%; (d) <i>t</i>-BuONO, CuCl<sub>2</sub>, MeCN, 65 °C, 66%; (e) SOCl<sub>2</sub>, MeOH, 65%; (f) NaNO<sub>2</sub>, H<sub>2</sub>SO<sub>4</sub>, H<sub>2</sub>O, 71%; (g) POCl<sub>3</sub>, 110 °C; (h) <i>t</i>-butyl nitrite, CuBr<sub>2</sub>, MeCN.</p></p></figure>Compounds outlined in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> were evaluated for LFA-1 mediated adhesion in a cell−cell based adhesion assay employing primary human T-cells and human umbilical vein endothelial cells (HUVEC) (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section ">Experimental Section </a> for details). Additionally, the activity of compounds on APC-dependent T-cell proliferation was evaluated in vitro using a one-way mixed lymphocyte reaction (MLR) assay (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for details). In contrast to the adhesion assay, the MLR assay was conducted in the presence of 10% serum.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42067" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42067" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The X-ray co-crystal structure of spirocyclic hydantoin <b>1</b> with the I-Domain of LFA-1 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) revealed that the compound binds to the I-Domain allosteric site (IDAS).<a onclick="showRef(event, 'cit6b'); return false;" href="javascript:void(0);" class="ref cit6b">(6b)</a> Additionally, the X-ray co-crystal structure revealed that most of the interactions of the ligand with the protein are hydrophobic in nature with the <i>p</i>-cyanophenyl aromatic ring forming a favorable edge-to-edge face π−π interaction with the <i>N</i>-3 3,5-dichlorophenyl ring in the pocket. The dichlorophenyl group itself occupies a hydrophobic pocket between α-helices 1 and 7 and β-strands 1, 3, and 4. The urea carbonyl is hydrogen-bonded to the amino acid residues Lys 287, Lys 305, and Glu 284 via a water molecule. Unlike the urea, the amide carbonyl does not appear to make any discernible contacts with the protein. As is evident from the crystal structure, the thiophene carboxylic acid moiety is projected into solvent and does not appear to interact with any residues in the I-Domain.</div><figure id="fig2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0018.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of compound <b>1</b> bound to the I-Domain of LFA-1. Also shown is the initial electron density prior to fitting the compound (magenta 2<i>F</i><sub>o</sub> − <i>F</i><sub>c</sub> contoured at 1σ and cyan: <i>F</i><sub>o</sub> − <i>F</i><sub>c</sub> contoured at 6σ, which indicates the positions of the chlorine atoms).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since extensive SAR suggested that the 2,5-dichlorophenyl, <i>N</i>-methyl, and 4-cyanophenyl moieties are optimal,<a onclick="showRef(event, 'cit6b'); return false;" href="javascript:void(0);" class="ref cit6b">(6b)</a> we decided to focus on modulating potency, physiochemical properties, and liability profiling parameters with further modifications to the substitution on the spirocyclic pyrrolidine nitrogen. In particular, we reasoned based on the X-ray co-crystal structure that a heteroaryl group directly appended to the pyrrolidine nitrogen would engage in a hydrogen-bonding interaction with Tyr 257 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and improve potency compared to compound <b>1</b>. As seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, our initial investigation into this hypothesis led to some promising results. The simple 1-pyridyl substituted derivative (<b>2a</b>) showed similar potency in both the T-cell/HUVEC adhesion assay (IC<sub>50</sub> = 11 nM) and the MLR T-cell proliferation assay (IC<sub>50</sub> = 200 nM) relative to our first clinical candidate (<b>1</b>). Addition of a 4-cyano substituent onto the pyridyl derivative (<b>2b</b>) maintained potency in the adhesion assay (IC<sub>50</sub> = 11 nM) but resulted in a 3-fold increase in potency in the MLR assay. To understand the impact of the pyridyl nitrogen, the 4-cyanophenyl derivative was prepared (<b>2c</b>) and was found to be ∼5-fold less potent than <b>2b</b> in the adhesion assay with an IC<sub>50</sub> of 60 vs 11 nM, respectively, thus suggesting that the pyridyl nitrogen is likely involved in a hydrogen-bonding interaction with Tyr 257. To further explore the effects of the pyridyl nitrogen, the 4-cyano-3-pyridine derivative (<b>2d</b>) was prepared. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <b>2d</b> showed similar potency as <b>2b</b> with an IC<sub>50</sub> of 12 nM in the adhesion assay and an IC<sub>50</sub> of 140 nM in the MLR assay. This was surprising since one would expect that moving the pyridyl nitrogen adjacent to cyano group would not only affect the geometry of the hydrogen-bonding interaction but would also result in a more electron deficient nitrogen atom relative to the 2-pyridyl derivative, resulting in a less favorable hydrogen-bonding interaction.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Potency of Spirocyclic Hydantoin Analogues<a class="ref internalNav" href="#tbl1-fn1" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0011.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are shown as mean values of three determinations.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values are shown as single determinations.</p></div><div class="footnote" id="tbl1-fn1"><sup>c</sup><p class="last">ND = not determined.</p></div></div></div><div class="NLM_p">Although compound <b>2b</b> was very promising, it was suboptimal with respect to liability profiling and physiochemical properties. As we have found in our previous SAR around the pyrrolidine based spirocyclic hydantoin class,<a onclick="showRef(event, 'cit6b'); return false;" href="javascript:void(0);" class="ref cit6b">(6b)</a> incorporation of a carboxylic acid or carboxylic acid isostere resulted in zwitterionic compounds with optimal physiochemical properties and acceptable liability profiles (e.g., CYP inhibition, hERG, metabolic stability). Interestingly, the 4-carboxylic acid substituted 2-pyridine derivative (<b>2e</b>) was prepared and was found to be a highly potent inhibitor of the LFA-1/ICAM interaction with an IC<sub>50</sub> of 2.5 nM in the adhesion assay and an IC<sub>50</sub> of 60 nM in the MLR assay. This represented a 4−8-fold improvement in in vitro potency when compared to the initial program lead, <b>1</b>.</div><div class="NLM_p">The X-ray co-crystal structure of <b>2e</b> bound to the I-Domain of LFA-1 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) revealed that the carboxylic acid moiety is involved in a hydrogen-bonding interaction with the Thr 231 residue in the active site. The X-ray co-crystal structure also revealed that the pyridyl nitrogen is engaged in a hydrogen-bonding interaction with a water molecule that is in proximity to the Tyr 257 residue, although the distance between the water molecule and the residue was measured to be 3.7 Å in this crystal form, which is somewhat long for a typical hydrogen-bond length of 3.3 Å. All other interactions seen in the X-ray co-crystal structure of <b>1</b> are conserved. The ∼5-fold loss in potency observed with the 4-cyanophenyl (<b>2c</b>) versus the 4-cyano-2-pyridyl (<b>2b</b>) would suggest that in a fully functioning protein, in an in vitro setting, the pyridyl nitrogen is potentially engaging in a hydrogen-bonding interaction with Tyr 257. Further analysis of the co-crystal structure of <b>2e</b> with molecular modeling suggests that a very small movement of either the water molecule or Tyr 257 does result in a hydrogen-bonding interaction with the pyridyl nitrogen. In considering the surprising activity seen with the 4-cyano-3-pyridyl analogue <b>2d</b>, a search of the Protein Data Bank (PDB) revealed that there are a number of examples of a pyridyl C−H <i>alpha</i> to the nitrogen interacting with a water molecule. It appears that the acidity of that hydrogen is sufficient enough to allow for an effective hydrogen-bond relative to the 4-cyanophenyl derivative (<b>2c</b>). Interestingly, by reducing the distance between the amino and the acid portions of the zwitterion, we have been able with <b>2e</b> to uncover a significant binding opportunity with the potential for a second, thus accounting for the observed increase in in vitro potency.</div><figure id="fig3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0019.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of compound <b>2e</b> bound to the I-Domain of LFA-1. Also shown is the initial electron density prior to fitting the compound (magenta 2<i>F</i><sub>o</sub> − <i>F</i><sub>c</sub> contoured at 1σ and cyan: <i>F</i><sub>o</sub> − <i>F</i><sub>c</sub> contoured at 6σ, which indicates the positions of the chlorine atoms).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As expected, <b>2e</b> had a clean liability profile, as outlined in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, as well as acceptable selectivity relative to other related integrins (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). On the basis of the new X-ray crystallographic data, excellent in vitro potency, and a clean partial profile for <b>2e</b>, we turned our attention to further exploring and optimizing these interactions, as outlined in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. As expected, the tetrazole carboxylic isostere (<b>2f</b>) was equipotent. Structural modeling based on the X-ray co-crystal structure suggested that moving the carboxylic acid to the adjacent carbon would be tolerated and would still engage Thr 231. As predicted, moving the carboxylic acid to the 5-position of the pyridine ring (<b>2j</b>) demonstrated equipotent activity relative to <b>2e</b>. However, when the nitrogen was moved to the 4-postion (<b>2k</b>), a loss in potency was observed. Compounds <b>2n</b> and <b>2o</b> represent an effort to structurally constrain the position of the pyridyl nitrogen and the carboxylic acid and to explore regions of the binding pocket. We rationalized that a small group adjacent to the carboxylic acid residue in <b>2e</b> might provide enhancements to the in vitro potency through restricted rotation of the carbonyl of the carboxylic acid, thus optimizing the Thr 231 interaction. Interestingly, both derivatives were ∼4 fold less potent than <b>2e</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Partial in Vitro Profiling Data for Compound <b>2e</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">parameter</th><th class="colsep0 rowsep0">result</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein binding</td><td class="colsep0 rowsep0" align="left">95% in human serum</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mutagenicity</td><td class="colsep0 rowsep0">Ames negative</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG (patch clamp)</td><td class="colsep0 rowsep0">20% inhibition @ 30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Purkinje fiber</td><td class="colsep0 rowsep0"><5% @ 30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> inhibition (IC<sub>50</sub>)</td><td class="colsep0 rowsep0">>35 μM 1A2, 2C9, 2D6, 2C19, 3A4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco2 permeability (apical to basolateral)</td><td class="colsep0 rowsep0">148 nm/s</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">CYP = cytochrome P450.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Partial in Vitro Selectivity Data for Compound <b>2e</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0">assay</th><th class="colsep0 rowsep0">selectivity</th><th class="colsep0 rowsep0">inhibition</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">THP-1 adhesion to i3Cb</td><td class="colsep0 rowsep0">Mac-1</td><td class="colsep0 rowsep0">18% @ 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">Jurkat: CS-1 adhesion</td><td class="colsep0 rowsep0">VLA-4</td><td class="colsep0 rowsep0">0% @ 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">platelet aggregation</td><td class="colsep0 rowsep0">α<sub>2</sub>β<sub>3</sub></td><td class="colsep0 rowsep0"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">adenosine diphosphate</td><td class="colsep0 rowsep0"> </td><td class="colsep0 rowsep0">0% @ 30 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">collagen</td><td class="colsep0 rowsep0"> </td><td class="colsep0 rowsep0">0% @ 30 μM</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Potency of Spirocyclic Hytantoin Analogues<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0012.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0013.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are shown as mean values of at least three determinations. ND = not determined.</p></div></div></div><div class="NLM_p">Other carboxylic acid substituted six-membered heterocycles were explored including pyrimidines (<b>2g</b>, <b>2l</b>, <b>2m</b>), a pyrazine (<b>2h</b>), and a pyridazine (<b>2i</b>), as seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. With the exception of compound <b>2m</b>, incorporation of a second nitrogen into the six-membered heterocycle (<b>2l</b>, <b>2g</b>−<b>i</b>) led to a >4-fold decrease in activity in the adhesion assay. On the basis of modeling studies, we had anticipated that the second nitrogen in the pyrimidine analogue (<b>2g</b>) might engage in an interaction with another Tyr residue (Tyr 166). Five-membered heterocycles were also explored. Thiazole <b>2p</b> was found to be a highly potent antagonist in both the adhesion and MLR assays (5.0 and 170 nM, respectfully), although less optimized than <b>2e</b>. The oxazole derivative <b>2q</b> was substantially less potent than <b>2p</b>, with an IC<sub>50</sub> of 58 nM in the cell adhesion assay.</div><div class="NLM_p">In continuing to leverage the X-ray co-crystal data from <b>2e</b>, we began to reason that carboxylic acid substituted bicyclic heterocycles would also be effective in engaging the Thr 231 interaction. With the support of molecular modeling, bicycles <b>2r</b>−<b>v</b> were prepared and evaluated, as seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. As predicted, the 7-carboxylic acid benzoxazole <b>2r</b> and the 7-carboxylic benzothiazole <b>2u</b> demonstrated similar activity to that of lead <b>2e</b> in the adhesion and the MLR assays. As exemplified by compounds <b>2s</b>, <b>2t</b>, and <b>2v</b>, relocating the acid residue to either the 5- or 6-position of the bicycle maintained potency in the adhesion assay, although a 4- to 7-fold decrease in activity in the MLR assay was observed.</div><div class="NLM_p">Although we prepared several highly potent antagonists of the LFA-1/ICAM-1 interaction, spirocyclic hydantoin <b>2e</b> demonstrated optimal in vitro potency with a desirable in vitro liability profile and was selected as our lead candidate. Compound <b>2e</b> was compared with <b>1</b> in a human IL-2 whole blood ex vivo assay where the level of IL-2 mRNA is assessed (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). This assay was conducted on heparinized human whole blood that had been activated with SEB. This response can be blocked with anti-LFA-1 antibody, demonstrating that IL-2 production is LFA-1 dependent. IL-2 mRNA levels were determined based on the RNA isolated from activated cells at 6 h post stimulation. In this ex vivo assay, <b>2e</b> was found to be 4-fold more potent than <b>1</b> (IC<sub>50</sub> of 65 vs 276 nM; Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), which is consistent with the MLR data.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. <a class="ref internalNav" href="#t5fn1" aria-label="a">a</a>Comparison of <b>2e</b> and <b>1</b> (BMS-587101) in a Human IL-2 Whole Blood ex Vivo Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0014.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0015.gif" alt="" id="_i9" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are shown as mean values of at least three determinations.</p></div></div></div><div class="NLM_p">As previously mentioned, small molecule LFA-1 antagonists exhibit a significant disconnect with regard to the inhibition of human LFA-1 vs rodent LFA-1. As a result of this cross species disconnect, we evaluated <b>2e</b> in a mouse-specific adhesion assay that employed mouse splenocytes and a mouse ICAM-1 expression cell line, b.END3. The original clinical candidate, <b>1</b>, was found to show activity in this assay with an IC<sub>50</sub> of 150 nM. This represents a 7- to 9-fold decrease in activity when compared to the results of the human T-cell/HUVEC adhesion assay data (IC<sub>50</sub> = 20 nM). As seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, <b>2e</b> was found to have an IC<sub>50</sub> of 78 nM, representing an approximately 30-fold decrease in activity relative to the human T-cell/HUVEC assay data (IC<sub>50</sub> = 2.5 nM).</div><div class="NLM_p">On the basis of its exceptional in vitro potency and clean profile, spirocyclic hydantoin <b>2e</b> was evaluated in vivo. In pharmacokinetic (PK) studies in mice, rats, and dogs (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>), bioavailabilities were around 50% or higher and half-lives ranged from 1.6−4.7 h. On the basis of its excellent in vitro potency, reasonable mouse LFA-1 antagonist activity, and its acceptable mouse PK profile, sprirocyclic hytantoin <b>2e</b> was evaluated in a mouse allergic eosinophilic lung inflammation model. The ability of <b>2e</b> to block eosinophil accumulation in the airways of the lung, as measured in bronchoalveolar lavage (BAL) fluid, was evaluated in ovalvumin (OVA)-sensitized and challenged BALB/c mice. Mice were given OVA intraperitoneally (IP) on day 0, boosted on day 14, and given an intranasal challenge with OVA on day 28. Compound <b>2e</b> was given at doses of 1, 3, and 10 mg/kg, PO, BID for a three-day duration following OVA challenge. Lungs were then lavaged and the cells quantified. Significant inhibition (<i>p</i> < 0.05 versus vehicle) of eosinophil accumulation was seen at a dose of 1 mg/kg BID (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), with dose-dependent inhibition at 3 mg/kg and 10 mg/kg. These results with <b>2e</b> approximate those seen with <b>1</b><a onclick="showRef(event, 'cit6b'); return false;" href="javascript:void(0);" class="ref cit6b">(6b)</a> and the antimouse LFA-1 antibody, M17.</div><figure id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0020.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Efficacy of <b>2e</b> (1, 3, and 10 mg/kg) vs vehicle in a mouse allergic eosinophilic lung inflammation model. Mice (<i>n</i> = 8/group) were immunized with OVA IP on day 0, boosted on day 14, and challenged on day 28; <b>2e</b> was administered PO/BID for 3 days starting on day 28. Vehicle: PEG400/0.1 M phosphate buffer (80/20 v/v). M17 is an anti-LFA-1 monoclonal antibody. *<i>p</i> value <0.05 compared to vehicle treatment group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Parameters for Compound <b>2e</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">parameter</th><th class="colsep0 rowsep0" align="left">mouse</th><th class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="left">dog<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">5<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM), PO</td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="left">2.3 ± 1.4</td><td class="colsep0 rowsep0" align="left">22 ± 4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (μM), PO</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.60</td><td class="colsep0 rowsep0" align="left">2.9 ± 2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (μM·h), PO</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">13 ± 8.1</td><td class="colsep0 rowsep0" align="left">102 ± 32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h), iv</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">3.3 ± 0.80</td><td class="colsep0 rowsep0" align="left">4.7 ± 0.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT (h), iv</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">3.5 ± 0.90</td><td class="colsep0 rowsep0" align="left">6.9 ± 0.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl (mL/min/kg), iv</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">11 ± 5.6</td><td class="colsep0 rowsep0" align="left">0.50 ± 0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg), iv</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">2.3 ± 1.1</td><td class="colsep0 rowsep0" align="left">0.20 ± 0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i><sub>po</sub> (%)</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">48</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Average of three animals with associated standard deviation.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Vehicle: PEG400/0.1 M phosphate buffer (80/20 v/v).</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a novel second generation series of spirocyclic hydantoin antagonists of LFA-1 have been identified. Through exploring carboxylic acid substituted heterocycles appended to the pyrrolidine ring of the spirocyclic hydantoin core, we have been able to uncover a new structural interaction with Thr 231 and a potential second interaction with Tyr 257, as determined by the X-ray co-crystal of <b>2e</b> with the I-Domain of LFA-1. SAR studies led to multiple highly potent antagonists of LFA-1. On the basis of in vitro and ex vivo potency, in vivo activity, and pharmacokinetic and safety profiles, 6-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic acid (<b>2e</b>) was selected as a lead compound. With the additional binding interactions, compound <b>2e</b> was found to have an approximately 4- to 8-fold improvement in human in vitro potency, a 4-fold improvement in a human IL-2 whole blood ex vivo assay, and a 2-fold higher free fraction relative to <b>1</b>. Compound <b>2e</b> was efficacious at a dose of 1 mg/kg BID in a mouse allergic eosinophilic lung inflammation model. On the basis of its preclinical profile and potential for improved efficacy in humans over <b>1</b>, spirocyclic hydantoin <b>2e</b> was advanced into clinical trials.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Proton magnetic resonance (<sup>1</sup>H) spectra were recorded on either a Bruker Avance 400 or a JEOL Eclipse 500 spectrometer and are reported in ppm relative to the reference solvent of the sample in which they were run. HPLC and LCMS analyses were conducted using a Shimadzu SCL-10A liquid chromatograph and a SPD UV−vis detector at 220 or 254 nm with the MS detection performed with either a Micromass Platform LC spectrometer or a Waters Micromass ZQ spectrometer. Preparative reverse-phase HPLC purifications were performed using the following conditions: YMC S5 ODS 20 mm × 100 mm column with a binary solvent system where solvent A = 10% methanol, 90% water, 0.1% trifluoroacetic acid and solvent B = 90% methanol, 10% water, and 0.1% trifluoroacetic acid, flow rate = 20 mL/min, linear gradient time = 10 min, start %B = 20, final %B = 100. Fractions containing the product were concentrated in vacuo to remove the methanol and neutralized with aqueous sodium bicarbonate. The pH was adjusted to ∼4.5−5.0, and the aqueous layer was extracted with organic solvents. The organic layer was collected, dried over anhydrous sodium sulfate or magnesium sulfate, and concentrated under reduced pressure. All flash column chromatography was performed on EM Science silica gel 60 (particle size of 40−60 μm). All reagents were purchased from commercial sources and used without further purification unless otherwise noted. All reactions were performed under an inert atmosphere.</div><div class="NLM_p">HPLC analyses were performed using the following conditions. All final compounds had an HPLC purity of ≥95% unless specifically mentioned.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Method A</h3><div class="NLM_p last">A linear gradient using 5% acetonitrile, 95% water, and 0.05% TFA (solvent A) and 95% acetonitrile, 5% water, and 0.05% TFA (solvent B); <i>t</i> = 0 min, 10% B; <i>t</i> = 15 min, 100% B (20 min.) was employed on a SunFire C18 3.5 μ 4.6 mm × 150 mm column. Flow rate was 1.0 mL/min and UV detection was set to 220/254 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Method B</h3><div class="NLM_p last">A linear gradient using 5% acetonitrile, 95% water, and 0.05% TFA (solvent A) and 95% acetonitrile, 5% water, and 0.05% TFA (solvent B); <i>t</i> = 0 min, 10% B; <i>t</i> = 15 min, 100% B (20 min.) was employed on a XBridge Ph 3.5 μ 4.6 mm × 150 mm column. Flow rate was 1.0 mL/min and UV detection was set to 220/254 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Method C</h3><div class="NLM_p last">A linear gradient using water/TFA (100/0.05) (solvent A) and acetonitrile/TFA (100/0/05) (solvent B); <i>t</i> = 0 min, 10% B; <i>t</i> = 35 min, 95% B (40 min.) was employed on a Luna C18(2) 0.46 cm × 15 cm, 3 μ column. Flow rate was 1.0 mL/min and UV detection was set to 220 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Method D</h3><div class="NLM_p last">A linear gradient using 10% methanol, 90% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent A) and 90% methanol, 10% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent B); <i>t</i> = 0 min, 0% B; <i>t</i> = 4 min, 100% B (5 min.) was employed on a Chromolith SpeedROD 4.6 mm × 50 mm column. Flow rate was 4.0 mL/min and UV detection was set to 220 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Method E</h3><div class="NLM_p last">A linear gradient using 10% methanol, 90% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent A) and 90% methanol, 10% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent B); <i>t</i> = 0 min, 0% B; <i>t</i> = 4 min, 100% B (5 min) was employed on a YMC ODS 4.6 mm × 50 mm column. Flow rate was 4.0 mL/min and UV detection was set to 220 or 254 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Method F</h3><div class="NLM_p last">A linear gradient using 10% methanol, 90% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent A) and 90% methanol, 10% water, and 0.2% H<sub>3</sub>PO<sub>4</sub> (solvent B); <i>t</i> = 0 min, 0% B; <i>t</i> = 8 min, 100% B (11 min) was employed on a Zorbax Rapid Res 3.5 μ 4.6 mm × 50 mm column. Flow rate was 2.5 mL/min and UV detection was set to 220 nm. The LC column was maintained at ambient temperature.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Method G</h3><div class="NLM_p">A linear gradient using 10% methanol, 90% water, and 0.1% TFA (solvent A) and 90% methanol, 10% water, and 0.1% TFA (solvent B); <i>t</i> = 0 min, 0% B; <i>t</i> = 4 min, 100% B (5 min) was employed on a Phenomenex Phenom-Prime 4.6 mm × 50 mm column. Flow rate was 4.0 mL/min and UV detection was set to 220 or 254 nm. The LC column was maintained at ambient temperature.</div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 4-((5<i>S</i>,9<i>R</i>)-3-(3,5-Dichlorophenyl)-1-methyl-2,4-dioxo-7-(pyridin-2-yl)-1,3,7-triazaspiro[4.4]nonan-9-yl)benzonitrile (<b>2a</b>)</h4><div class="NLM_p last">A mixture of <b>6</b> (0.100 g, 0.240 mmol), potassium carbonate (0.037 mg, 0.270 mmol), and 2-bromopyridine (0.025 mL, 0.260 mmol) was heated at 100 °C in dimethylformamide (1.0 mL) for 20 h. After cooling to room temperature, the insoluble salts were removed and the filtrate was partitioned between water and ethyl acetate. The aqueous layer was extracted with ethyl acetate, and the combined organic layers were washed with brine, concentrated under reduced pressure, and purified by flash silica gel chromatography to yield <b>2a</b> (30 mg, 25%) as a white solid. HPLC purity 97.1%; <i>t</i><sub>r</sub> = 10.86 min (method A); 95.9%; <i>t</i><sub>r</sub> = 12.30 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>25</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 492.10. Found: 492.10. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.24 (s, 3H), 3.95−4.30 (m, 5H), 6.50 (m, 1H), 6.70 (m, 1H), 6.79 (m, 2H), 7.10 (m, 1H), 7.39 (m, 2H), 7.70 (m, 3H), and 8.22 (m, 1H).</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 6-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinonitrile (<b>2b</b>)</h4><div class="NLM_p last">A mixture of <b>6</b> (0.083 g, 0.200 mmol), 6-chloro-nicotinonitrile (0.040 g, 0.290 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.046 g, 0.050 mmol), biphenyl-2-yldicyclohexylphosphine (17.5 mg, 0.050 mmol), potassium <i>t</i>-butoxide (0.042 g, 0.380 mmol), and dimethylformamide (3.0 mL) was flushed well with nitrogen. The mixture was stirred at 85 °C overnight and then purified by preparative HPLC to provide <b>2b</b> (0.042 g, 41%) as a yellow solid. HPLC purity 99.1%; <i>t</i><sub>r</sub> = 15.97 min (method A); 99.1%; <i>t</i><sub>r</sub> = 15.28 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>26</sub>H<sub>18</sub>C<sub>l2</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 517.09. Found: 517.12. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.24 (s, 3H), 3.94−4.04 (m, 2H), 4.09−4.22 (m, 2H), 4.34 (t, <i>J</i> = 11.0 Hz, 1H), 6.51 (d, <i>J</i> = 8.80 Hz, 1H), 6.80 (s, 2H), 7.29 (s, 1H), 7.38 (2H, d, <i>J</i> = 8.25 Hz), 7.66−7.75 (m, 3H), and 8.48 (s, 1H).</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 4,4′-((5<i>S</i>,9<i>R</i>)-3-(3,5-Dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonane-7,9-diyl)dibenzonitrile (<b>2c</b>)</h4><div class="NLM_p last">To a solution of <b>6</b> (0.100 g, 0.240 mmol) in dichloromethane (5.0 mL) were sequentially added 4-cyanophenylboronic acid (0.071 g, 0.480 mmol), copper(II) acetate (0.066 g, 0.360 mmol), triethylamine (0.067 mL, 0.480 mmol), and 4 Å molecular sieves (0.200 g) at room temperature. The reaction mixture was stirred for 20 h exposed to the atmosphere and then quenched by the addition of aqueous ammonia (2.0 mL). After stirring at room temperature for 10 min, the reaction mixture was concentrated. To the resulting residue was added 20 mL of dichloromethane, and the contents were filtered over a pad of celite. The filtrate was concentrated under reduced pressure and purified by flash silica gel chromatography to yield <b>2c</b> (0.018 g, 14%) as a solid. HPLC purity 99.2%; <i>t</i><sub>r</sub> = 16.48 min (method A); 97.7%; <i>t</i><sub>r</sub> = 15.81 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>27</sub>H<sub>19</sub>C<sub>l2</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 516.10. Found: 516<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.27 (s, 3H), 3.80−3.85 (m, 1H), 3.89−3.94 (m, 1H), 3.98−4.05 (m, 2H), 4.21−4.29 (m, 1H), 6.66 (d, <i>J</i> = 9.06 Hz, 2H), 6.80 (d, <i>J</i> = 1.76 Hz, 2H), 7.30 (t, <i>J</i> = 1.76 Hz, 1H), 7.40 (d, <i>J</i> = 8.31 Hz, 2H,), 7.57 (d, <i>J</i> = 8.81 Hz, 2H,), and 7.71 (d, <i>J</i> = 8.56 Hz, 2H).</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 5-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)picolinonitrile (<b>2d</b>)</h4><div class="NLM_p last">A mixture of <b>6</b> (0.021 g, 0.050 mmol), 5-bromopicolinonitrile (13.7 mg, 0.075 mmol), tris(dibenzylideneacetone)dipalladium(0) (11.4 mg, 0.013 mmol), biphenyl-2-yldicyclohexylphosphine (4.4 mg, 0.013 mmol), and potassium <i>t</i>-butoxide (10.6 mg, 0.095 mmol) was flushed well with nitrogen. Dimethylformamide (4.0 mL) was added, and the reaction mixture was stirred at 96 °C overnight. The mixture was diluted with dichloromethane, filtered through a pad of celite, and the filtrate was washed with water (2×), concentrated under reduced pressure, and purified by flash silica gel chromatography to provide <b>2d</b> (2.0 mg, 7.7%) as white solid. HPLC purity 99%; <i>t</i><sub>r</sub> = 6.61 min (method F); 99%; <i>t</i><sub>r</sub> = 3.23 min (method E). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>26</sub>H<sub>18</sub>C<sub>l2</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 517.09. Found: 517.10. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.27 (s, 3H), 3.49−4.32 (m, 5H), 6.79 (d, <i>J</i> = 1.65 Hz, 2H), 6.93 (m, 1H), 7.31 (s, 1H), 7.39 (d, <i>J</i> = 8.5 Hz, 2H), 7.59 (d, <i>J</i> = 8.25 Hz, 1H), 7.71 (d, <i>J</i> = 8.25 Hz, 2H), and 8.14 (d, <i>J</i> = 2.75 Hz, 1H).</div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 6-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (<b>2e</b>)</h4><div class="NLM_p">A mixture of 6-chloronicotinic acid (12.0 g, 76.0 mmol) and thionyl chloride (65.0 mL) was heated at reflux for 3.0 h. The excess thionyl chloride was removed under reduced pressure, and the residual liquid was diluted with dichloromethane (20.0 mL) and then added to a solution of <i>tert</i>-butyl alcohol (71.0 mL, 760 mmol) in dichloromethane (40.0 mL). To the mixture was added triethylamine (31.7 mL, 760 mmol) and <i>N</i>,<i>N</i>-dimethylpyridine (0.500 g, 4.00 mmol), and the reaction mixture was stirred overnight (14 h) at reflux under nitrogen. The solution was diluted with dichloromethane (200 mL), washed with a saturated aqueous solution of sodium bicarbonate (3 × 100 mL), washed with water (3 × 100 mL), and dried over anhydrous sodium sulfate. Concentration under reduced pressure provided <i>tert</i>-butyl 6-chloronicotinate (<b>7</b>, 11.4 g, 70%) as a yellow solid. HPLC purity 96%; <i>t</i><sub>r</sub> = 3.18 min (method E). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>10</sub>H<sub>12</sub>ClNO<sub>2</sub> [M + H]<sup>+</sup> 213.06. Found: 214<sup>+</sup>.</div><div class="NLM_p">To a mixture of <b>6</b> (14.5 g, 34.9 mmol) and <i>tert</i>-butyl 6-chloronicotinate (<b>7</b>, 8.0 g, 35.6 mmol) in dimethylacetamide (50.0 mL) was added diisopropylethylamine (11.3 g, 87.3 mmol). The reaction mixture was stirred at 112 °C for 18 h under nitrogen. After cooling, the mixture was added slowly to ice water (200 mL) with stirring. After 10 min, the resulting precipitate was collected by vacuum filtration and washed with water (3 × 20 mL). The crude product was dried and purified by flash silica gel chromatography using a mixture of ethyl acetate and dichloromethane (5−10%) to give <i>tert</i>-butyl 6-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinate (<b>8</b>) as yellow solid (15.8 g, 77%). HPLC <i>t</i><sub>r</sub> = 3.91 min (method E). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>30</sub>H<sub>27</sub>C<sub>l2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 591.14. Found: 592<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ = 1.59 (s, 9H), 3.26 (s, 3H), 3.95−4.25 (m, 5H), 6.47 (d, <i>J</i> = 9.0 Hz, 1H), 6.81−6.82 (m, 2H), 7.29−7.30 (m, 1H), 7.40 (d, <i>J</i> = 8.0 Hz, 2H), 7.70 (d, <i>J</i> = 8.0 Hz, 2H), 8.08 (dd, <i>J</i> = 9.0 and 2.4 Hz, 1H), and 8.82 (d, <i>J</i> = 2.4 Hz, 1H).</div><div class="NLM_p">To the solution of <i>tert</i>-butyl 6-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinate (<b>8</b>, 15.5 g, 26.2 mmol) in dichloromethane (50.0 mL) was added trifluoroacetic acid (50.0 mL) dropwise with stirring between 0 and 5 °C. After the addition was complete, the ice water bath was removed and the mixture was stirred at room temperature for 3.5 h. The solvent was then removed under reduced pressure, and the residue was diluted with dichloromethane (400 mL) and water (100 mL). After stirring for 10 min, the pH of the aqueous layer was adjusted to ∼9 with a saturated aqueous solution of sodium bicarbonate. The mixture was stirred for 15 min, and the pH was rechecked to ensure basicity. The pH was then adjusted to ∼4.5 with a 1N aqueous solution of hydrochloric acid. After stirring for 15 min, the organic layer was collected and the aqueous layer was extracted with dichloromethane (50 mL). The organic phases were combined, washed with brine (100 mL), and dried over anhydrous sodium sulfate. Concentration under reduced pressure gave the crude product as a solid, which was dissolved in chloroform (55 mL) and stirred gently overnight at room temperature. The mixture was stirred for 30 min in an ice bath, and the resulting precipitate was collected by vacuum filtration. The white crystals were washed with cold chloroform (2 × 5 mL) and dried under reduced pressure to give the product (11.5 g). A second crop (0.600 g) was obtained through partial concentration of the mother liquor to give a total of 12.1 g (86%) of 6-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]-nonan-7-yl)nicotinic acid (<b>2e</b>) as a white solid.</div><div class="NLM_p last">HPLC purity 99.8%; <i>t</i><sub>r</sub> = 13.03 min (method B); 99.8%; <i>t</i><sub>r</sub> = 19.63 min (method C). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>26</sub>H<sub>19</sub>C<sub>l2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 536.09. Found: 536.23 and 538.22. Anal. Calcd for C<sub>26</sub>H<sub>19</sub>C<sub>l2</sub>N<sub>5</sub>O<sub>4</sub>; 0.48% H<sub>2</sub>O: C 57.92, H 3.61, N 12.99, Cl 13.19. Found C 57.77, H 3.54, N 12.79, Cl 13.07. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.20 (s, 3 H), 4.01 (d, <i>J</i> = 12.10 Hz, 1H), 4.13−4.21 (m, <i>J</i> = 10.17, 10.17 Hz, 3H), 4.37 (t, <i>J</i> = 9.62 Hz, 1H), 6.69 (d, <i>J</i> = 8.25 Hz, 1H), 6.81 (s, 2H), 7.48 (d, <i>J</i> = 8.80 Hz, 2H), 7.64 (s, 1H), 7.89 (d, <i>J</i> = 8.80 Hz, 2H), 8.02 (dd, <i>J</i> = 8.80, 2.20 Hz, 1H), 8.69 (s, 1H), and 12.57 (s, 1H). Enatiomeric excess = 100% [Chiralcel OD-H, 0.46 cm × 25 cm, 5 μm particle size; EtOH/TFA (100:0.1)].</div></div><div id="sec5_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-((5<i>S</i>,9<i>R</i>)-7-(5-(1<i>H</i>-Tetrazol-5-yl)pyridin-2-yl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-9-yl)benzonitrile (<b>2f</b>)</h4><div class="NLM_p">To a solution of 6-chloronicotinonitrile (2.76 g, 20.0 mmol) in anisole (30 mL) at 60 °C was added sequentially triethylamine (5.00 g, 50.0 mmol), acetic acid (3.00 g, 50.0 mmol), and sodium azide (3.30 g, 36.0 mmol). The reaction mixture was heated at 130 °C for 1.2 h and then cooled to 90 °C. Water (30 mL) followed by anisole (10 mL) was added, and the mixture was stirred for 10 min. The mixture was extracted with ethyl acetate (3×), and the aqueous layer was acidified to a pH of 5 with 2N aqueous hydrochloric acid and extracted with dichloromethane (3×). The organic layer was collected, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to give 2-chloro-5-(1<i>H</i>-tetrazol-5-yl)pyridine (<b>9</b>, 1.10 g, 30%). HPLC purity 74%; <i>t</i><sub>r</sub> = 1.77 min (method D). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.39 (d, <i>J</i> = 8.25 Hz, 1H), 8.44 (dd, <i>J</i> = 8.25, 2.20 Hz, 1H), and 9.17 (d, <i>J</i> = 2.20 Hz, 1H).</div><div class="NLM_p">To the solution of 2-chloro-5-(1<i>H</i>-tetrazol-5-yl)pyridine (<b>9</b>, 0.360 g, 2.00 mmol) in chloroform (20 mL) was added a 10% aqueous solution of sodium hydroxide (10 mL) and TBAB (0.064 g, 0.200 mmol). After stirring for 5 min, a solution of trityl chloride (0.668 g, 2.40 mmol) in chloroform (5.0 mL) was added dropwise. The mixture was stirred at room temperature for 3 h. The organic phase was separated, washed with a 10% aqueous solution of sodium hydroxide, washed with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The crude product was recrystallized from ethyl acetate/hexane (1:10) to give 2-chloro-5-(1-trityl-1<i>H</i>-tetrazol-5-yl)pyridine (<b>10</b>, 330 mg, 39%). HPLC purity 78%; <i>t</i><sub>r</sub> = 4.29 min (method D). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.11−7.46 (m, 16H), 8.35 (dd, <i>J</i> = 8.52, 2.47 Hz, 1H), and 9.12 (d, <i>J</i> = 2.20 Hz, 1H).</div><div class="NLM_p last">The mixture of <b>6</b> (0.021 g, 0.050 mmol), 2-chloro-5-(1-trityl-1<i>H</i>-tetrazol-5-yl)pyridine (<b>10</b>, 0.021 g, 0.050 mmol), and diisopropylethylamine (100 μL) was stirred at 120 °C overnight. After cooling, the diisopropylamine was removed under reduced pressure, and the crude product mixture (<b>11</b>) was dissolved in methanol (3.0 mL). Trifluoroacetic acid (1.0 mL) was added, and the mixture was stirred for 1 h at room temperature. Concentration under reduced pressure followed by purification by preparative HPLC provided <b>2f</b> as a white solid (3.3 mg, 12%). HPLC purity 97.7%; <i>t</i><sub>r</sub> = 13.21 min (method A); 96.9%; <i>t</i><sub>r</sub> = 13.01 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>26</sub>H<sub>19</sub>C<sub>l2</sub>N<sub>9</sub>O<sub>2</sub> [M + H]<sup>+</sup> 560.11. Found: 560.11. <sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>) δ 3.28 (s, 3H), 4.09−4.19 (m, 2H), 4.24 (s, 1H), 4.31−4.40 (m, 2H), 6.83 (d, <i>J</i> = 2.20 Hz, 2H), 6.89 (d, <i>J</i> = 9.35 Hz, 1H,), 7.42 (s, 1H), 7.55 (d, <i>J</i> = 8.25 Hz, 2H), 7.79 (d, <i>J</i> = 8.25 Hz, 2H), 8.21 (dd, <i>J</i> = 9.35, 2.20 Hz, 1H), and 8.79 (d, <i>J</i> = 2.20 Hz, 1H).</div></div><div id="sec5_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyrimidine-5-carboxylic Acid (<b>2g</b>)</h4><div class="NLM_p">A mixture of <b>6</b> (0.100 g, 0.241 mmol), ethyl 2-chloropyrimidine-5-carboxylate<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (0.068 g, 0.362 mmol), and diisopropyl ethylamine (0.084 mL, 0.482 mmol) in anhydrous dimethylformamide (3 mL) was heated at 100 °C for 2 h. Water was added, the solvent was removed under reduced pressure, and the residue was diluted with dichloromethane, washed with water, and dried over anhydrous sodium sulfate. Concentration under reduced pressure followed by purification by flash silica gel chromatography using a 1:1 mixture of ethyl acetate and dichloromethane afforded ethyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyrimidine-5-carboxylate (0.054 g, 40%) as a white solid. HPLC purity 99%; <i>t</i><sub>r</sub> = 3.84 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>27</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup> 565.12. Found: 565.16 and 567.16. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.38 (t, <i>J</i> = 6.87 Hz, 3H), 3.24 (s, 3H), 3.97 (t, <i>J</i> = 9.62 Hz, 1H), 4.06 (d, <i>J</i> = 12.65 Hz, 1H), 4.24 (d, <i>J</i> = 13.20 Hz, 1H), 4.37 (q, <i>J</i> = 7.15 Hz, 2H), 4.45 (d, <i>J</i> = 9.90 Hz, 2H), 6.79 (s, 2H), 7.29 (s, 1H), 7.38 (d, <i>J</i> = 7.70 Hz, 2H), 7.69 (d, <i>J</i> = 8.25 Hz, 2H), and 8.94 (s, 2H).</div><div class="NLM_p last">A mixture of ethyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyrimidine-5-carboxylate (0.017 g, 0.031 mmol) and 1,2-propanediol (0.005 mL, 0.061 mmol) in tetrahydrofuran (1.0 mL) and water (0.5 mL) was stirred for 15 min at room temperature. A 1.0 M aqueous solution of potassium hydroxide (0.076 mL, 0.077 mmol) was added, and the reaction mixture was stirred for 7 h. To the mixture was added water (0.5 mL) followed by acetic acid (0.042 mL), and the tetrahydrofuran was removed under reduced pressure. The aqueous residue was diluted with water and dichloromethane, and the aqueous pH was adjusted to ∼6.0 with 1N aqueous hydrochloric acid. The organic layer was collected, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by preparative HPLC to give <b>2g</b> (0.006 g) as a white solid. HPLC purity 97.2%; <i>t</i><sub>r</sub> = 14.31 min (method A); 97.0%; <i>t</i><sub>r</sub> = 13.72 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>25</sub>H<sub>18</sub>C<sub>l2</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup> 537.08. Found: 537.19 and 537.16. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.26 (s, 3H), 3.98 (t, <i>J</i> = 8.8 Hz, 1H), 4.09 (d, <i>J</i> = 13.0 Hz, 1H), 4.28 (d, <i>J</i> = 13.0 Hz, 1H), 4.47−4.49 (m, 2H), 6.80 (s, 2H), 7.30 (s, 1H), 7.39 (d, <i>J</i> = 7.5 Hz, 2H), 7.70 (d, <i>J</i> = 7.5 Hz, 2H), and 8.98−8.99 (m, 2H).</div></div><div id="sec5_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyrazine-2-carboxylic Acid (<b>2h</b>)</h4><div class="NLM_p">A mixture of <b>6</b> (0100 g, 0.241 mmol), methyl 5-chloropyrazine-2-carboxylate (0.046 g, 0.265 mmol), and diisopropylethylamine (0.084 mL, 0.482 mmol) in anhydrous dimethylformamide (3.0 mL) was heated at 100 °C overnight. The solvent was removed under reduced pressure, and the residue was dissolved in dichloromethane, washed with water, and dried over anhydrous sodium sulfate. Concentration under reduced pressure followed by purification by preparative HPLC afforded methyl 5-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyrazine-2-carboxylate (0.114 g, 86%) (<b>12</b>) as a white solid. HPLC purity >99%; <i>t</i><sub>r</sub> = 3.27 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>26</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup> 551.10. Found: 551.17 and 553.16. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.26 (s, 3H), 3.98 (s, 3H), 4.00−4.06 (m, 2H), 4.17 (d, <i>J</i> = 12.65 Hz, 1H,) 4.30 (t, 1H), 4.43 (t, <i>J</i> = 11.00 Hz, 1H), 6.80 (s, 2H), 7.30 (s, 1H), 7.40 (d, <i>J</i> = 8.25 Hz, 2H), 7.70 (d, <i>J</i> = 8.25 Hz, 2H), 8.05 (s, 1H), and 8.89 (s, 1H).</div><div class="NLM_p last">A mixture of methyl 5-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyrazine-2-carboxylate (<b>12</b>, 0.099 g, 0.180 mmol) and 1,2-propanediol (0.026 mL, 0.360 mmol) in tetrahydrofuran (1.0 mL) and water (0.5 mL) was stirred for 15 min at room temperature. A 1.0 M aqueous solution of potassium hydroxide (0.45 mL, 0.450 mmol) was added, and the reaction mixture was stirred for 20 h. The tetrahydrofuran was removed under reduced pressure, and the aqueous residue was extracted with dichloromethane. The organic layer was collected, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by preparative HPLC to give <b>2h</b> (0.027 g) as a white solid. HPLC purity 97.8%; <i>t</i><sub>r</sub> = 13.63 min (method A); 94.5%; <i>t</i><sub>r</sub> = 13.25 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>25</sub>H<sub>18</sub>C<sub>l2</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup> 537.08. Found: 537.45 and 539.40. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.20 (s, 3H), 4.02−4.12 (m, <i>J</i> = 10.45 Hz, 1H), 4.15−4.32 (m, 3H), 4.34−4.45 (m, <i>J</i> = 9.90 Hz, 1H), 6.82 (s, 2H), 7.49 (d, <i>J</i> = 8.25 Hz, 2H), 7.64 (s, 1H), 7.90 (d, <i>J</i> = 8.25 Hz, 2H), 8.13 (s, 1H), and 8.72 (s, 1H).</div></div><div id="sec5_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-((5<i>S</i>,9<i>R</i>)-3-(3,5-Dichlorophenyl)-1-methyl-2,4-dioxo-9-phenyl-1,3,7-triazaspiro[4.4]nonan-7-yl)pyridazine-3-carboxylic Acid (<b>2i</b>)</h4><div class="NLM_p">To a suspension of 6-hydroxypyridazine-3-carboxylic acid (2.00 g, 14.3 mmol) in methanol (50 mL) was added concentrated sulfuric acid (1.5 mL). The mixture was heated at reflux for 4 h, cooled to room temperature, and concentrated under reduced pressure to give a solid. The solid was suspended in ice water (50 mL), filtered under reduced pressure, and washed with additional ice water (50 mL). The precipitate was air-dried to give methyl 6-hydroxypyridazine-3-carboxylate (2.00 g,). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>6</sub>H<sub>6</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 155.05. Found: 155<sup>+</sup>. The compound was used in the next step without any further purification.</div><div class="NLM_p">Methyl 6-hydroxypyridazine-3-carboxylate (0.200 g) was suspended in phosphorus oxychloride (2.0 mL) and heated at 110 °C for 4 h. The reaction mixture was cooled to room temperature, the excess phosphorus oxychloride was removed under reduced pressure, and the resulting slurry was treated with ice water (5 mL). The resulting precipitate was filtered, rinsed with ice water (10 mL), and air-dried to give methyl 6-chloropyridazine-3-carboxylate (<b>21</b>, 110 mg). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>6</sub>H<sub>5</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 173.01. Found: 172.90. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.07 (s, 3H), 7.67 (d, <i>J</i> = 8.81 Hz, 1H), and 8.15 (d, <i>J</i> = 8.81 Hz, 1H).</div><div class="NLM_p">To a solution of <b>6</b> (0.082 g, 0.200 mmol) and methyl 6-chloropyridazine-3-carboxylate (<b>21</b>, 0.040 g) in dimethylformamide (1.5 mL) was added diisopropylethylamine (0.090 mL, 0.500 mmol). The reaction mixture was heated at 95 °C for 4 h, cooled to room temperature, and purified by preparative HPLC to give methyl 6-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyridazine-3-carboxylate as a trifluoroacetic acid salt (95 mg, 71%). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>26</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup> 551.10. Found: 553<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.25 (s, 3H), 4.00 (s, 3H), 4.08 (m, 1H), 4.16−4.26 (m, 2H), 4.31 (m, 1H), 4.45 (t, <i>J</i> = 10.83 Hz, 1H), 6.80 (d, <i>J</i> = 2.01 Hz, 2H), 6.97 (d, <i>J</i> = 9.57 Hz, 1H), 7.30 (t, <i>J</i> = 2.01 Hz, 1H), 7.39 (d, <i>J</i> = 8.06 Hz, 2H), 7.70 (d, <i>J</i> = 8.06 Hz, 2H), and 8.10 (d, <i>J</i> = 9.57 Hz, 1H).</div><div class="NLM_p last">To a solution the methyl 6-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyridazine-3-carboxylate, trifluoroacetic acid salt (0.055 g, 0.100 mmol) in tetrahydrofuran (2.5 mL) and methanol (0.5 mL) was added 1,2-propanediol (0.020 mL) followed by 1N aqueous solution of potassium hydroxide (0.250 mL, 0.250 mmol). The mixture was stirred at room temperature for 4 h, acidified with a 10% aqueous solution of acetic acid to a pH of 5−6, and extracted with dichloromethane. The combined organic layers were filtered through a plug of a 1:1 MgSO<sub>4</sub>/celite mixture, concentrated under reduced pressure, and purified by preparative HPLC to give <b>2i</b> as a trifluoroacetic acid salt, (12 mg, 37%). HPLC purity 98%; <i>t</i><sub>r</sub> = 6.04 min (method F); 98%; <i>t</i><sub>r</sub> = 3.00 min (method E). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>25</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup> 537.08. Found: 537<sup>+</sup> and 539<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 3.28 (s, 3H), 4.15−4.48 (m, 5H), 6.84 (s, 2H), 7.32 (d, <i>J</i> = 9.06 Hz, 1H), 7.43 (s, 1H), 7.56 (d, <i>J</i> = 8.06 Hz, 2H), 7.78 (d, <i>J</i> = 8.06 Hz, 2H), and 8.13 (d, <i>J</i> = 9.32 Hz, 1H).</div></div><div id="sec5_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)isonicotinic Acid (<b>2j</b>)</h4><div class="NLM_p">A mixture of <b>6</b> (5.00 g, 0.012 mol) and 2-chloroisonicotinic acid, methyl ester (16.5 g, 0.096 mol), in a sealed tube was heated at 96 °C for 4.5 days. By HPLC, the reaction was complete. After cooling, the reaction mixture was diluted with dichloromethane, washed with a saturated aqueous solution of sodium bicarbonate, and dried over anhydrous sodium sulfate. Concentration under reduced pressure followed by purification by flash silica gel chromatography afforded methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)-isonicotinate (<b>15</b>, 2.45 g, 37%) as an off-white solid. HPLC purity >98%; <i>t</i><sub>r</sub> = 3.24 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>27</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 550.10. Found: 550.29 and 552.28. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.24 (s, 3H), 3.93 (s, 3H), 3.97−4.05 (m, 2H), 4.08−4.12 (m, 1H), 4.19 (t, <i>J</i> = 8.80 Hz, 1H), 4.30−4.35 (m, 1H), 6.79 (s, 2H), 7.09 (s, 1H), 7.22 (d, <i>J</i> = 5.50 Hz, 1H), 7.27 (s, 1H), 7.39 (d, <i>J</i> = 8.25 Hz, 2H), 7.68 (d, <i>J</i> = 8.25 Hz, 2H), and 8.32 (d, <i>J</i> = 4.95 Hz, 1H).</div><div class="NLM_p last">A mixture of methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)-isonicotinate (<b>15</b>, 1.55 g, 2.82 mmol) and lithium iodide (11.6 g) in anhydrous dimethylacetamide (15 mL) was heated at 140 °C overnight. HPLC analysis indicated that there was ∼20% starting material remaining. An additional 5.0 g of lithium iodide was added, and the mixture was heated overnight. The reaction was cooled to room temperature, and acetic acid (∼4.0 mL) was added followed by water (20 mL). The pH was adjusted to 5.0 with a 1.0 M aqueous solution of sodium hydroxide. The solid was collected by vacuum filtration, washed with water, and dried well under reduced pressure to give the product (1.40 g) as a light-brown solid. The compound was further purified by flash silica gel chromatography to give <b>2j</b> (1.30 g) as a yellow solid. HPLC purity 99.0%; <i>t</i><sub>r</sub> = 11.89 min (method A); 99.4%; <i>t</i><sub>r</sub> = 12.36 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>26</sub>H<sub>19</sub>C<sub>l2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 536.09. Found: 536.23 and 538.22. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.20 (s, 3H) 3.98 (d, <i>J</i> = 12.10 Hz, 1H), 4.05−4.16 (m, 3H), 4.35 (t, <i>J</i> = 9.62 Hz, 1H), 6.80 (s, 2 H), 7.05 (s, 1H), 7.08 (d, <i>J</i> = 4.95 Hz, 1H), 7.48 (d, <i>J</i> = 8.25 Hz, 2H), 7.63 (s, 1H), 7.88 (d, <i>J</i> = 8.25 Hz, 2H), and 8.21 (d, <i>J</i> = 4.95 Hz, 1H).</div></div><div id="sec5_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)picolinic Acid (<b>2k</b>)</h4><div class="NLM_p last">A mixture of <b>6</b> (0.021 mg, 0.050 mmol), 4-chloropicolinic acid (11.8 mg, 0.075 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.014 g, 0.016 mmol), BINAP (0.010 g, 0.016 mmol), and diisopropylamine (0.020 mL) was flushed well with nitrogen. Dimethylacetamide (2.0 mL) was added, and the mixture was stirred at 90 °C overnight. The mixture was diluted with dichloromethane (50 mL), filtered through a pad of celite, and the filtrate was washed with water (2×), concentrated under reduced pressure, and purified by preparative HPLC to provide <b>2k</b> (9.0 mg, 33%) as a white solid. HPLC purity 99%; <i>t</i><sub>r</sub> = 5.62 min (method F); 99%; <i>t</i><sub>r</sub> = 2.81 min (method E). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>26</sub>H<sub>19</sub>C<sub>l2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 536.09. Found: 536.18. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 3.21 (s, 3H), 4.10−4.30 (m, 5H), and 6.75−8.05 (m, 10H).</div></div><div id="sec5_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyrimidine-4-carboxylic Acid (<b>2l</b>)</h4><div class="NLM_p">To a solution of <b>6</b> (100 mg, 0.240 mmol) in dimethylformamide (1.0 mL) was added methyl 2-(methylsulfonyl)pyrimidine-4-carboxylate<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (0.052 g, 0.240 mmol). The reaction mixture was allowed to heat for 4 h at 100 °C. The reaction mixture was diluted with water, extracted with diethyl ether, and concentrated under reduced pressure. The resulting residue was purified by flash silica gel chromatography to give methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyrimidine-4-carboxylate (0.037 g, 28%). HPLC <i>t</i><sub>r</sub> = 3.59 min (method G). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>26</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup> 551.10. Found: 551<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.19 (s, 3H), 3.91 (s, 3H), 3.91 (m, 1H), 4.03 (m, 1H), 4.21 (m, 1H), 4.39 (m, 2H), 6.72 (d, <i>J</i> = 1.65 Hz, 2H,), 7.23 (m, 1H), 7.24 (d, <i>J</i> = 4.95 Hz, 1H), 7.33 (d, <i>J</i> = 8.25 Hz, 2H), 7.62 (d, <i>J</i> = 8.25 Hz, 2H), and 8.54 (m, 1H).</div><div class="NLM_p last">To a solution of methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyrimidine-4-carboxylate (0.033 g, 0.060 mmol) in tetrahydrofuran (2.8 mL) and water (1.4 mL) was added 1,2-propanediol (0.083 mL). The mixture was stirred at room temperature for 5 min, at which point a 1.0 M aqueous solution of potassium hydroxide (0.147 mL) was added. After stirring for 2 h, the reaction mixture was concentrated under reduced pressure, and the resulting residue was neutralized with an ion-exchange resin to give <b>2l</b> as a white soid (22.5 mg, 70%). HPLC purity 98.1%; <i>t</i><sub>r</sub> = 14.11 min (method A); 97.3%; <i>t</i><sub>r</sub> = 13.52 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>25</sub>H<sub>18</sub>C<sub>l2</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup> 537.08. Found: 537<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.19 (s, 3H), 3.96 (d, <i>J</i> = 12.1 Hz, 1H), 4.19 (m, 3H), 4.34 (m, 1H), 6.78 (m, 2H), 7.05 (d, <i>J</i> = 5.0 Hz, 1H), 7.46 (d, <i>J</i> = 8.25 Hz, 2H), 7.62 (m, 1H), 7.86 (d, <i>J</i> = 8.25 Hz, 2H), and 8.50 (d, <i>J</i> = 5.0 Hz, 1H).</div></div><div id="sec5_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyrimidine-4-carboxylic Acid (<b>2m</b>)</h4><div class="NLM_p">To a mixture of <b>6</b> (0.096 g, 0.231 mmol) and methyl 6-chloropyrimidine-4-carboxylate<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (0.042 g, 0.231 mmol) in dimethylformamide (1.5 mL) was added diisopropylamine (0.121 mL, 0.691 mmol). The reaction mixture was heated for 2 h at 100 °C. The mixture was diluted with water, extracted with diethyl ether, and the organic layer was collected and dried over anhydrous sodium sulfate to give methyl 6-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyrimidine-4-carboxylate (96 mg, 76%). HPLC <i>t</i><sub>r</sub> = 3.12 min (method G). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>26</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup> 551.10. Found: 551<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.26 (s, 3H), 3.60 (m, 1H), 3.83 (m, 1H), 4.01 (s, 3H), 4.09 (m, 2H), 4.40 (m, 1H), 6.79 (m, 2H), 7.24 (s, 1H), 7.29 (s, 1H), 7.38 (d, <i>J</i> = 8.25 Hz, 2H), 7.69 (d, <i>J</i> = 8.25 Hz, 2H), 8.77 (m, 1H).</div><div class="NLM_p last">To a solution of methyl 6-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)pyrimidine-4-carboxylate (0.096 g, 0.174 mmol) in tetrahydrofuran (8.4 mL) and water (4.2 mL) was added 1,2-propanediol (0.25 mL). The reaction mixture was stirred at room temperature for 15 min, and then a 1.0 M aqueous solution of potassium hydroxide (0.440 mL) was added. After stirring at room temperature for 16 h, the reaction mixture was concentrated under reduced pressure, and the resulting residue was purified by preparative HPLC to give <b>2m</b> as a white solid (34.6 mg, 37%). HPLC purity 95.0%; <i>t</i><sub>r</sub> = 11.35 min (method A); 94.8%; <i>t</i><sub>r</sub> = 11.52 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>25</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup> 537.08. Found: 537<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.19 (s, 3H), 4.00−4.40 (m, 5H), 6.79 (d, <i>J</i> = 1.65 Hz, 2H), 7.00 (brs, 1H), 7.48 (d, <i>J</i> = 8.0 Hz, 2H), 7.63 (dd, <i>J</i> = 1.65, 1.65 Hz, 1H), 7.87 (d, <i>J</i> = 8.0 Hz, 2H), 8.52 (s, 1H).</div></div><div id="sec5_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 6-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)-2-methylnicotinic Acid (<b>2n</b>)</h4><div class="NLM_p">A mixture of ethyl-3-amino crotonate (5.20 g, 40.0 mmol) and methyl propiolate (3.40 g, 40.0 mmol) was stirred at 108 °C for 3 h under nitrogen. After cooling, the resulting solid was recrystallized from methanol to give (2<i>E</i>,4<i>Z</i>)-5-ethyl 1-methyl 4-(1-aminoethylidene)pent-2-enedioate as yellow solid (<b>16</b>, 6.10 g, 72%). HPLC purity >95%; <i>t</i><sub>r</sub> = 2.58 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>10</sub>H<sub>15</sub>NO<sub>4</sub> [M + H]<sup>+</sup> 214.11. Found: 214.45. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.35 (t, <i>J</i> = 7.12 Hz, 3H), 2.26 (s, 3H), 3.72 (s, 3H), 4.25 (q, <i>J</i> = 7.12 Hz, 2H), 6.17 (d, <i>J</i> = 15.26 Hz, 1H), and 7.64 (d, <i>J</i> = 15.77 Hz, 1H).</div><div class="NLM_p">A mixture of (2<i>E</i>,4<i>Z</i>)-5-ethyl 1-methyl 4-(1-aminoethylidene)pent-2-enedioate (<b>16</b>, 6.00 g, 28.2 mmol) in dimethylformamide (30 mL) was heated at reflux for 14 h. After cooling, the resulting solid was collected by vacuum filtration, washed with dimethyformamide (3×), washed with diethyl ether (3×), and dried to give ethyl 2-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate (<b>17</b>) as an off-white solid (2.8 g, 55%). HPLC purity >95%; <i>t</i><sub>r</sub> = 1.95 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>9</sub>H<sub>11</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 182.08. Found: 182.42. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.35 (t, <i>J</i> = 7.38 Hz, 3H), 2.72 (s, 3H), 4.30 (q, <i>J</i> = 7.12 Hz, 2H), 6.41 (d, <i>J</i> = 9.66 Hz, 1H), 8.03 (d, <i>J</i> = 9.66 Hz, 1H), and 12.66 (s, 1H).</div><div class="NLM_p">A mixture of ethyl 2-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate (<b>17</b>, 0.610 g, 3.40 mmol) and phosphorus oxychloride (15 mL) was heated at 128 °C for 4 h. After cooling, the mixture was added to 100 mL of ice water, and the pH was then adjusted to 9 with a saturated aqueous solution of sodium bicarbonate. The aqueous mixture was extracted with ethyl acetate (3×), washed with a saturated aqueous solution of sodium chloride (2×), and dried over anhydrous sodium sulfate. Concentration under reduced pressure provided ethyl 6-chloro-2-methylnicotinate (2.3 g, 77%) as white solid. HPLC purity 98%; <i>t</i><sub>r</sub> = 2.84 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>9</sub>H<sub>10</sub>ClNO<sub>2</sub> [M + H]<sup>+</sup> 200.05. Found: 200.39. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.39 (t, <i>J</i> = 7.15 Hz, 3H), 2.81 (s, 3H), 4.37 (q, <i>J</i> = 7.15 Hz, 2H), 7.23 (d, <i>J</i> = 8.25 Hz, 1H), and 8.15 (d, <i>J</i> = 8.25 Hz, 1H).</div><div class="NLM_p">To a solution of ethyl 6-chloro-2-methylnicotinate (2.30 g, 11.5 mmol) and methanol (5.0 mL) was added a 25% aqueous solution of sodium hydroxide (1.0 mL) dropwise. The mixture was stirred at room temperature for 2.5 h. The pH was adjusted to 5−6 with acetic acid, and the solution was concentrated under reduced pressure to give the crude 6-chloro-2-methylnicotinic acid (<b>18</b>, 2.50 g, 98%), which was used to next step without further purification. HPLC purity 99%; <i>t</i><sub>r</sub> = 1.62 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>7</sub>H<sub>6</sub>ClNO<sub>2</sub> [M + H]<sup>+</sup> 172.02. Found: 172.36. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 2.63 (s, 3 H), 7.23 (d, <i>J</i> = 8.14 Hz, 1H), and 7.84 (d, <i>J</i> = 8.14 Hz, 1H).</div><div class="NLM_p">A mixture of 6-chloro-2-methylnicotinic acid (<b>18</b>, 0.172 g, 1.00 mmol) and thionyl chloride (5.0 mL) was stirred at reflux for 3 h. The excess of thionyl chloride was removed under reduced pressure. To the residue was added <i>t</i>-butanol (5.0 mL), dimethylaminopyridine (200 mg, 1.63 mmol), and triethylamine (1.0 mL), and the reaction mixture was stirred at 70 °C overnight under nitrogen. After cooling, the mixture was diluted with dichloromethane (100 mL), washed with a saturated aqueous solution of sodium bicarbonate, and dried over magnesium sulfate. Concentration under reduced pressure followed by purification by flash silica gel chromatography afforded <i>tert</i>-butyl 6-chloro-2-methylnicotinate (<b>19</b>, 0.022 g, 10%). HPLC purity 57%; <i>t</i><sub>r</sub> = 3.40 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>11</sub>H<sub>14</sub>ClNO<sub>2</sub> [M + H]<sup>+</sup> 228.08. Found: 228.42. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.58 (s, 9H), 2.77 (s, 3H), 7.20 (s, 1H), and 8.05 (d, <i>J</i> = 8.14 Hz, 1H).</div><div class="NLM_p">A mixture of <b>6</b> (0.042 g, 0.100 mmol), <i>tert</i>-butyl 6-chloro-2-methylnicotinate (<b>19</b>, 0.022 g, 0.100 mmol), diisopropylethylamine (0.1 mL), and demethylacetamide (2.0 mL) was stirred at 112 °C for 18 h. After cooling, the mixture was added slowly to ice water (10 mL) and extracted with dichloromethane (3×). The organic layer was collected, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by flash silica gel chromatography to provide <i>tert</i>-butyl 6-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)-2-methylnicotinate (<b>20</b>, 30 mg, 50%). HPLC purity 74%; <i>t</i><sub>r</sub> = 3.98 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>31</sub>H<sub>29</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 606.17. Found: 606.14. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.56−1.60 (m, 9H) 2.70 (s, 3H), 3.23 (s, 3H), 3.94−4.04 (m, 2H), 4.16 (d, <i>J</i> = 11.70 Hz, 2H), 4.23−4.32 (m, 1H), 6.29−6.35 (m, 1H), 6.80 (d, <i>J</i> = 2.03 Hz, 2H), 7.26 (t, <i>J</i> = 5.34 Hz, 1H), 7.38 (d, <i>J</i> = 8.14 Hz, 2H), 7.61−7.70 (m, 2H), and 8.04 (d, <i>J</i> = 8.65 Hz, 1H).</div><div class="NLM_p last">To <i>tert</i>-butyl 6-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)-2-methylnicotinate (<b>20</b>, 0.030 g, 0.050 mmol) in dichloromethane (2.0 mL) was added trifluoromethane (2.0 mL) at 0 °C. The mixture was stirred at room temperature for 2.5 h. The solvent and excess trifluoromethane was removed under reduced pressure, and the residue was purified with preparative HPLC to give <b>2n</b> (0.021 g, 76%) as a white solid. HPLC purity 99%; <i>t</i><sub>r</sub> = 6.42 min (method F); 99%; <i>t</i><sub>r</sub> = 2.58 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>27</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 550.10. Found: 550.08. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.77 (s, 3H), 3.25 (s, 3H), 3.99−4.14 (m, 3H), 4.21 (d, <i>J</i> = 10.45 Hz, 1H), 4.34 (d, <i>J</i> = 11.00 Hz, 1H), 6.39 (d, <i>J</i> = 9.35 Hz, 1H), 6.80 (s, 2H), 7.28 (s, 1H), 7.38 (d, <i>J</i> = 8.25 Hz, 2H), 7.67 (d, <i>J</i> = 8.25 Hz, 2H), and 8.18 (d, <i>J</i> = 8.80 Hz, 1H).</div></div><div id="sec5_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 6-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)-4-methylnicotinic Acid (<b>2o</b>)</h4><div class="NLM_p">To a heterogeneous mixture of 6-amino-4-methylnicotinic acid (1.00 g, 6.50 mmol) in methanol (20 mL) was added dropwise thionyl chloride (0.90 mL, 8.20 mmol). The mixture was refluxed for 20 h, cooled to room temperature, and the solvent was removed under reduced pressure. The resulting solid was dissolved in water (25 mL), and the pH was adjusted to 13 with a 1N aqueous solution of sodium hydroxide to give a white solid. The solid was collected by vacuum filtration, rinsed with water (25 mL), and air-dried to give methyl 6-amino-4-methylnicotinate (700 mg, 65%). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>8</sub>H<sub>10</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 167.08. Found: 167<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.37 (s, 3H), 3.72 (s, 3H), 6.25 (s, 2H), 6.62 (s, 2H), and 8.45 (s, 1 H).</div><div class="NLM_p">To an ice cold 15% aqueous solution of sulfuric acid (30 mL) was added methyl 6-amino-4-methylnicotinate (1.40 g, 8.4 mmol) followed by portionwise addition of sodium nitrite (1.20 g, 16.8 mmol). The reaction mixture was stirred at 0 °C for 2 h and at room temperature for an additional 2 h. The resulting solid was collected by vacuum filtration, rinsed sequentially with water (35 mL) and diethyl ether (35 mL), and air-dried to give methyl 6-hydroxy-4-methylnicotinate (<b>24</b>, 1.00 g, 71%). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>8</sub>H<sub>9</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 168.07. Found: 168<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.37 (s, 3H), 3.72 (s, 3H), 6.25 (s, 1H), 6.62 (s, 2 H), and 8.46 (s, 1H).</div><div class="NLM_p">To a suspension of methyl 6-hydroxy-4-methylnicotinate (<b>24</b>, 0.250 g, 1.50 mmol) in toluene (5.0 mL) was added phosphorus oxychloride (1.0 mL). The mixture was heated at 110 °C for 4 h, cooled to room temperature, and the excess phosphorus oxychloride was removed under reduced pressure. The resulting slurry was diluted with dichloromethane (25 mL) and washed sequentially with a saturated aqueous solution of sodium bicarbonate and water. The organic layer was collected and dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure to give methyl 6-chloro-4-methylnicotinate (<b>13</b>, 0.200 g, 72%) as a solid. (EI) <i>m</i>/<i>z</i> Calcd for C<sub>8</sub>H<sub>8</sub>ClNO<sub>2</sub> [M + H]<sup>+</sup> 186.03. Found: 186<sup>+</sup> and 188<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.53 (s, 3H), 3.85 (s, 3H), 7.58 (s, 1H), and 8.74 (s, 1H).</div><div class="NLM_p">To a solution of <b>6</b> (0.165 g, 0.400 mmol) in <i>N</i>-methylpyrrolidine (1.5 mL) was added methyl 6-chloro-4-methylnicotinate (<b>13</b>, 0.075 g, 0.400 mmol) and diisopropylethylamine (0.175 mL, 1.00 mmol). The reaction mixture was heated at 100 °C for 18 h, cooled to room temperature, and diluted with water (20 mL). The resulting solid was collected by vacuum filtration, rinsed with additional water (25 mL), rinsed with heptane (25 mL), and air-dried to give methyl 6-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)-4-methylnicotinate (<b>14</b>, 0.185 g). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>28</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 564.12. Found: 566<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.72 (s, 3H), 3.24 (s, 3H), 3.91 (s, 3H), 4.04−4.15 (m, 2H), 4.21 (m, 1H), 4.35 (m, 1H), 4.48 (t, <i>J</i> = 11.0 Hz, 1H), 6.58 (s, 1H), 6.79 (d, <i>J</i> = 1.5 Hz, 2H), 7.30 (t, <i>J</i> = 1.5 Hz, 1H), 7.37 (d, <i>J</i> = 8.0 Hz, 2H), 7.72 (t, <i>J</i> = 8.0 Hz, 2H), and 8.77 (s, 1H).</div><div class="NLM_p last">Methyl 6-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)-4-methylnicotinate (<b>14</b>, 0.050 g, 0.089 mmol) and lithium iodide (0.025 g, 0.140 mmol) were suspended in <i>N</i>-methylpyrrolidine (1.0 mL) and heated at 140 °C for 20 h. The mixture was cooled to room temperature, diluted with methanol (3.0 mL), and purified by preparative HPLC to give the product as a trifluoroacetic acid salt. The trifluoroacetic acid salt was dissolved in methanol (1.0 mL) and neutralized on a CUBCX1-HL (benzenesulfonic acid) ion exchange cartridge (UCT part number CUBX1HL5R3, 500 mg) to afford <b>2o</b> as a solid (0.020 g, 42%). HPLC purity 96.5%; <i>t</i><sub>r</sub> = 12.22 min (method A); 97.4%; <i>t</i><sub>r</sub> = 12.84 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>27</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup> 550.10. Found: 550<sup>+</sup> and 552<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 2.49 (s, 3H). 3.15 (s, 3H), 3.89−4.01 (m, 3H), 4.07 (t, <i>J</i> = 7.73 Hz, 1H), 4.22 (t, <i>J</i> = 10.7 Hz, 1H), 6.24 (s, 1H), 6.69 (d, <i>J</i> = 1.53 Hz, 2H), 7.20 (t, <i>J</i> = 1.53 Hz, 1H), 7.32 (d, <i>J</i> = 8.14 Hz, 2H), 7.60 (d, <i>J</i> = 8.14 Hz, 2H), and 8.68 (s, 1H).</div></div><div id="sec5_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)thiazole-5-carboxylic Acid (<b>2p</b>)</h4><div class="NLM_p">A mixture of <b>6</b> (0.187 g, 0.450 mmol), methyl 2-bromothiazole-5-carboxylate (0.111 g, 0.500 mmol), and diisopropylamine (0.10 mL) in dimethylacetamide was stirred at 105 °C for 4.5 h. After cooling, the mixture was added dropwise to ice water (50 mL). The resulting precipitate was collected by vacuum filtration, washed with water (3×), and dried to give methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)thiazole-5-carboxylate (0.215 g, 86%). HPLC purity >95%; <i>t</i><sub>r</sub> = 3.60 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>25</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 556.06. Found: 556.08. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.25 s, 3H), 3.83 (s, 3H), 4.06−4.15 (m, 3H), 4.33−4.41 (m, 2H), 6.82 (d, <i>J</i> = 2.03 Hz, 2H), 7.43 (s, 1H), 7.52 (d, <i>J</i> = 8.65 Hz, 2H), 7.78 (d, <i>J</i> = 8.14 Hz, 2H), and 7.93 (s, 1H).</div><div class="NLM_p last">To a mixture of methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)thiazole-5-carboxylate (0.040 mg, 0.072 mmol) in tetrahydrofuran (2.0 mL) and water (1.0 mL) was added 1,2- propanediol (0.011 g, 0.144 mmol) followed by a 1N aqueous solution of potassium hydroxide (0.180 mL, 0.180 mmol). The mixture was stirred at room temperature overnight. After adjusting the pH to 4−5, the mixture was concentrated under reduced pressure. The residue was diluted with water (20 mL) and extracted with dichloromethane (3×). The organic layer was washed with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by preparative HPLC to give (<b>2p</b>, 16.0 mg, 41%) as white solid (41%). HPLC purity 98.9%; <i>t</i><sub>r</sub> = 14.57 min (method A); 97.8%; <i>t</i><sub>r</sub> = 13.96 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>24</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 542.05. Found: 542.18. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 3.25 (s, 3H), 4.08 (m, 3H), 4.37 (m, 2H), 6.82 (d, <i>J</i> = 1.65 Hz, 2H), 7.42 (s, 1H), 7.52 (d, <i>J</i> = 8.25 Hz, 2H), 7.78 (d, <i>J</i> = 8.25 Hz, 2H), and 7.88 (s, 1H).</div></div><div id="sec5_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)oxazole-4-carboxylic Acid (<b>2q</b>)</h4><div class="NLM_p">A mixture of ethyl bromopyruvate (6.00 g, 0.030 mol) and urea (3.00 g, 0.050 mol) was heated at 100 °C for 1 h under nitrogen. To the brown solid was added water (50 mL), and the pH was adjusted to ∼9−10 with a 1N aqueous solution of potassium hydroxide. The mixture was extracted with diethyl ether (3×), and the organic layer was washed with water (2×), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to provide ethyl 2-aminooxazole-4-carboxylate (<b>22</b>, 1.87 g, 40%) as a yellow solid. HPLC purity 78%; <i>t</i><sub>r</sub> = 0.830 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>6</sub>H<sub>8</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 157.06. Found: 157.35. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.34 (t, <i>J</i> = 7.12 Hz, 3H), 4.32 (q, <i>J</i> = 7.12 Hz, 2H), 5.13 (s, 2H), and 7.72 (s, 1H).</div><div class="NLM_p">To a mixture of <i>tert</i>-butyl nitrite (0.990 g, 9.60 mmol) and copper(II) chloride (1.29 g, 9.60 mmol) in anhydrous acetonitrile (5.0 mL) was added ethyl 2-aminooxazole-4-carboxylate (<b>22</b>, 1.00 g, 6.40 mmol) dissolved in acetonitrile (2.0 mL) at 65 °C. Once nitrogen evolution subsided (∼20 min), the solution was cooled to room temperature and poured into 150 mL of a 20% aqueous solution of hydrochloric acid. The mixture was extracted with diethyl ether (3×), washed with a 20% aqueous solution of hydrochloric acid, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to provide ethyl 2-chlorooxazole-4-carboxylate (<b>23</b>, 0.740 g, 66%) as yellow oil. HPLC purity 84%; <i>t</i><sub>r</sub> = 1.93 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>6</sub>H<sub>6</sub>ClNO<sub>3</sub> [M + H]<sup>+</sup> 176.01. Found: 176.36. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.37 (t, <i>J</i> = 7.12 Hz, 3H,), 4.38 (q, <i>J</i> = 7.12 Hz, 2H), and 8.18 (s, 1H).</div><div class="NLM_p">The mixture of <b>6</b> (0.200 g, 0.480 mmol), ethyl 2-chlorooxazole-4-carboxylate (<b>23</b>, 0.120 g, 0.680 mmol), diisopropylamine (0.40 mL), and dimethylacetamide (2.0 mL) was stirred at 112 °C for 14 h. After cooling, the mixture was poured into ice water (50 mL). The resulting solid was collected by vacuum filtration and purified by flash silica gel column chromatography to give ethyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)oxazole-4-carboxylate as yellow solid (0.108 g, 41%). HPLC purity 99%; <i>t</i><sub>r</sub> = 3.55 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>26</sub>H<sub>21</sub>C<sub>l2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup> 554.10. Found: 554.14. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.36 (3H, t, <i>J</i> = 7.12 Hz), 3.21 (s, 3H), 3.93 (dd, <i>J</i> = 11.70, 7.63 Hz, 1H), 3.99−4.12 (m, 2H), 4.18−4.26 (m, 1H), 4.32−4.46 (m, 3H), 6.74 (d, <i>J</i> = 2.03 Hz, 2H), 7.27−7.29 (m, 1H), 7.33 (d, <i>J</i> = 8.14 Hz, 2H), 7.68 (d, <i>J</i> = 8.65 Hz, 2H), and 7.87 (s, 1H).</div><div class="NLM_p last">To a solution of ethyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)oxazole-4-carboxylate (0.060 g, 0.108 mmol) in tetrahydrofuran (2.0 mL) and water (1.0 mL) was added 1,2-propanediol (0.016 mg, 0.216 mmol) followed by a 1N aqueous solution of potassium hydroxide (0.270 mL, 0.270 mmol). The mixture was stirred at room temperature for 2.5 h. The mixture was concentrated under reduced pressure, and the pH of the aqueous residue was adjusted to ∼5 with acetic acid. The mixture was purified by preparative HPLC to provide <b>2q</b> as off-white solid (0.016 g, 28%). HPLC purity 98.5%; <i>t</i><sub>r</sub> = 13.69 min (method A); 98.5%; <i>t</i><sub>r</sub> = 13.33 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>24</sub>H<sub>17</sub>C<sub>l2</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 526.07. Found: 526.16. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.23 (s, 3H), 3.91−4.15 (m, 3H), 4.23 (d, <i>J</i> = 2.75 Hz, 1H), 4.43 (s, 1H), 6.76 (s, 3H), 7.29 (s, 1H), 7.34 (d, <i>J</i> = 7.70 Hz, 2H), 7.69 (d, <i>J</i> = 7.15 Hz, 2H), and 7.96 (s, 1H).</div></div><div id="sec5_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]oxazole-7-carboxylic Acid (<b>2r</b>)</h4><div class="NLM_p">To a solution of <b>6</b> (0.102 g, 0.246 mmol) and methyl 2-chlorobenzo[d]oxazole-7-carboxylate<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (0.055 g, 0.246 mmol) in anhydrous dimethylformamide (1.5 mL) was added diisopropylethylamine (0.128 mL, 0.738 mmol). The reaction mixture was stirred at 100 °C for 1 h, diluted with water, and extracted with diethyl ether. The organic layer was collected and dried under reduced pressure to give methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]oxazole-7-carboxylate (0.078 g, 54%). HPLC <i>t</i><sub>r</sub> = 3.83 min (method G). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>29</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup> 590.10. Found: 590<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.21 (s, 3H), 3.92 (s, 3H), 4.02 (m, 1H), 4.27 (m, 2H), 4.45 (m, 1H), 4.55 (m, 1H), 6.72 (d, <i>J</i> = 1.65 Hz, 2H), 7.24 (m, 2H), 7.32 (d, <i>J</i> = 8.25 Hz, 2H), 7.58 (d, <i>J</i> = 8.25 Hz, 1H), 7.64 (d, <i>J</i> = 8.25 Hz, 2H), and 7.67 (d, <i>J</i> = 8.25 Hz, 1H).</div><div class="NLM_p last">To a solution of methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]oxazole-7-carboxylate (0.075 g, 0.127 mmol) in anhydrous tetrahydrofuran (4.0 mL) and water (2.0 mL) was added 1,2-propanediol (0.171 mL) and 1.0 M aqueous potassium hydroxide (0.302 mL). After stirring at room temperature for 16 h, the reaction mixture was concentrated under reduced pressure, and the resulting residue was purified by preparative HPLC followed by neutralization with an ion-exchange resin to give <b>2r</b> (22.4 mg, 31%) as a white solid. HPLC purity 98.8%; <i>t</i><sub>r</sub> = 14.37 min (method A); 98.7%; <i>t</i><sub>r</sub> = 13.81 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>28</sub>H<sub>19</sub>C<sub>l2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup> 576.08. Found: 576<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.19 (s, 3H), 4.10−4.34 (m, 5H), 6.81 (m, 2H), 7.22 (m, 1H), 7.48 (m, 4H), 7.64 (s, 1H), and 7.88 (d, <i>J</i> = 8.0 Hz, 2H).</div></div><div id="sec5_7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]oxazole-6-carboxylic Acid (<b>2s</b>)</h4><div class="NLM_p">To a solution <b>6</b> (0.102 g, 0.246 mmol) and methyl 2-chlorobenzo[d]oxazole-6-carboxylate<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (0.055 g, 0.246 mmol) in anhydrous dimethylformamide (1.5 mL) was added diisopropylethylamine (0.128 mL, 0.738 mmol). The reaction mixture was stirred at 100 °C for 1 h, diluted with water, and extracted with diethyl ether. The organic layer was collected and dried under reduced pressure to give methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]oxazole-6-carboxylate (0.140 g, 97%). HPLC <i>t</i><sub>r</sub> = 3.86 min (method G). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>29</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup> 590.10. Found: 590<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.26 (s, 3H), 3.90 (s, 3H), 4.33 (m, 2H), 4.60 (m, 3H), 6.73 (s, 2H), 7.19 (s, 1H), 7.28 (d, <i>J</i> = 8.0 Hz, 2H), 7.40 (d, <i>J</i> = 8.0 Hz, 1H), 7.62 (d, <i>J</i> = 8.0 Hz, 2H), 7.90 (d, <i>J</i> = 8.0 Hz, 1H), and 8.00 (s, 1H).</div><div class="NLM_p last">To a solution of methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]oxazole-6-carboxylate (0.140 g, 0.237 mmol) in anhydrous tetrahydrofuran (11.5 mL) and water (5.75 mL) was added 1,2-propanediol (0.684 mL) and 1.0 M aqueous potassium hydroxide (0.603 mL). After stirring at room temperature for 16 h, the reaction mixture was concentrated under reduced pressure, and the resulting residue was purified by preparative HPLC followed by neutralization with ion-exchange resin to provide <b>2s</b> (11.6 mg, 8.5%) as a white solid. HPLC purity 94.5%; <i>t</i><sub>r</sub> = 11.50 min (method A; column: SunFire C18 3.5 μ 3.0 mm × 150 mm); 94.5%; <i>t</i><sub>r</sub> = 11.06 min (method B; column: Xbridge Ph 3.5 μ 3.0 mm × 150 mm); LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>28</sub>H<sub>19</sub>C<sub>l2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup> 576.08. Found: 576<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.19 (s, 3H), 4.17 (m, 1H), 4.28 (m, 2H), 4.38 (m, 2H), 6.80 (m, 2H), 7.40 (d, <i>J</i> = 8.25 Hz, 1H), 7.48 (d, <i>J</i> = 8.25 Hz, 2H), 7.65 (m, 1H), 7.86 (m, 1H), 7.89 (d, <i>J</i> = 8.25 Hz, 2H), and 7.93 (s, 1H).</div></div><div id="sec5_7_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]oxazole-5-carboxylic Acid (<b>2t</b>)</h4><div class="NLM_p">To a solution of <b>6</b> (0.106 g, 0.256 mmol) and methyl 2-chlorobenzo[d]oxazole-5-carboxylate<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (0.055 g, 0.256 mmol) in anhydrous dimethylformamide (1.5 mL) was added diisopropylethylamine (0.134 mL, 0.768 mmol). The reaction mixture was stirred at 100 °C for 1 h, diluted with water, extracted with diethyl ether, and dried under reduced pressure. The resulting residue was purified by flash silica gel chromatography using a 97:3 mixture of dichloromethane and methanol to give methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]oxazole-5-carboxylate (0.083 g, 55%). HPLC <i>t</i><sub>r</sub> = 3.76 min (method G). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>29</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup> 590.10. Found: 590<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.26 (s, 3H), 3.92 (s, 3H), 4.13−4.60 (m, 5H), 6.76 (m, 2H), 7.29 (s, 1H), 7.34 (m, 3H), 7.68 (d, <i>J</i> = 7.2 Hz, 2H), 7.80 (d, <i>J</i> = 8.0 Hz, 1H), and 8.07 (s, 1H).</div><div class="NLM_p last">To a solution of methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]oxazole-5-carboxylate (0.080 g, 0.135 mmol) in anhydrous tetrahydrofuran (4.0 mL) and water (2.0 mL) was added 1,2-propanediol (0.182 mL) and 1.0 M aqueous potassium hydroxide (0.322 mL). After stirring at room temperature for 16 h, the reaction mixture was concentrated under reduce pressure, and the resulting residue was purified by preparative HPLC followed by neutralization with ion-exchange resin to afford <b>2t</b> (8.0 mg, 10%) as a white solid. HPLC purity 94.7%; <i>t</i><sub>r</sub> = 7.04 min (method F); 97%; <i>t</i><sub>r</sub> = 3.53 min (method E). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>28</sub>H<sub>19</sub>C<sub>l2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup> 576.08. Found: 576<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.12 (s, 3H), 4.08 (m, 1H), 4.19 (m, 2H), 4.31 (m, 2H), 6.73 (m, 2H), 7.41 (d, <i>J</i> = 8.25 Hz, 2H), 7.46 (d, <i>J</i> = 8.25 Hz, 1H), 7.58 (m, 1H), 7.64 (d, <i>J</i> = 8.25 Hz, 1H), 7.77 (m, 1H), and 7.82 (d, <i>J</i> = 7.7 Hz, 2H).</div></div><div id="sec5_7_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]thiazole-7-carboxylic Acid (<b>2u</b>)</h4><div class="NLM_p">To copper(II) bromide (0.200 g, 0.860 mmol) in anhydrous acetonitrile (2.0 mL) was added <i>tert</i>-butyl nitrite (0.12 mL, 1.08 mmol) at room temperature over a period of 3 min. After stirring for 5 min at room temperature, methyl 2-aminobenzothiazole-7-carboxylate (0.150 g, 0.720 mmol) was added, and the reaction mixture was heated at 70 °C for 2 h. The reaction mixture was cooled, concentrated under reduced pressure, diluted with ethyl acetate (10 mL), and filtered over a pad of celite. The filtrate was washed with brine (2 × 25 mL), dried over sodium sulfate, and concentrated to give methyl 2-bromobenzo[d]thiazole-7-carboxylate as a yellow solid (<b>25</b>, 0.036 g). The compound was used without further purification</div><div class="NLM_p">Methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro-[4.4]nonan-7-yl)benzo[d]thiazole-7-carboxylate was prepared as described in the preparation of <b>2o</b> starting from the spirocyclic pyrrolidine (<b>6</b>, 0.045 g, 0.108 mmol) and methyl 2-bromobenzo[d]thiazole-7-carboxylate (<b>25</b>) to give the desired product (0.025 g; 31%). HPLC purity 93%; <i>t</i><sub>r</sub> = 4.09 min (method E). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>29</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 606.08. Found: 606<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.27 (s, 3H), 4.01 (s, 3H), 4.03−4.16 (m, 2H), 4.18−4.30 (m, 2H), 4.46−4.56 (m, 1H), 6.79 (d, <i>J</i> = 1.51 Hz, 2H), 7.29−7.32 (m, 1H), 7.39 (m, 3H), 7.44 (2H, t, <i>J</i> = 7.81 Hz, 2H), and 7.84 (dd, <i>J</i> = 14.10, 8.06 Hz, 2H).</div><div class="NLM_p last">To methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triaza-spiro[4.4]nonan-7-yl)benzo[d]thiazole-7-carboxylate (0.013 g, 0.020 mmol) in dimethylformamide (1.0 mL) was added lithium chloride (0.100 g), and the contents were heated at 115 °C for 3 h. The reaction mixture was cooled to room temperature, and acetic acid (3.0 mL) and water (3.0 mL) were added. The resulting precipitate was collected by vacuum filtration and dried in a vacuum oven at 50 °C for 50 h to give <b>2u</b> as a white solid (0.011 g; 86%). HPLC purity 97.4%; <i>t</i><sub>r</sub> = 11.51 min (method A; column: SunFire C18 3.5 μ 3.0 mm × 150 mm); 96.5%; <i>t</i><sub>r</sub> = 11.22 min (method B; column: Xbridge Ph 3.5 μ 3.0 mm × 150 mm). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>28</sub>H<sub>19</sub>C<sub>l2</sub>N<sub>5</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 592.06. Found: 592<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.23 (s, 3H), 4.11−4.40 (m, 4H), 4.41−4.55 (m, 1H), 6.75−6.88 (m, <i>J</i> = 1.51 Hz, 2H), 7.41−7.55 (m, 3H), 7.64−7.69 (m, 1H), 7.75 (dd, <i>J</i> = 12.34, 7.30 Hz, 2H), and 7.91 (d, <i>J</i> = 8.06 Hz, 2H).</div></div><div id="sec5_7_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-((5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]thiazole-6-carboxylic Acid (<b>2v</b>)</h4><div class="NLM_p">A mixture of <b>6</b> (0.100 g, 0.241 mol), methyl 2-bromobenzo[d]thiazole-6-carboxylate (0.072 g, 0.265 mmol), and diisopropylamine (0.084 mL, 0.482 mmol) in anhydrous dimethylformamide (3.0 mL) was heated at 100 °C overnight. The reaction mixture was cooled to room temperature, and water was added until a precipitate formed. The solid was collected by vacuum filtration, washed with water, and dried to give a tan solid. Purification by flash silica gel chromatography afforded methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]thiazole-6-carboxylate (0.064 g) as an off-white solid. HPLC purity 98%; <i>t</i><sub>r</sub> = 3.64 min (method D). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>29</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 606.08. Found: 606.39 and 608.30. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.06 (s, 3H), 2.97 (s, 3H), 4.18 (d, <i>J</i> = 11.6 Hz, 1H), 4.28 (t, <i>J</i> = 13.8 Hz, 1H), 4.35−4.37 (m, 3H), 7.20 (s, 2H), 7.34−7.36 (m, 3H), 7.63 (d, <i>J</i> = 8.25 Hz, 1H), 7.69 (d, <i>J</i> = 8.25 Hz, 2H), 8.10 (d, <i>J</i> = 9.35 Hz, 1H), and 8.43 (s, 1H).</div><div class="NLM_p last">A mixture of methyl 2-((5<i>S</i>,9<i>R</i>)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)benzo[d]thiazole-6-carboxylate (0.037 g, 0.061 mmol) and lithium iodide (0.250 g) in anhydrous dimethylacetamide (1.0 mL) was heated at 140 °C overnight. The reaction was cooled to room temperature, and acetic acid (∼12 drops from a pipet) was added followed by water (3.0 mL). The dimethylformamide was removed under reduced pressure, and the resulting residue was purified by preparative HPLC to give <b>2v</b> (14 mg) as a white solid. HPLC purity 96.6%; <i>t</i><sub>r</sub> = 14.69 min (method A); 96.7%; <i>t</i><sub>r</sub> = 14.17 min (method B). LCMS (EI) <i>m</i>/<i>z</i> Calcd for C<sub>28</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 592.06. Found: 592.09 and 594.07. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.26 (s, 3H), 4.03−4.25 (m, 4H), 4.50 (t, <i>J</i> = 10.72 Hz, 1H), 6.79 (s, 2H), 7.29 (s, 1H), 7.37 (d, <i>J</i> = 8.25 Hz, 2H), 7.65 (d, <i>J</i> = 8.25 Hz, 1H), 7.69 (d, <i>J</i> = 7.70 Hz, 2H), 8.09 (d, <i>J</i> = 8.80 Hz, 1H), and 8.40 (s, 1H).</div></div><div id="sec5_7_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 4-((5<i>S</i>,9<i>R</i>)-3-(3,5-Dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-9-yl)benzonitrile (<b>6</b>)</h4><div class="NLM_p last">The detailed procedure for the preparation of <b>6</b> is outlined in refs <a onclick="showRef(event, 'cit6b'); return false;" href="javascript:void(0);" class="ref cit6b">6b</a> and <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a>. The retention times on the Chiralpak-AD column and specific rotations for these compounds are as follows: enatiomeric excess >99%.; <i>t</i><sub>R</sub> = 5.74 min [Chiralpak-AD column (7.5 cm × 30 cm) under SFC conditions (70% CO<sub>2</sub>/30% MeOH)]; specific rotation: [ α ]<sub>D</sub> = +95.2 (<i>c</i> = 1, MeOH).</div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> HUVEC:Human T-Cell Adhesion Assay</h3><div class="NLM_p last">PBMCs were isolated from human peripheral blood and T cells expanded with phytohemoagglutinin (PHA). HUVEC were obtained from Clonetics (San Diego, CA), grown to confluence in 96-well plates and stimulated overnight with PMA to increase ICAM-1 expression. PHA blasts were labeled with calcein-AM according to the manufacturer’s instructions (Invitrogen, Carlsbad, CA) and treated with PMA to increase LFA-1 avidity. PHA blasts were then added to the activated HUVEC monolayer in the presence or absence of compound or an excess of anti-LFA-1 antibody. The monolayers were washed and adhesion of calcein-labeled cells was determined by reading plates on a Cytofluor (fluorescence plate reader; excitation 485/emission 530 nm). Adhesion in the presence of vehicle control was considered equivalent to 0% inhibition. Adhesion in the presence of an excess of antihuman LFA-1 antibody was considered equivalent to 100% inhibition.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> b.END3 Mouse T-Cell Adhesion Assay</h3><div class="NLM_p last">Given the observation that mouse LFA-1 fails to recognize human ICAM-1<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> combined with the observations of others that some LFA-1 antagonists demonstrate a preference for human LFA-1 versus mouse LFA-1,<a onclick="showRef(event, 'cit9a'); return false;" href="javascript:void(0);" class="ref cit9a">(9a)</a> a mouse adhesion assay was established to identify compounds appropriate for in vivo evaluation. Adhesion of the murine T-cells to mTNFα -activated monolayers of the mouse b.END3 cell line was used for the mouse cell−cell adhesion assay. Splenocytes were isolated from C57BL/6 mice and grown for 4 d on anti-CD3 (145−2C11)/anti-CD28 (3N7)-coated plates. The T-cells were then transferred to uncoated plates and grown overnight in IL-2-containing media. Prior to adhesion assays, the expanded mouse T-cells were harvested, resuspended in HBSS, labeled with calcein-AM, and then treated with PMA to increase the avidity of LFA-1. These activated, calcein-labeled T-cells were then added to a monolayer of TNFα-activated b.END3 cells in the presence or absence of BMS-688521 or antimouse LFA-1 Ab. The monolayers were washed, and adhesion of calcein-labeled T-cells was determined by reading plates on a Cytofluor. Adhesion in the presence of vehicle alone was considered equivalent to 0% inhibition. Adhesion in the presence of an excess (10 μg/mL) of antimouse LFA-1 Ab (M17) was considered equivalent to 100% inhibition.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Human Mixed Lymphocyte Reaction (MLR) Assay</h3><div class="NLM_p last">Peripheral blood mononuclear cells (PBMC) were obtained by density-gradient separation (Lymphocyte Separation Media; Mediatech Inc., Herndon, VA) of EDTA-treated whole blood from normal healthy donors. T-cells were prepared from E<sup>+</sup> fractions of PBMC rosetted with sheep red blood cells (SRBC, Colorado Serum Company; Denver, CO). T-cells were cultured at 1 × 10<sup>5</sup> cells/well in quadruplicate wells together with 1 × 10<sup>5</sup> of irradiated allogeneic PBMCs as antigen-presenting cells (APCs) in 96-well round-bottom plates in a total volume of 200 μL of 10% FCS-RPMI. Compounds were added to the cell mixture at the initiation of the response. On day 4 after initiation of the MLR, cultures were pulsed with one μCi of <sup>3</sup>[H]-thymidine (PerkinElmer, Boston, MA) for 6 h, harvested on a Packard cell harvester (PerkinElmer), and counted by liquid scintillation on a Packard TopCount NXT (PerkinElmer). Proliferation was determined by incorporation of the <sup>3</sup>H label into DNA.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Human Whole-Blood IL-2 mRNA Determination</h3><div class="NLM_p last">A whole blood IL-2 mRNA assay was used to further characterize compound <b>2e</b>. The IL-2 assay was conducted on heparinized whole blood that had been activated with SEB. This response can be blocked with anti-LFA-1 antibody, demonstrating that SEB-induced IL-2 mRNA production is LFA-1-dependent. For this assay, total RNA was isolated from whole blood leukocytes at 6 h post SEB-induced activation by using the QIAamp RNA Blood Mini Kit (Qiagen, Valencia, CA) according to the manufacturer’s instructions. The IL-2 mRNA was quantified by real-time polymerase chain reaction (RT-PCR) using SYBR Green I reagent (Applied Biosystems, Foster City, CA) (30), and GAPDH mRNA as an internal standard. Specifically, 500 ng of RNA was used to make cDNA using SuperScript II RNase H (Invitrogen, Carlsbad CA) reverse transcriptase with oligo (dT)<sub>12−18</sub> primer (Invitrogen, Carlsbad CA). IL-2 message was detected with the forward primer CTGCTGGATTTACAGATGATTTTGA and the reverse primer TTGGGCATGTAAAACTTAAATGTGA. The primers used to detect GAPDH message were AATTCCATGGCACCGTCAAG (forward primer) and GAAGACGCCAGT-GGACTCCA (reverse primer). IC<sub>50</sub> values were calculated using the ΔΔ<i>C</i><sub>T</sub> method to determine relative IL-2 mRNA levels.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> OVA Lung Inflammation in Mice</h3><div class="NLM_p last">BALB/c female mice, 6−8 week of age, (Harlan, Indianapolis, IN) were immunized intraperitoneally with 100 μg of ovalbumin (OVA; Sigma) in alum adjuvant (Pierce) and similarly boosted 14 days later. Fourteen days after the booster, the mice were challenged intranasally with 100 μg OVA in 50 μL of pyrogen-free saline. Seventy-two hours after challenge, mice were killed by barbiturate overdose, and the lungs were lavaged via a tracheostomy with 1 mL of ice-cold Hank’s balanced salt solution (Ca++- and Mg++-free) containing 10% fetal bovine serum. Total recovered leukocytes were enumerated by electronic cell counter (Scharfe System, Reutingen, Germany). Cytocentrifuge smears (Shandon, Pittsburgh) were stained with Wright’s Giemsa stain, and 200 cells per sample were classified by microscopic differential</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> X-ray Crystallography</h3><div class="NLM_p last">The I-Domain of LFA-1 was incubated overnight at 4 °C with a 2.1 molar excess of ligand. Crystals were grown by hanging drop vapor diffusion with a drop consisting of 1 μL of protein/ligand solution and 1 μL of reservoir solution, which contained 0.1 M sodium citrate, pH 5.6, 80% (v/v) saturated sodium citrate, which was not titrated, and 3%(v/v) ethylene glycol. The crystal was prepared for flash cooling by placing the crystal in a solution consisting 80% reservoir solution and 20% ethylene glycol and then plunging the looped crystal into liquid nitrogen. Data were collected using a Rigaku FR-E equipped with MicroMax optics and a Rigaku Saturn92 detector. The data was processed with HKL2000<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and had symmetry consistent with space group <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> and unit cell parameters of <i>a</i> = 40.6 Å, <i>b</i> = 63.6 Å, and <i>c</i> = 63.1 Å (the inverted distance order of the <i>b</i> and <i>c</i> axes kept the same indexing as a canonical data set where the <i>c</i> axis was longer than the <i>b</i> axis). A cycle of rigid body fitting was carried out with the CCP4 version of AMoRe.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Refinement was performed with CNX<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> starting with a cycle of rigid body refinement and followed by an annealing protocol and individual B-factor refinement. QUANTA<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> was used for examining the model and the electron density maps. The ligand was placed by the X-ligand module of QUANTA,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and water molecules were placed by examination. Electron density map fitting was alternated with refinement of the model with CNX using only minimization and individual <i>B</i> factor refinement until no significant electron density was uninterpreted. The final <i>R</i><sub>work</sub> was 0.219 and <i>R</i><sub>free</sub> was 0.255. The rmsd for bond distances was 0.007 Å and the rmsd for bond angles was 1.4° (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).<div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. X-ray Crystallography Data Collection and Refinement Statistics</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left" valign="bottom">space group</td><td class="colsep0 rowsep0" align="right" valign="bottom"><i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub></td><td class="colsep0 rowsep0" align="right" valign="bottom"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>a</i>, Å</td><td class="colsep0 rowsep0" align="left">40.6</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>b</i>, Å</td><td class="colsep0 rowsep0" align="left">63.6</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>c</i>, Å</td><td class="colsep0 rowsep0" align="left">63.1</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table><table class="table "><colgroup><col width="33.33333333333333%" align="left" /></col><col width="33.33333333333333%" align="left" /></col><col width="33.33333333333333%" align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left" valign="top"> </th><th class="colsep0 rowsep0" align="left" valign="top">overall</th><th class="colsep0 rowsep0" align="left" valign="top">last</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution, Å</td><td class="colsep0 rowsep0" align="left">50−1.85</td><td class="colsep0 rowsep0" align="left">1.92−1.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">measured</td><td class="colsep0 rowsep0" align="left">91910</td><td class="colsep0 rowsep0" align="left">≥6398</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unique</td><td class="colsep0 rowsep0" align="left">13552</td><td class="colsep0 rowsep0" align="left">1089</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">redundancy</td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% complete</td><td class="colsep0 rowsep0" align="left">93.3</td><td class="colsep0 rowsep0" align="left">76.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i> value</td><td class="colsep0 rowsep0" align="left">0.86</td><td class="colsep0 rowsep0" align="left">0.310</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>I</i>/σ<sub>I</sub></td><td class="colsep0 rowsep0" align="left">23.0</td><td class="colsep0 rowsep0" align="left">5.8</td></tr></tbody></table><table class="table "><colgroup><col width="33.33333333333333%" align="left" /></col><col width="33.33333333333333%" align="left" /></col><col width="33.33333333333333%" align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>work</sub></td><td class="colsep0 rowsep0" align="left">0.192</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>free</sub></td><td class="colsep0 rowsep0" align="left">0.227</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rmsd bond distances, Å</td><td class="colsep0 rowsep0" align="left">0.006</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rmsd bond angles, deg</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div></div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40833" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40833" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott H. Watterson</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5427373b20207a233520203126273b3a143639277a373b39"><span class="__cf_email__" data-cfemail="c9baaaa6bdbde7bea8bdbdacbbbaa6a789aba4bae7aaa6a4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zili Xiao</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dharmpal S. Dodd</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David R. Tortolani</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wayne Vaccaro</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dominique Potin</span> - <span class="hlFld-Affiliation affiliation">Cerep, 19 Avenue du Quebec, 91951 Courtaboeuf cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michele Launay</span> - <span class="hlFld-Affiliation affiliation">Cerep, 19 Avenue du Quebec, 91951 Courtaboeuf cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dawn K. Stetsko</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stacey Skala</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patric M. Davis</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah Lee</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoxia Yang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kim W. McIntyre</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Praveen Balimane</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karishma Patel</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zheng Yang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Punit Marathe</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pathanjali Kadiyala</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew J. Tebben</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Sheriff</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">ChiehYing Y. Chang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theresa Ziemba</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huiping Zhang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bang-Chi Chen</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albert J. DelMonte</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nelly Aranibar</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Murray McKinnon</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel C. Barrish</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne J. Suchard</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">T. G. Murali Dhar</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm100348u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hogg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitinger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, P.</span><span> </span><span class="NLM_article-title">Mechanisms contributing to the activity of integrins on leukocytes</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1034%2Fj.1600-065X.2002.18614.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=12234370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFeht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2002&pages=164-171&author=N.+Hoggauthor=R.+Hendersonauthor=B.+Leitingerauthor=A.+McDowallauthor=J.+Porterauthor=P.+Stanley&title=Mechanisms+contributing+to+the+activity+of+integrins+on+leukocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms contributing to the activity of integrins on leukocytes</span></div><div class="casAuthors">Hogg, Nancy; Henderson, Robert; Leitinger, Birgit; McDowall, Alison; Porter, Joanna; Stanley, Paula</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">A review.  Understanding how the integrins on leukocytes operate is important because these receptors control the activity of leukocytes in all phases of their lives.  Thus integrins control leukocyte development and maturation in bone marrow, the circulation of naive cells in secondary lymphoid tissue, e.g. the lymph nodes, and leukocyte responses to inflammatory signals emanating from injured tissues.  Using as an example LFA-1, which is expressed by all leukocytes, the authors outline how the activity of this integrin is modified to meet the challenges posed by these leukocyte activities.  Briefly, the authors discuss three means by which LFA-1 is adapted to bind more efficiently to its chief ligand, ICAM-1.  LFA-1 can undergo changes in conformation leading to increased affinity, can be clustered on the membrane and, finally, when activated can move into the lipid raft compartment of the membrane.  The study of humans with the β2 deficiency syndrome termed leukocyte adhesion deficiency (LAD)-1 and anal. of LFA-1 null mice has given further insight into integrin activation mechanisms and the in vivo roles of LFA-1 and other leukocyte integrins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZtQv56tpiurVg90H21EOLACvtfcHk0liwJqRW8kOpUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFeht7c%253D&md5=073ec79461608a7d57dee45331ade5c7</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-065X.2002.18614.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-065X.2002.18614.x%26sid%3Dliteratum%253Aachs%26aulast%3DHogg%26aufirst%3DN.%26aulast%3DHenderson%26aufirst%3DR.%26aulast%3DLeitinger%26aufirst%3DB.%26aulast%3DMcDowall%26aufirst%3DA.%26aulast%3DPorter%26aufirst%3DJ.%26aulast%3DStanley%26aufirst%3DP.%26atitle%3DMechanisms%2520contributing%2520to%2520the%2520activity%2520of%2520integrins%2520on%2520leukocytes%26jtitle%3DImmunol.%2520Rev.%26date%3D2002%26volume%3D186%26spage%3D164%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, N.</span><span> </span><span class="NLM_article-title">The role of the integrin LFA-1 in T-lymphocyte migration</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">218</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1111%2Fj.1600-065X.2007.00537.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=17624950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSiu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=2007&pages=135-146&author=A.+Smithauthor=P.+Stanleyauthor=K.+Jonesauthor=L.+Svenssonauthor=A.+McDowallauthor=N.+Hogg&title=The+role+of+the+integrin+LFA-1+in+T-lymphocyte+migration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the integrin LFA-1 in T-lymphocyte migration</span></div><div class="casAuthors">Smith, Andrew; Stanley, Paula; Jones, Kristian; Svensson, Lena; McDowall, Alison; Hogg, Nancy</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">135-146</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  A successful immune response depends on the migration of lymphocytes into lymph nodes or inflamed tissues where they make contact with antigen-presenting cells.  We are interested in how one member of the integrin family, leukocyte function-assocd. antigen-1 (LFA-1), controls the function and, in particular, the migration of immune cells.  We find that this integrin operates not only as an adhesion receptor for T lymphoblasts (T cells) but also induces their migration in vitro at approx. 15 μm/min.  Migration requires active myosin light chain kinase at the leading edge and Rho kinase at the trailing edge of the cell.  Two active conformations of LFA-1 are differently distributed on the T-cell membrane and regulate independent aspects of migration.  High-affinity LFA-1 is located in a midcell 'focal zone' and influences the speed of migration, whereas intermediate affinity LFA-1 controls leading edge adhesions.  Manipulating LFA-1 conformation in vivo can be performed, for example, by creating the active conformation in a transgenic mouse, and this model gives further insight into the role of LFA-1 in migration.  In humans, the beneficial effect of functioning CD 18 integrins in combating infections in vivo is illustrated by rare patients displaying two forms of leukocyte adhesion deficiency.  In summary, we speculate that T cells have evolved a mode of rapid migration that is of paramount importance in achieving the high-speed immune surveillance upon which depends the body's protection against diverse invaders from pathogens to cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_51XrMAHxlrVg90H21EOLACvtfcHk0liwJqRW8kOpUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSiu7zO&md5=812e99e2ba174b1c351160db13c46800</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2007.00537.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2007.00537.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DStanley%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DSvensson%26aufirst%3DL.%26aulast%3DMcDowall%26aufirst%3DA.%26aulast%3DHogg%26aufirst%3DN.%26atitle%3DThe%2520role%2520of%2520the%2520integrin%2520LFA-1%2520in%2520T-lymphocyte%2520migration%26jtitle%3DImmunol.%2520Rev.%26date%3D2007%26volume%3D218%26spage%3D135%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Welzenbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitz-Schmidt, G.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors induce conformational changes in the I Domain and the I-like domain of lymphocyte function-associated antigen-1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">10590</span><span class="NLM_x">–</span> <span class="NLM_lpage">10598</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=10590-10598&author=K.+Welzenbachauthor=U.+Hommelauthor=G.+Weitz-Schmidt&title=Small+molecule+inhibitors+induce+conformational+changes+in+the+I+Domain+and+the+I-like+domain+of+lymphocyte+function-associated+antigen-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWelzenbach%26aufirst%3DK.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DWeitz-Schmidt%26aufirst%3DG.%26atitle%3DSmall%2520molecule%2520inhibitors%2520induce%2520conformational%2520changes%2520in%2520the%2520I%2520Domain%2520and%2520the%2520I-like%2520domain%2520of%2520lymphocyte%2520function-associated%2520antigen-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D10590%26epage%3D10598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shimaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Therapeutic antagonists and the conformational regulation of the β<sub>2</sub> intergrins</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.2174%2F1568026043387575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=15544539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFakt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=1485-1495&author=M.+Shimaokaauthor=T.+A.+Springer&title=Therapeutic+antagonists+and+the+conformational+regulation+of+the+%CE%B22+intergrins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic antagonists and the conformational regulation of the β2 integrins</span></div><div class="casAuthors">Shimaoka, Motomu; Springer, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1485-1495</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The β2 integrins are validated therapeutic targets for inflammatory disorders.  Two distinct mechanistic classes of small mol. inhibitors, termed α I allosteric and α/β I-like allosteric antagonist, have recently been developed.  The α I allosteric antagonists bind underneath the C-terminal helix of the I domain and stabilize the I domain in the inactive closed conformation.  By contrast, the α/β I-like allosteric antagonists bind to the β2 I-like domain MIDAS and disrupt conformational signal transmission between the I and the I-like domain, leaving the I domain in a default inactive form.  Furthermore, the two classes of the antagonists have opposite effects on integrin conformation; the α I allosteric antagonists stabilize the bent conformation, whereas the α/β I-like allosteric antagonists induce the extended conformation with inactive I domain.  The small mol. antagonists to the β2 integrin highlight the importance of the structural linkages within and between integrin domains for transmission of the conformational signals and regulation of the overall conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqoL7f2YG1JrVg90H21EOLACvtfcHk0liYYpY9ughTQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFakt74%253D&md5=728aa985273c09d8b18b88e4d5e0f630</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.2174%2F1568026043387575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026043387575%26sid%3Dliteratum%253Aachs%26aulast%3DShimaoka%26aufirst%3DM.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DTherapeutic%2520antagonists%2520and%2520the%2520conformational%2520regulation%2520of%2520the%2520%25CE%25B22%2520intergrins%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D1485%26epage%3D1495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shimaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, C.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormiack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Structures of the aL I Domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=99-111&author=M.+Shimaokaauthor=T.+Xiaoauthor=J.-H.+Liuauthor=Y.+Yangauthor=Y.+Dongauthor=C.-D.+Junauthor=A.+McCormiackauthor=R.+Zhangauthor=A.+Joachimakauthor=J.+Takagiauthor=J.-H.+Wangauthor=T.+A.+Springer&title=Structures+of+the+aL+I+Domain+and+its+complex+with+ICAM-1+reveal+a+shape-shifting+pathway+for+integrin+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimaoka%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.-H.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DJun%26aufirst%3DC.-D.%26aulast%3DMcCormiack%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DJoachimak%26aufirst%3DA.%26aulast%3DTakagi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.-H.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DStructures%2520of%2520the%2520aL%2520I%2520Domain%2520and%2520its%2520complex%2520with%2520ICAM-1%2520reveal%2520a%2520shape-shifting%2520pathway%2520for%2520integrin%2520regulation%26jtitle%3DCell%26date%3D2003%26volume%3D112%26spage%3D99%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carman, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Activation-induced conformational changes in the I Domain region of lymphocyte function-associated antigen-1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">10638</span><span class="NLM_x">–</span> <span class="NLM_lpage">10641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=10638-10641&author=Q.+Maauthor=M.+Shimaokaauthor=C.+Luauthor=H+Jingauthor=C.+V.+Carmanauthor=T.+A.+Springer&title=Activation-induced+conformational+changes+in+the+I+Domain+region+of+lymphocyte+function-associated+antigen-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DShimaoka%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DJing%26aufirst%3DH%26aulast%3DCarman%26aufirst%3DC.%2BV.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DActivation-induced%2520conformational%2520changes%2520in%2520the%2520I%2520Domain%2520region%2520of%2520lymphocyte%2520function-associated%2520antigen-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D10638%26epage%3D10641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Salas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carman, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T.</span><span> </span><span class="NLM_article-title">Transition from rolling to firm adhesion is regulated by the conformation of the I Domain of the integrin lymphocyte function-associated antigen-1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">50255</span><span class="NLM_x">–</span> <span class="NLM_lpage">50262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=50255-50262&author=A.+Salasauthor=M.+Shimaokaauthor=S.+Chenauthor=C.+V.+Carmanauthor=T.+Springer&title=Transition+from+rolling+to+firm+adhesion+is+regulated+by+the+conformation+of+the+I+Domain+of+the+integrin+lymphocyte+function-associated+antigen-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalas%26aufirst%3DA.%26aulast%3DShimaoka%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DCarman%26aufirst%3DC.%2BV.%26aulast%3DSpringer%26aufirst%3DT.%26atitle%3DTransition%2520from%2520rolling%2520to%2520firm%2520adhesion%2520is%2520regulated%2520by%2520the%2520conformation%2520of%2520the%2520I%2520Domain%2520of%2520the%2520integrin%2520lymphocyte%2520function-associated%2520antigen-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D50255%26epage%3D50262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Takagi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Integrin activation and structural rearrangement</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1034%2Fj.1600-065X.2002.18613.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=12234369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2002&pages=141-163&author=J.+Takagiauthor=T.+A.+Springer&title=Integrin+activation+and+structural+rearrangement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2eR"><div class="casContent"><span class="casTitleNuber">2e</span><div class="casTitle"><span class="NLM_cas:atitle">Integrin activation and structural rearrangement</span></div><div class="casAuthors">Takagi, Junichi; Springer, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-163</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">A review.  Among adhesion receptor families, integrins are particularly important in biol. processes that require rapid modulation of adhesion and de-adhesion.  Activation on a timescale of <1s of β2 integrins on leukocytes and β3 integrins on platelets enables deposition of these cells at sites of inflammation or vessel wall injury.  Recent crystal, NMR, and electron microscope (EM) structures of integrins and their domains lead to a unifying mechanism of activation for both integrins that contain and those that lack an inserted (I) domain.  The I domain adopts two alternative conformations, termed open and closed.  In striking similarity to signaling G-proteins, rearrangement of a Mg2+-binding site is linked to large conformational movements in distant backbone regions.  Mutations that stabilize a particular conformation show that the open conformation has high affinity for ligand, whereas the closed conformation has low affinity.  Movement of the C-terminal α-helix 10 Å down the side of the domain in the open conformation is sufficient to increase affinity at the distal ligand-binding site 9000-fold.  This C-terminal "bell-rope" provides a mechanism for linkage to conformational movements in other domains.  Recent structures and functional studies reveal interactions between β-propeller, I, and I-like domains in the integrin headpiece, and a crit. role for integrin epidermal growth factor (EGF) domains in the stalk region.  The headpiece of the integrin faces down towards the membrane in the inactive conformation, and extends upward in a "switchblade"-like opening upon activation.  These long-range structural rearrangements of the entire integrin mol. involving interdomain contacts appear closely linked to conformational changes within the I and I-like domains, which result in increased affinity and competence for ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD_jVUWoex9bVg90H21EOLACvtfcHk0liYYpY9ughTQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFeht7Y%253D&md5=ed99d53bc5be08fa0119b0af20038900</span></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-065X.2002.18613.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-065X.2002.18613.x%26sid%3Dliteratum%253Aachs%26aulast%3DTakagi%26aufirst%3DJ.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DIntegrin%2520activation%2520and%2520structural%2520rearrangement%26jtitle%3DImmunol.%2520Rev.%26date%3D2002%26volume%3D186%26spage%3D141%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Berlin-Rufenach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathies, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, N.</span><span> </span><span class="NLM_article-title">Lymphocyte Migration in Lymphocyte Function-Associated Antigen (LFA)-1-deficient Mice</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=1999&pages=1467-1478&author=C.+Berlin-Rufenachauthor=F.+Ottoauthor=M.+Mathiesauthor=J.+Westermannauthor=M.+J.+Owenauthor=A.+Hamannauthor=N.+Hogg&title=Lymphocyte+Migration+in+Lymphocyte+Function-Associated+Antigen+%28LFA%29-1-deficient+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerlin-Rufenach%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DF.%26aulast%3DMathies%26aufirst%3DM.%26aulast%3DWestermann%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DM.%2BJ.%26aulast%3DHamann%26aufirst%3DA.%26aulast%3DHogg%26aufirst%3DN.%26atitle%3DLymphocyte%2520Migration%2520in%2520Lymphocyte%2520Function-Associated%2520Antigen%2520%2528LFA%2529-1-deficient%2520Mice%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1999%26volume%3D189%26spage%3D1467%26epage%3D1478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Selenko-Gebauer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlhofer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingl, G.</span><span> </span><span class="NLM_article-title">Efalizumab in routine use: a clinical experience</span> <span class="citation_source-journal">Br. J. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1111%2Fj.1365-2133.2007.07762.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=17371316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFehtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2007&pages=1-6&author=N.+Selenko-Gebauerauthor=F.+Karlhoferauthor=G.+Stingl&title=Efalizumab+in+routine+use%3A+a+clinical+experience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Efalizumab in routine use: a clinical experience</span></div><div class="casAuthors">Selenko-Gebauer, N.; Karlhofer, F.; Stingl, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology, Supplement</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">BJDSA9</span>;
        ISSN:<span class="NLM_cas:issn">0366-077X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  With the advent of biol. therapies, continuous long-term control of psoriasis is now becoming a reality.  We report our experience with biologics based on the treatment of more than 550 psoriatic patients with such compds. at our special outpatient care center of Bio-Immunotherapy at the Department of Dermatol. of the Medical University of Vienna.  Approx. 220 of these patients are currently receiving efalizumab.  In our hands, efalizumab was generally found to be safe and well tolerated and, after 12 wk of treatment, resulted in a PASI redn. of 50% or more in approx. two-thirds of patients treated.  In most of these 'early' responders, the therapeutic efficacy of efalizumab can be maintained for a prolonged period of time, in certain patients up to 36 mo.  Flares occurring during long-term therapy were rare and, in most instances, triggered by infections.  During such flares, we usually do not discontinue efalizumab therapy, but rather try to combat the infection by appropriate antibiotics and to control the activity of the cutaneous eruption by the addn. of topical (corticosteroids) and, when needed, systemic (e.g. methotrexate 15-20 mg week-1 for 8-10 wk) medication.  In such a situation, it is of utmost importance for the care-taking physician to closely communicate with the affected patients in a scientifically competent fashion and to have an open ear for their concerns.  This helps and improves patient compliance and minimizes the need for treatment discontinuation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmEkfXsWpUkrVg90H21EOLACvtfcHk0lj8eLVXejrUOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFehtL4%253D&md5=6c9b4c757cbdf6a747c6c8adcbf3f0ad</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2007.07762.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2007.07762.x%26sid%3Dliteratum%253Aachs%26aulast%3DSelenko-Gebauer%26aufirst%3DN.%26aulast%3DKarlhofer%26aufirst%3DF.%26aulast%3DStingl%26aufirst%3DG.%26atitle%3DEfalizumab%2520in%2520routine%2520use%253A%2520a%2520clinical%2520experience%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2007%26volume%3D156%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lebwohl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyring, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glazer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawfik, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walicke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dummer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garovoy, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pariser, D.</span><span> </span><span class="NLM_article-title">A novel targeted T-cell modulator, Efalizumab, for plaque psoriasis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">2004</span><span class="NLM_x">–</span> <span class="NLM_lpage">2013</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1056%2FNEJMoa030002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=14627785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2003&pages=2004-2013&author=M.+Lebwohlauthor=S.+K.+Tyringauthor=T.+K.+Hamiltonauthor=D.+Tothauthor=S.+Glazerauthor=N.+H.+Tawfikauthor=P.+Walickeauthor=W.+Dummerauthor=X.+Wangauthor=M.+R.+Garovoyauthor=D.+Pariser&title=A+novel+targeted+T-cell+modulator%2C+Efalizumab%2C+for+plaque+psoriasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">A novel targeted T-cell modulator, efalizumab, for plaque psoriasis</span></div><div class="casAuthors">Lebwohl, Mark; Tyring, Stephen K.; Hamilton, Tiffani K.; Toth, Darryl; Glazer, Scott; Tawfik, Naji H.; Walicke, Patricia; Dummer, Wolfgang; Wang, Xiaolin; Garovoy, Marvin R.; Pariser, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2004-2013</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Interactions between leukocyte-function-assocd. antigen type 1 (LFA-1) and intercellular adhesion mols. are important in the pathogenesis of psoriasis.  Efalizumab, a humanized monoclonal antibody, binds to the a subunit (CD11a) of LFA-1 and inhibits the activation of T cells.  METHODS: In a phase 3, multicenter, randomized, placebo-controlled, double-blind study, we assign 597 subjects with psoriasis to receive s.c. efalizumab (1 or 2 mg per kg of body wt. per wk) or placebo for 12 wk.  Depending on the response after 12 wk, subjects received an addnl. 12 wk of treatment with efalizumab or placebo.  Study treatments were discontinued at week 24, and subjects were followed for an addnl. 12 wk.  RESULTS: At week 12, there was an improvement of 75 % or more in the psoriasis area-and-severity index in 22 % of the subjects who had received 1 mg of efalizumab per kg per wk and 28 % of those who had received 2 mg of efalizumab per kg per wk, as compared with 5 % of the subjects in the placebo group (P<0.001 for both comparisons).  Efalizumab-treated subjects had greater improvement than those in the placebo group as early as week 4(P<0.001).  Among the efalizumab-treated subjects who had an improvement of 75 % or more at week 12, improvement was maintained through week 23 in 77 % of those who continued to receive efalizumab, as compared with 20 % of those who were switched to placebo (P<0.001 for both comparisons).  After the discontinuation of efalizumab at week 24, an improvement of 50 % or more in the psoriasis area-and-severity index was maintained in approx. 30 % of subjects during the 12 wk of follow-up.  Efalizumab was well tolerated, and adverse events were generally mild to moderate.  CONCLUSIONS: Efalizumab therapy resulted in significant improvements in plaque psoriasis in subjects with moderate-to-severe disease.  Extending treatment from 12 to 24 wk resulted in both maintenance and improvement of responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz_2_0iKywCrVg90H21EOLACvtfcHk0lj8eLVXejrUOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFGnsb8%253D&md5=b3565c9d9de945cd8c947039ef951803</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030002%26sid%3Dliteratum%253Aachs%26aulast%3DLebwohl%26aufirst%3DM.%26aulast%3DTyring%26aufirst%3DS.%2BK.%26aulast%3DHamilton%26aufirst%3DT.%2BK.%26aulast%3DToth%26aufirst%3DD.%26aulast%3DGlazer%26aufirst%3DS.%26aulast%3DTawfik%26aufirst%3DN.%2BH.%26aulast%3DWalicke%26aufirst%3DP.%26aulast%3DDummer%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGarovoy%26aufirst%3DM.%2BR.%26aulast%3DPariser%26aufirst%3DD.%26atitle%3DA%2520novel%2520targeted%2520T-cell%2520modulator%252C%2520Efalizumab%252C%2520for%2520plaque%2520psoriasis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D349%26spage%3D2004%26epage%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cather, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cather, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menter, A.</span><span> </span><span class="NLM_article-title">Modulating T cell responses for the treatment of psoriasis: a focus on Efalizumab</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1517%2F14712598.3.2.361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=12662148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitl2itLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=361-370&author=J.+C.+Catherauthor=J.+C.+Catherauthor=A.+Menter&title=Modulating+T+cell+responses+for+the+treatment+of+psoriasis%3A+a+focus+on+Efalizumab"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab</span></div><div class="casAuthors">Cather, Jennifer Clay; Cather, J. Christian; Menter, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">361-370</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">An improved understanding regarding the pathophysiol. of psoriasis, coupled with advances in mol. research, has prompted the development of targeted biol. treatments for patients with plaque psoriasis.  T lymphocytes play an important role in initiating the immune system and the inflammatory responses that result in the development and maintenance of psoriatic plaques.  Efalizumab (anti-CD11a, Raptiva; Genentech, Inc.) is a mAb that targets the T cell adhesion mol., leukocyte function-assocd. antigen-1 (LFA-1).  By binding to CD11a - the α-subunit of LFA-1 - LFA-1 is prevented from binding with its ligand, intercellular adhesion mol.-1 (ICAM-1).  This inhibits various T cell processes believed to be important in the pathogenesis of psoriasis, including T cell activation, T cell adhesion to endothelial cells and T cell migration.  Clin. trials demonstrate that efalizumab, given s.c. once-weekly, provides clin. benefit, including improved quality of life, in patients with moderate-to-severe plaque psoriasis.  Efalizumab is assocd. with an early onset of action, with improvement noted as early as 14 days.  Studies with extended treatment suggest that continuing efalizumab therapy is more beneficial in maintaining and improving responses.  Relapse of psoriasis is usually seen within 60-70 days after discontinuation of therapy, and rebound in ∼ 5% of patients (i.e., flare to > 125% of baseline) is noted.  Efalizumab is assocd. with acute adverse events during the first and second injections, which decrease in incidence with each subsequent injection.  Data indicate that efalizumab can be safely administered for extended periods of time.  Given the efficacy, early onset of clin. benefit, the safety profile and the convenience of once-weekly s.c. home dosing, efalizumab offers an interesting new therapeutic option for the treatment of psoriasis and the potential for improved and potentially safer long-term, continuous 'maintenance' therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYQBAncoXPx7Vg90H21EOLACvtfcHk0lj8eLVXejrUOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitl2itLc%253D&md5=83f44740a5690138ce94bb1b0ded2f48</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1517%2F14712598.3.2.361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.3.2.361%26sid%3Dliteratum%253Aachs%26aulast%3DCather%26aufirst%3DJ.%2BC.%26aulast%3DCather%26aufirst%3DJ.%2BC.%26aulast%3DMenter%26aufirst%3DA.%26atitle%3DModulating%2520T%2520cell%2520responses%2520for%2520the%2520treatment%2520of%2520psoriasis%253A%2520a%2520focus%2520on%2520Efalizumab%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2003%26volume%3D3%26spage%3D361%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Dedrick, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walicke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garovoy, M.</span><span> </span><span class="NLM_article-title">Anti-adhesion antibodies Efalizumab, a humanized anti-CD11a monoclonal antibody</span> <span class="citation_source-journal">Transplant Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1016%2FS0966-3274%2802%2900029-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=12180828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlektLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=181-186&author=R.+L.+Dedrickauthor=P.+Walickeauthor=M.+Garovoy&title=Anti-adhesion+antibodies+Efalizumab%2C+a+humanized+anti-CD11a+monoclonal+antibody"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-adhesion antibodies efalizumab, a humanized anti-CD11a monoclonal antibody</span></div><div class="casAuthors">Dedrick, Russell L.; Walicke, Patricia; Garovoy, Marvin</div><div class="citationInfo"><span class="NLM_cas:title">Transplant Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2-4</span>),
    <span class="NLM_cas:pages">181-186</span>CODEN:
                <span class="NLM_cas:coden">TRIME2</span>;
        ISSN:<span class="NLM_cas:issn">0966-3274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The acquired immune response that leads to graft rejection depends on regulated adhesive interactions between T lymphocytes, endothelial cells, dendritic cells, graft tissue and the extracellular matrix to coordinate cellular trafficking and activation of antigen-reactive T lymphocytes.  Inhibiting the function of mols. involved in the adhesion processes offers the potential for interfering with the allograft response.  The leukocyte function assocd. antigen-1 mol. (LFA-1), a heterodimer of CD11a (αL) and CD18 (β2) integrin subunits, is an attractive therapeutic target because it plays an important role in key steps of inflammation and tissue rejection.  These include: (1) binding of leukocytes to endothelium; (2) trafficking through activated endothelium; and (3) costimulatory interactions between T lymphocytes and antigen presenting cells.  Clin. experience with efalizumab, a humanized anti-CD11a monoclonal antibody (mAb), in patients with chronic plaque psoriasis has shown that anti-CD11a therapy is well tolerated and effective at reducing the severity of the disease without depleting lymphocytes.  Initial results in renal transplant patients are also promising.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW06gOkUeKKLVg90H21EOLACvtfcHk0lh_BDBUppDkRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlektLg%253D&md5=9d0aa0f994a35380cb68a28c6616e50b</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1016%2FS0966-3274%2802%2900029-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0966-3274%252802%252900029-1%26sid%3Dliteratum%253Aachs%26aulast%3DDedrick%26aufirst%3DR.%2BL.%26aulast%3DWalicke%26aufirst%3DP.%26aulast%3DGarovoy%26aufirst%3DM.%26atitle%3DAnti-adhesion%2520antibodies%2520Efalizumab%252C%2520a%2520humanized%2520anti-CD11a%2520monoclonal%2520antibody%26jtitle%3DTransplant%2520Immunol.%26date%3D2002%26volume%3D9%26spage%3D181%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Liu, G.</span><span> </span><span class="NLM_article-title">Inhibitors of LFA-1/ICAM-1 interaction: From monoclonal antibodies to small molecules</span>.  <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span>− <span class="NLM_lpage">778</span> and references cited therein.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1358%2Fdof.2001.026.08.858713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlGhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2001&pages=767-778&author=G.+Liu&title=Inhibitors+of+LFA-1%2FICAM-1+interaction%3A+From+monoclonal+antibodies+to+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of LFA-1/ICAM-1 interaction: from monoclonal antibodies to small molecules</span></div><div class="casAuthors">Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">767-778</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The interaction between leukocyte function-assocd. antigen-1 (LFA-1), a member of β2-integrin family, and intercellular adhesion mol.-1 (ICAM-1) plays a crit. role in mediating cell adhesion, leukocyte transmigration and augmentation of T-cell receptor signaling.  Inhibitors of LFA-1/ICAM-1 interaction represent a new therapeutic area for treatment of diseases such as rheumatoid arthritis, psoriasis and ischemic reperfusion injury, and have evolved from monoclonal antibodies (MAbs) to small mols. as potential therapeutic agents.  This review will summarize the MAbs that have been or are being evaluated in clin. trials and will examine the discovery of the small-mol. antagonists.  The SAR of several of the leading series and the mechanism of action for some of these mols. will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxq8Qv8kyc6LVg90H21EOLACvtfcHk0lh_BDBUppDkRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlGhsL4%253D&md5=9bfe5cc765ec3cd25199c6b4d905f7a2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1358%2Fdof.2001.026.08.858713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2001.026.08.858713%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DInhibitors%2520of%2520LFA-1%252FICAM-1%2520interaction%253A%2520From%2520monoclonal%2520antibodies%2520to%2520small%2520molecules%26jtitle%3DDrugs%2520Future%26date%3D2001%26volume%3D26%26spage%3D767%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_contrib-group">Dodd, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheriff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetsko, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varcarro, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G. M.</span><span> </span><span class="NLM_article-title">Design of LFA-1 agonists based on a 2,3-dihydro-1<i>H</i>-pyrrolizin-5(7aH)-one scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1908</span><span class="NLM_x">–</span> <span class="NLM_lpage">1911</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1908-1911&author=D.+S.+Doddauthor=S.+Sheriffauthor=C.-Y.+J.+Changauthor=D.+K.+Stetskoauthor=L.+M.+Phillipsauthor=Y.+Zhangauthor=M.+Launayauthor=D.+Potinauthor=W.+Varcarroauthor=M.+A.+Possauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=S.+J.+Suchardauthor=T.+G.+M.+Dhar&title=Design+of+LFA-1+agonists+based+on+a+2%2C3-dihydro-1H-pyrrolizin-5%287aH%29-one+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDodd%26aufirst%3DD.%2BS.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DC.-Y.%2BJ.%26aulast%3DStetsko%26aufirst%3DD.%2BK.%26aulast%3DPhillips%26aufirst%3DL.%2BM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLaunay%26aufirst%3DM.%26aulast%3DPotin%26aufirst%3DD.%26aulast%3DVarcarro%26aufirst%3DW.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DSuchard%26aufirst%3DS.%2BJ.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26atitle%3DDesign%2520of%2520LFA-1%2520agonists%2520based%2520on%2520a%25202%252C3-dihydro-1H-pyrrolizin-5%25287aH%2529-one%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1908%26epage%3D1911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Potin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monatlik, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malabre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabreguette, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fouquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maillet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorgeret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevallier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufort, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caussade, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetsko, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balimane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postelneck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfarb, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherriff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einspahr, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMarco, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gougoutas, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadiyala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejwani, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traeger, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G. M.</span><span> </span><span class="NLM_article-title">Discovery and Development of 5-[(5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro [4.4]non-7-yl]methyl]-3-thiophenecarboxylic acid (BMS-587101)—A small molecule antagonist of leukocyte function associated antigen-1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6946</span><span class="NLM_x">–</span> <span class="NLM_lpage">6949</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0610806" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6946-6949&author=D.+Potinauthor=M.+Launayauthor=F.+Monatlikauthor=P.+Malabreauthor=M+Fabreguetteauthor=A.+Fouquetauthor=M.+Mailletauthor=E.+Nicolaiauthor=L.+Dorgeretauthor=F.+Chevallierauthor=D.+Besseauthor=M.+Dufortauthor=F.+Caussadeauthor=S.+Z.+Ahmadauthor=D.+K.+Stetskoauthor=S.+Skalaauthor=P.+M.+Davisauthor=P.+Balimaneauthor=K.+Patelauthor=Z.+Yangauthor=P.+Maratheauthor=J.+Postelneckauthor=R.+M.+Townsendauthor=V.+Goldfarbauthor=S.+Sherriffauthor=H.+Einspahrauthor=K.+Kishauthor=M.+F.+Malleyauthor=J.+D.+DiMarcoauthor=J.+Z.+Gougoutasauthor=P.+Kadiyalaauthor=D.+L.+Cheneyauthor=R.+W.+Tejwaniauthor=D.+K.+Murphyauthor=K.+W.+McIntyreauthor=X.+Yangauthor=S.+Chaoauthor=L.+Leithauthor=Z.+Xiaoauthor=A.+Mathurauthor=B.-C.+Chenauthor=D.-R.+Wuauthor=S.+C.+Traegerauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=J.+A.+Roblauthor=E.+J.+Iwanowiczauthor=S.+J.+Suchardauthor=T.+G.+M.+Dhar&title=Discovery+and+Development+of+5-%5B%285S%2C9R%29-9-%284-Cyanophenyl%29-3-%283%2C5-dichlorophenyl%29-1-methyl-2%2C4-dioxo-1%2C3%2C7-triazaspiro+%5B4.4%5Dnon-7-yl%5Dmethyl%5D-3-thiophenecarboxylic+acid+%28BMS-587101%29%E2%80%94A+small+molecule+antagonist+of+leukocyte+function+associated+antigen-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm0610806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610806%26sid%3Dliteratum%253Aachs%26aulast%3DPotin%26aufirst%3DD.%26aulast%3DLaunay%26aufirst%3DM.%26aulast%3DMonatlik%26aufirst%3DF.%26aulast%3DMalabre%26aufirst%3DP.%26aulast%3DFabreguette%26aufirst%3DM%26aulast%3DFouquet%26aufirst%3DA.%26aulast%3DMaillet%26aufirst%3DM.%26aulast%3DNicolai%26aufirst%3DE.%26aulast%3DDorgeret%26aufirst%3DL.%26aulast%3DChevallier%26aufirst%3DF.%26aulast%3DBesse%26aufirst%3DD.%26aulast%3DDufort%26aufirst%3DM.%26aulast%3DCaussade%26aufirst%3DF.%26aulast%3DAhmad%26aufirst%3DS.%2BZ.%26aulast%3DStetsko%26aufirst%3DD.%2BK.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DP.%2BM.%26aulast%3DBalimane%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DPostelneck%26aufirst%3DJ.%26aulast%3DTownsend%26aufirst%3DR.%2BM.%26aulast%3DGoldfarb%26aufirst%3DV.%26aulast%3DSherriff%26aufirst%3DS.%26aulast%3DEinspahr%26aufirst%3DH.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DMalley%26aufirst%3DM.%2BF.%26aulast%3DDiMarco%26aufirst%3DJ.%2BD.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DKadiyala%26aufirst%3DP.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DTejwani%26aufirst%3DR.%2BW.%26aulast%3DMurphy%26aufirst%3DD.%2BK.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DLeith%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DWu%26aufirst%3DD.-R.%26aulast%3DTraeger%26aufirst%3DS.%2BC.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DSuchard%26aufirst%3DS.%2BJ.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26atitle%3DDiscovery%2520and%2520Development%2520of%25205-%255B%25285S%252C9R%2529-9-%25284-Cyanophenyl%2529-3-%25283%252C5-dichlorophenyl%2529-1-methyl-2%252C4-dioxo-1%252C3%252C7-triazaspiro%2520%255B4.4%255Dnon-7-yl%255Dmethyl%255D-3-thiophenecarboxylic%2520acid%2520%2528BMS-587101%2529%25E2%2580%2594A%2520small%2520molecule%2520antagonist%2520of%2520leukocyte%2520function%2520associated%2520antigen-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6946%26epage%3D6949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Potin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabreguette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malabre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caussade, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetsko, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todderud, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheriff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenbaugh, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G. M.</span><span> </span><span class="NLM_article-title">De novo design, synthesis and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold</span> <span class="citation_source-journal">Biorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1161</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1016%2Fj.bmcl.2004.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=15686933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1Cruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1161-1164&author=D.+Potinauthor=M.+Launayauthor=E.+Nicolaiauthor=M.+Fabreguetteauthor=P.+Malabreauthor=F.+Caussadeauthor=D.+Besseauthor=S.+Skalaauthor=D.+K.+Stetskoauthor=G.+Todderudauthor=B.+R.+Benoauthor=D.+L.+Cheneyauthor=C.+J.+Changauthor=S.+Sheriffauthor=D.+L.+Hollenbaughauthor=J.+C.+Barrishauthor=E.+J.+Iwanowiczauthor=S.+J.+Suchardauthor=T.+G.+M.+Dhar&title=De+novo+design%2C+synthesis+and+in+vitro+activity+of+LFA-1+antagonists+based+on+a+bicyclic%5B5.5%5Dhydantoin+scaffold"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic [5.5]hydantoin scaffold</span></div><div class="casAuthors">Potin, Dominique; Launay, Michele; Nicolai, Eric; Fabreguette, Maud; Malabre, Patrice; Caussade, Francois; Besse, Dominique; Skala, Stacey; Stetsko, Dawn K.; Todderud, Gordon; Beno, Brett R.; Cheney, Daniel L.; Chang, Chiehying J.; Sheriff, Steven; Hollenbaugh, Diane L.; Barrish, Joel C.; Iwanowicz, Edwin J.; Suchard, Suzanne J.; Dhar, T. G. Murali</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1161-1164</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">LFA-1 (leukocyte function-assocd. antigen-1), is a member of the β2-integrin family and is expressed on all leukocytes.  The LFA-1/ICAM interaction promotes tight adhesion between activated leukocytes and the endothelium, as well as between T cells and antigen-presenting cells.  Evidence from both animal models and clin. trials provides support for LFA-1 as a target in several different inflammatory diseases.  This paper describes the de novo design, synthesis and in vitro activity of LFA-1 antagonists I [X = O, OCH2, SCH2, NHCH2, NH(CH2)2, NMeCH2, NEtCH2; R = 4-BrC6H4, 3-BrC6H4, 4-NCC6H4, 4-ClC6H4, etc.] based on a bicyclic [5.5]hydantoin scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpMFNMv9bg97Vg90H21EOLACvtfcHk0lhZyM5SFrcAeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1Cruw%253D%253D&md5=26f3ddbe2971e9c4a5a8b4278da733c1</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DPotin%26aufirst%3DD.%26aulast%3DLaunay%26aufirst%3DM.%26aulast%3DNicolai%26aufirst%3DE.%26aulast%3DFabreguette%26aufirst%3DM.%26aulast%3DMalabre%26aufirst%3DP.%26aulast%3DCaussade%26aufirst%3DF.%26aulast%3DBesse%26aufirst%3DD.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DStetsko%26aufirst%3DD.%2BK.%26aulast%3DTodderud%26aufirst%3DG.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DHollenbaugh%26aufirst%3DD.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DSuchard%26aufirst%3DS.%2BJ.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26atitle%3DDe%2520novo%2520design%252C%2520synthesis%2520and%2520in%2520vitro%2520activity%2520of%2520LFA-1%2520antagonists%2520based%2520on%2520a%2520bicyclic%255B5.5%255Dhydantoin%2520scaffold%26jtitle%3DBiorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1161%26epage%3D1164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wattanasin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weckbecker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzenbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitz-Schmidt, G.</span><span> </span><span class="NLM_article-title">1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1217-1220&author=S.+Wattanasinauthor=J.+Kallenauthor=S.+Myersauthor=Q.+Guoauthor=M.+Sabioauthor=C.+Ehrhardtauthor=R.+Albertauthor=U.+Hommelauthor=G.+Weckbeckerauthor=K.+Welzenbachauthor=G.+Weitz-Schmidt&title=1%2C4-Diazepane-2%2C5-diones+as+novel+inhibitors+of+LFA-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWattanasin%26aufirst%3DS.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DMyers%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DSabio%26aufirst%3DM.%26aulast%3DEhrhardt%26aufirst%3DC.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DWeckbecker%26aufirst%3DG.%26aulast%3DWelzenbach%26aufirst%3DK.%26aulast%3DWeitz-Schmidt%26aufirst%3DG.%26atitle%3D1%252C4-Diazepane-2%252C5-diones%2520as%2520novel%2520inhibitors%2520of%2520LFA-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1217%26epage%3D1220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wu, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emeigh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzmich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potocki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorcek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainolfi, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabozny, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothlein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woska, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T. A.</span><span> </span><span class="NLM_article-title">Second-generation lymphocyte function-associated antigen-1 inhibitors: 1<i>H</i>-Imidazo[1,2-a]imidazol-2-one derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5356</span><span class="NLM_x">–</span> <span class="NLM_lpage">5366</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049657b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5356-5366&author=J.-P.+Wuauthor=J.+Emeighauthor=A.+A.+Gaoauthor=D.+R.+Goldbergauthor=D.+Kuzmichauthor=C.+Miaoauthor=I.+Potockiauthor=K.+C.+Qianauthor=R.+J.+Sorcekauthor=D.+D.+Jeanfavreauthor=K.+Kishimotoauthor=E.+A.+Mainolfiauthor=G.+Naboznyauthor=C.+Pengauthor=P.+Reillyauthor=R.+Rothleinauthor=R.+H.+Sellatiauthor=J.+R.+Woskaauthor=S.+Chenauthor=J.+A.+Gunnauthor=D.+O%E2%80%99Brienauthor=S.+H.+Norrisauthor=T.+A.+Kelly&title=Second-generation+lymphocyte+function-associated+antigen-1+inhibitors%3A+1H-Imidazo%5B1%2C2-a%5Dimidazol-2-one+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Fjm049657b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049657b%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-P.%26aulast%3DEmeigh%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DA.%2BA.%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DKuzmich%26aufirst%3DD.%26aulast%3DMiao%26aufirst%3DC.%26aulast%3DPotocki%26aufirst%3DI.%26aulast%3DQian%26aufirst%3DK.%2BC.%26aulast%3DSorcek%26aufirst%3DR.%2BJ.%26aulast%3DJeanfavre%26aufirst%3DD.%2BD.%26aulast%3DKishimoto%26aufirst%3DK.%26aulast%3DMainolfi%26aufirst%3DE.%2BA.%26aulast%3DNabozny%26aufirst%3DG.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DReilly%26aufirst%3DP.%26aulast%3DRothlein%26aufirst%3DR.%26aulast%3DSellati%26aufirst%3DR.%2BH.%26aulast%3DWoska%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DGunn%26aufirst%3DJ.%2BA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DD.%26aulast%3DNorris%26aufirst%3DS.%2BH.%26aulast%3DKelly%26aufirst%3DT.%2BA.%26atitle%3DSecond-generation%2520lymphocyte%2520function-associated%2520antigen-1%2520inhibitors%253A%25201H-Imidazo%255B1%252C2-a%255Dimidazol-2-one%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5356%26epage%3D5366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gadek, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsters, J. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paris, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oare, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zioncheck, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumas, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claark, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilley, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presta, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodary, S. C.</span><span> </span><span class="NLM_article-title">Generation of an LFA-1 antagonist by the transfer of ICAM-1 immunoregulatory epitope to a small molecule</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1089</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2002&pages=1086-1089&author=T.+R.+Gadekauthor=D.+J.+Burdickauthor=R.+S.+McDowellauthor=M.+S.+Stanleyauthor=J.+C.+Marstersauthor=K.+J.+Parisauthor=D.+A.+Oareauthor=M.+E.+Reynoldsauthor=C.+Ladnerauthor=K.+A.+Zioncheckauthor=W.+P.+Leeauthor=P.+Griblingauthor=M.+S.+Dennisauthor=N.+J.+Skeltonauthor=D.+B.+Tumasauthor=K.+R.+Claarkauthor=S.+M.+Keatingauthor=M.+H.+Beresiniauthor=J.+W.+Tilleyauthor=L.+G.+Prestaauthor=S.+C.+Bodary&title=Generation+of+an+LFA-1+antagonist+by+the+transfer+of+ICAM-1+immunoregulatory+epitope+to+a+small+molecule"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGadek%26aufirst%3DT.%2BR.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DMcDowell%26aufirst%3DR.%2BS.%26aulast%3DStanley%26aufirst%3DM.%2BS.%26aulast%3DMarsters%26aufirst%3DJ.%2BC.%26aulast%3DParis%26aufirst%3DK.%2BJ.%26aulast%3DOare%26aufirst%3DD.%2BA.%26aulast%3DReynolds%26aufirst%3DM.%2BE.%26aulast%3DLadner%26aufirst%3DC.%26aulast%3DZioncheck%26aufirst%3DK.%2BA.%26aulast%3DLee%26aufirst%3DW.%2BP.%26aulast%3DGribling%26aufirst%3DP.%26aulast%3DDennis%26aufirst%3DM.%2BS.%26aulast%3DSkelton%26aufirst%3DN.%2BJ.%26aulast%3DTumas%26aufirst%3DD.%2BB.%26aulast%3DClaark%26aufirst%3DK.%2BR.%26aulast%3DKeating%26aufirst%3DS.%2BM.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DTilley%26aufirst%3DJ.%2BW.%26aulast%3DPresta%26aufirst%3DL.%2BG.%26aulast%3DBodary%26aufirst%3DS.%2BC.%26atitle%3DGeneration%2520of%2520an%2520LFA-1%2520antagonist%2520by%2520the%2520transfer%2520of%2520ICAM-1%2520immunoregulatory%2520epitope%2520to%2520a%2520small%2520molecule%26jtitle%3DScience%26date%3D2002%26volume%3D295%26spage%3D1086%26epage%3D1089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sircar, I.; Furth, P.; Teegarden, B. R.; Morningstar, M.; Smith, N.; Griffith, R.</span> Patent WO 0130781 (Tanabe Seiyaku)<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sircar%2C+I.%3B+Furth%2C+P.%3B+Teegarden%2C+B.+R.%3B+Morningstar%2C+M.%3B+Smith%2C+N.%3B+Griffith%2C+R.+Patent+WO+0130781+%28Tanabe+Seiyaku%29+2001."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSircar%26aufirst%3DI.%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Weitz-Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzenbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommel, U.</span><span> </span><span class="NLM_article-title">Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1038%2F89058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=11385505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlGkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=687-692&author=G.+Weitz-Schmidtauthor=K.+Welzenbachauthor=V.+Brinkmannauthor=T.+Kamataauthor=J.+Kallenauthor=C.+Brunsauthor=S.+Cottensauthor=Y.+Takadaauthor=U.+Hommel&title=Statins+selectively+inhibit+leukocyte+function+antigen-1+by+binding+to+a+novel+regulatory+integrin+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site</span></div><div class="casAuthors">Weitz-Schmidt, Gabriele; Welzenbach, Karl; Brinkmann, Volker; Kamata, Tetsji; Kallen, Joerg; Bruns, Christian; Cottens, Sylvain; Takada, Yoshikazu; Hommel, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">687-692</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The β2 integrin leukocyte function antigen-1 (LFA-1) has an important role in the pathophysiol. of inflammatory and autoimmune diseases.  Here we report that statin compds. commonly used for the treatment of hypercholesterolemia selectively blocked LFA-1-mediated adhesion and costimulation of lymphocytes.  This effect was unrelated to the statins' inhibition of 3-hydroxy-3-methylglutaryl coenzyme-A reductase; instead it occurred via binding to a novel allosteric site within LFA-1.  Subsequent optimization of the statins for LFA-1 binding resulted in potent, selective and orally active LFA-1 inhibitors that suppress the inflammatory response in a murine model of peritonitis.  Targeting of the statin-binding site of LFA-1 could be used to treat diseases such as psoriasis, rheumatoid arthritis, ischemia/reperfusion injury and transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_fuB_LsBXg7Vg90H21EOLACvtfcHk0lhMf19BcuvWdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlGkurc%253D&md5=74f1565e9ec7a8561b9ccfdd27782c66</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1038%2F89058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F89058%26sid%3Dliteratum%253Aachs%26aulast%3DWeitz-Schmidt%26aufirst%3DG.%26aulast%3DWelzenbach%26aufirst%3DK.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DKamata%26aufirst%3DT.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DHommel%26aufirst%3DU.%26atitle%3DStatins%2520selectively%2520inhibit%2520leukocyte%2520function%2520antigen-1%2520by%2520binding%2520to%2520a%2520novel%2520regulatory%2520integrin%2520site%26jtitle%3DNat.%2520Med.%26date%3D2001%26volume%3D7%26spage%3D687%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Kelly, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woska, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainolfi, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabozny, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothlein, R.</span><span> </span><span class="NLM_article-title">Cutting edge: A small molecule antagonist of LFA-1 mediated cell adhesion</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">5173</span><span class="NLM_x">–</span> <span class="NLM_lpage">5177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1999&pages=5173-5177&author=T.+A.+Kellyauthor=D.+D.+Jeanfavreauthor=D.+W.+McNeilauthor=R.+J.+Woskaauthor=L.+P.+Reillyauthor=E.+A.+Mainolfiauthor=K.+M.+Kishimotoauthor=G.+H.+Naboznyauthor=R.+Zinterauthor=B.+Bormannauthor=R.+Rothlein&title=Cutting+edge%3A+A+small+molecule+antagonist+of+LFA-1+mediated+cell+adhesion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DT.%2BA.%26aulast%3DJeanfavre%26aufirst%3DD.%2BD.%26aulast%3DMcNeil%26aufirst%3DD.%2BW.%26aulast%3DWoska%26aufirst%3DR.%2BJ.%26aulast%3DReilly%26aufirst%3DL.%2BP.%26aulast%3DMainolfi%26aufirst%3DE.%2BA.%26aulast%3DKishimoto%26aufirst%3DK.%2BM.%26aulast%3DNabozny%26aufirst%3DG.%2BH.%26aulast%3DZinter%26aufirst%3DR.%26aulast%3DBormann%26aufirst%3DB.%26aulast%3DRothlein%26aufirst%3DR.%26atitle%3DCutting%2520edge%253A%2520A%2520small%2520molecule%2520antagonist%2520of%2520LFA-1%2520mediated%2520cell%2520adhesion%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D163%26spage%3D5173%26epage%3D5177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Last-Barney, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grygon, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zindell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T. A.</span><span> </span><span class="NLM_article-title">Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary techniques: Evidence for the allosteric inhibition of a protein−protein interaction</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">5643</span><span class="NLM_x">–</span> <span class="NLM_lpage">5650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2001&pages=5643-5650&author=K.+Last-Barneyauthor=W.+Davidsonauthor=M.+Cardozoauthor=L.+L.+Fryeauthor=C.+A.+Grygonauthor=J.+L.+Hopkinsauthor=D.+D.+Jeanfavreauthor=S.+Pavauthor=C.+Qianauthor=J.+M.+Stevensonauthor=L.+Tongauthor=R.+Zindellauthor=T.+A.+Kelly&title=Binding+site+elucidation+of+hydantoin-based+antagonists+of+LFA-1+using+multidisciplinary+techniques%3A+Evidence+for+the+allosteric+inhibition+of+a+protein%E2%88%92protein+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLast-Barney%26aufirst%3DK.%26aulast%3DDavidson%26aufirst%3DW.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGrygon%26aufirst%3DC.%2BA.%26aulast%3DHopkins%26aufirst%3DJ.%2BL.%26aulast%3DJeanfavre%26aufirst%3DD.%2BD.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DStevenson%26aufirst%3DJ.%2BM.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DZindell%26aufirst%3DR.%26aulast%3DKelly%26aufirst%3DT.%2BA.%26atitle%3DBinding%2520site%2520elucidation%2520of%2520hydantoin-based%2520antagonists%2520of%2520LFA-1%2520using%2520multidisciplinary%2520techniques%253A%2520Evidence%2520for%2520the%2520allosteric%2520inhibition%2520of%2520a%2520protein%25E2%2588%2592protein%2520interaction%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D125%26spage%3D5643%26epage%3D5650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="note"><p class="first last">Similar results were seen with a Boehringer−Igelheim series of LFA-1 antagonists.</p></div><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Winquist, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabozny, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzenbeck, M.</span><span> </span><span class="NLM_article-title">The role of leukocyte function-associated antigen-1 in animal models of inflammation</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">429</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1016%2FS0014-2999%2801%2901328-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=11698049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFWitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=429&publication_year=2001&pages=297-302&author=R.+J.+Winquistauthor=S.+Desaiauthor=S.+Fogalauthor=N.+A.+Haynesauthor=G.+H.+Naboznyauthor=P.+L.+Reillyauthor=D.+Souzaauthor=M.+Panzenbeck&title=The+role+of+leukocyte+function-associated+antigen-1+in+animal+models+of+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of leukocyte function-associated antigen-1 in animal models of inflammation</span></div><div class="casAuthors">Winquist, Raymond J.; Desai, Sudha; Fogal, Stephen; Haynes, Nancy A.; Nabozny, Gerald H.; Reilly, Patricia L.; Souza, Donald; Panzenbeck, Maret</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">429</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">297-302</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Both preclin. and clin. data have identified leukocyte function-assocd. antigen-1 (LFA-1) as an important component of inflammatory disease states.  The authors evaluated small mol. inhibitors of this glycoprotein in several animal models in which the inflammatory process is dependent on human or non-human primate LFA-1. (R)-5(4-bromobenzyl)-3(3,5-dichlorophenyl)-1,5-dimethylimidazolidine-2,4-dione, BIRT 377, effectively suppressed the prodn. of human Ig (IgG) following reconstitution of severe combined immunodeficient (SCID) mice with human peripheral blood mononuclear cells.  The BIRT 377 analog, BIX 642, inhibited the cellular infiltrate and increase in skin thickness assocd. with the delayed-type hypersensitivity reaction in previously immunized squirrel monkeys challenged with antigen.  BIX 642 also inhibited the trans-vivo delayed-type hypersensitivity response in the footpads of SCID mice injected with human peripheral blood mononuclear cells and donor-sensitive antigen.  These results demonstrate the efficacy of small mol. inhibitors of LFA-1 in preclin. models of inflammation dependent on human or non-human primate LFA-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0Qvv4aTLgobVg90H21EOLACvtfcHk0ljRy6XzZdf2qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFWitLw%253D&md5=d0251932ab9bd1d8d9284c069812bbfb</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2901328-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252901328-0%26sid%3Dliteratum%253Aachs%26aulast%3DWinquist%26aufirst%3DR.%2BJ.%26aulast%3DDesai%26aufirst%3DS.%26aulast%3DFogal%26aufirst%3DS.%26aulast%3DHaynes%26aufirst%3DN.%2BA.%26aulast%3DNabozny%26aufirst%3DG.%2BH.%26aulast%3DReilly%26aufirst%3DP.%2BL.%26aulast%3DSouza%26aufirst%3DD.%26aulast%3DPanzenbeck%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520leukocyte%2520function-associated%2520antigen-1%2520in%2520animal%2520models%2520of%2520inflammation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D429%26spage%3D297%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Panzenbeck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabozny, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, S.</span><span> </span><span class="NLM_article-title">An orally active, primate selective antagonist of LFA-1 inhibits delayed-type hypersensitivity in a humanized-mouse model</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">534</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1016%2Fj.ejphar.2006.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=16487962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit12jtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=534&publication_year=2006&pages=233-240&author=M.+J.+Panzenbeckauthor=D.+D.+Jeanfavreauthor=T.+A.+Kellyauthor=R.+Lemieuxauthor=G.+Naboznyauthor=P.+L.+Reillyauthor=S.+Desai&title=An+orally+active%2C+primate+selective+antagonist+of+LFA-1+inhibits+delayed-type+hypersensitivity+in+a+humanized-mouse+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">An orally active, primate selective antagonist of LFA-1 inhibits delayed-type hypersensitivity in a humanized-mouse model</span></div><div class="casAuthors">Panzenbeck, Maret J.; Jeanfavre, Deborah D.; Kelly, Terence A.; Lemieux, Rene; Nabozny, Gerald; Reilly, Patricia L.; Desai, Sudha</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">534</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">233-240</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Compd. I, a novel small mol. antagonist (Kd = 6 nM) of human lymphocyte function-assocd. antigen-1 (LFA-1, CD11a/CD18) was tested for activity in a humanized mouse model of delayed-type hypersensitivity (trans vivo delayed-type hypersensitivity).  Trans vivo delayed-type hypersensitivity is a model for testing compds. with human targets in mice.  Tetanus toxoid and 7-10 × 106 human peripheral blood mononuclear cells from tetanus-sensitized donors were coinjected into footpads of naive mice.  Footpads were measured before and 24 h later.  Injection of peripheral blood mononuclear cells plus antigen resulted in swelling of 0.178-0.254 mm, significantly greater than peripheral blood mononuclear cells or tetanus toxoid alone (P < 0.05).  Preincubation of peripheral blood mononuclear cells with anti-human major histocompatibility complex class II (MHCII) or anti-human LFA-1 monoclonal antibody (mAb), but not anti-mouse MHCII or anti-mouse LFA-1 mAb, significantly inhibited the response.  Compd. I inhibited footpad swelling in a dose related manner (0.1-100 mg/kg, p.o.; ED50 ∼ 1 mg/kg), whereas its enantiomer had no effect.  These data demonstrate the oral efficacy of a novel antagonist of LFA-1 in trans vivo delayed-type hypersensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD6dwX49BszrVg90H21EOLACvtfcHk0ljRy6XzZdf2qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit12jtLo%253D&md5=ffff54b30a9738bfcab4c892c03580f6</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DPanzenbeck%26aufirst%3DM.%2BJ.%26aulast%3DJeanfavre%26aufirst%3DD.%2BD.%26aulast%3DKelly%26aufirst%3DT.%2BA.%26aulast%3DLemieux%26aufirst%3DR.%26aulast%3DNabozny%26aufirst%3DG.%26aulast%3DReilly%26aufirst%3DP.%2BL.%26aulast%3DDesai%26aufirst%3DS.%26atitle%3DAn%2520orally%2520active%252C%2520primate%2520selective%2520antagonist%2520of%2520LFA-1%2520inhibits%2520delayed-type%2520hypersensitivity%2520in%2520a%2520humanized-mouse%2520model%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D534%26spage%3D233%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Sushard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetsko, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Susulic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter-Cid, L.</span><span> </span><span class="NLM_article-title">An LFA-1 (a<sub>L</sub>,b<sub>2</sub>) small-modecule antagonist reduces inflammation and joint destruction in murine models of arthritis</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">3917</span><span class="NLM_x">–</span> <span class="NLM_lpage">3926</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2010&pages=3917-3926&author=S.+J.+Sushardauthor=D.+K.+Stetskoauthor=P.+M.+Davisauthor=S.+Skalaauthor=D.+Potinauthor=M.+Launayauthor=T.+G.+M.+Dharauthor=J.+C.+Barrishauthor=V.+Susulicauthor=D.+J.+Shusterauthor=K.+W.+McIntyreauthor=M.+McKinnonauthor=L.+Salter-Cid&title=An+LFA-1+%28aL%2Cb2%29+small-modecule+antagonist+reduces+inflammation+and+joint+destruction+in+murine+models+of+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSushard%26aufirst%3DS.%2BJ.%26aulast%3DStetsko%26aufirst%3DD.%2BK.%26aulast%3DDavis%26aufirst%3DP.%2BM.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DPotin%26aufirst%3DD.%26aulast%3DLaunay%26aufirst%3DM.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DSusulic%26aufirst%3DV.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DSalter-Cid%26aufirst%3DL.%26atitle%3DAn%2520LFA-1%2520%2528aL%252Cb2%2529%2520small-modecule%2520antagonist%2520reduces%2520inflammation%2520and%2520joint%2520destruction%2520in%2520murine%2520models%2520of%2520arthritis%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D184%26spage%3D3917%26epage%3D3926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Dhar, T. G. M.; Launay, M.; Potin, D; Watterson, S. H.; Xiao, Z.</span><span> </span><span class="NLM_article-title">Pyridyl-substituted spiro-hydantoin compounds and their preparation, pharmaceutical compositions and use for treatment of immune and inflammatory diseases</span>. US 7186727 2007; </span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dhar%2C+T.+G.+M.%3B+Launay%2C+M.%3B+Potin%2C+D%3B+Watterson%2C+S.+H.%3B+Xiao%2C+Z.+Pyridyl-substituted+spiro-hydantoin+compounds+and+their+preparation%2C+pharmaceutical+compositions+and+use+for+treatment+of+immune+and+inflammatory+diseases.+US+7186727+2007%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26atitle%3DPyridyl-substituted%2520spiro-hydantoin%2520compounds%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520for%2520treatment%2520of%2520immune%2520and%2520inflammatory%2520diseases" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="ref11_2"><span> <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">83333</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem.+Abstr.+2006%2C+145%2C+83333."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref11_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2006%26volume%3D145%26spage%3D83333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Jiang, L.; Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Palladium catalyzed aromatic carbon-nitrogen bond formation</span>. In  <span class="citation_source-book">Metal-Catalyzed Cross-Coupling Reactions</span>, <span class="NLM_edition">2nd</span> ed.: <span class="NLM_contrib-group">De Meijere, A.; Diederich, F.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">699</span>− <span class="NLM_lpage">760</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1002%2F9783527619535.ch13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=699-760&author=L.+Jiang&author=S.+L.+Buchwaldauthor=A.+De+Meijere&author=F.+Diederich&title=Metal-Catalyzed+Cross-Coupling+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2F9783527619535.ch13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527619535.ch13%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26atitle%3DPalladium%2520catalyzed%2520aromatic%2520carbon-nitrogen%2520bond%2520formation%26btitle%3DMetal-Catalyzed%2520Cross-Coupling%2520Reactions%26aulast%3DDe%2BMeijere%26aufirst%3DA.%26pub%3DWiley-VCH%26date%3D2004%26spage%3D699%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Chan, D. M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaco, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, P. Y. S.</span><span> </span><span class="NLM_article-title">Copper promoted C−N and C−O bond cross-coupling with phenyl and pryidylboronates</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3863</span><span class="NLM_x">–</span> <span class="NLM_lpage">3865</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=3863-3865&author=D.+M.+T.+Chanauthor=K.+L.+Monacoauthor=R.+Liauthor=D.+Bonneauthor=C.+G.+Clarkauthor=P.+Y.+S.+Lam&title=Copper+promoted+C%E2%88%92N+and+C%E2%88%92O+bond+cross-coupling+with+phenyl+and+pryidylboronates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BM.%2BT.%26aulast%3DMonaco%26aufirst%3DK.%2BL.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DBonne%26aufirst%3DD.%26aulast%3DClark%26aufirst%3DC.%2BG.%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26atitle%3DCopper%2520promoted%2520C%25E2%2588%2592N%2520and%2520C%25E2%2588%2592O%2520bond%2520cross-coupling%2520with%2520phenyl%2520and%2520pryidylboronates%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D3863%26epage%3D3865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ohta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawachi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagechika, H.</span><span> </span><span class="NLM_article-title">Retinoidal pyrimidinecarboxylic acids. Unexpected diaza-substituent effects in retinobenzoic acids</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1504</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2000&pages=1504-1513&author=K.+Ohtaauthor=E.+Kawachiauthor=N.+Inoueauthor=H.+Fukasawaauthor=Y.+Hashimotoauthor=A.+Itaiauthor=H.+Kagechika&title=Retinoidal+pyrimidinecarboxylic+acids.+Unexpected+diaza-substituent+effects+in+retinobenzoic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhta%26aufirst%3DK.%26aulast%3DKawachi%26aufirst%3DE.%26aulast%3DInoue%26aufirst%3DN.%26aulast%3DFukasawa%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DItai%26aufirst%3DA.%26aulast%3DKagechika%26aufirst%3DH.%26atitle%3DRetinoidal%2520pyrimidinecarboxylic%2520acids.%2520Unexpected%2520diaza-substituent%2520effects%2520in%2520retinobenzoic%2520acids%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2000%26volume%3D48%26spage%3D1504%26epage%3D1513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Takamizawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, K.</span><span> </span><span class="NLM_article-title">Pyrimidine derivatives, XXX1. Reactions of ethyl 2-methoxy-methylene-3-ethoxypropionate with ureas</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1964&pages=804-808&author=A.+Takamizawaauthor=K.+Hirai&title=Pyrimidine+derivatives%2C+XXX1.+Reactions+of+ethyl+2-methoxy-methylene-3-ethoxypropionate+with+ureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakamizawa%26aufirst%3DA.%26aulast%3DHirai%26aufirst%3DK.%26atitle%3DPyrimidine%2520derivatives%252C%2520XXX1.%2520Reactions%2520of%2520ethyl%25202-methoxy-methylene-3-ethoxypropionate%2520with%2520ureas%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1964%26volume%3D12%26spage%3D804%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McOmie, J. F. W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, I. M.</span><span> </span><span class="NLM_article-title">Pyrimidines. Part VI. 5-Bromopyrimidine</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_fpage">3129</span><span class="NLM_x">–</span> <span class="NLM_lpage">3131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1953&pages=3129-3131&author=J.+F.+W+McOmieauthor=I.+M.+White&title=Pyrimidines.+Part+VI.+5-Bromopyrimidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcOmie%26aufirst%3DJ.%2BF.%2BW%26aulast%3DWhite%26aufirst%3DI.%2BM.%26atitle%3DPyrimidines.%2520Part%2520VI.%25205-Bromopyrimidine%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1953%26spage%3D3129%26epage%3D3131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kim, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haines, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, J. J.</span><span> </span><span class="NLM_article-title">Synthesis of pyrimidine-2-one nuclorsides as acid-stable inhibitors of cytidine deaminase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1374</span><span class="NLM_x">–</span> <span class="NLM_lpage">1380</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00158a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=1374-1380&author=C.-H.+Kimauthor=V.+E.+Marquezauthor=D.+T.+Maoauthor=D.+R.+Hainesauthor=J.+J.+McCormack&title=Synthesis+of+pyrimidine-2-one+nuclorsides+as+acid-stable+inhibitors+of+cytidine+deaminase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fjm00158a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00158a009%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DC.-H.%26aulast%3DMarquez%26aufirst%3DV.%2BE.%26aulast%3DMao%26aufirst%3DD.%2BT.%26aulast%3DHaines%26aufirst%3DD.%2BR.%26aulast%3DMcCormack%26aufirst%3DJ.%2BJ.%26atitle%3DSynthesis%2520of%2520pyrimidine-2-one%2520nuclorsides%2520as%2520acid-stable%2520inhibitors%2520of%2520cytidine%2520deaminase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D1374%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Clark, M. P.; Laufersweiler, M. J.; Djung, J. F.; Natchus, M. G.; De, B.</span><span> </span><span class="NLM_article-title">Preparation of 3-(pyrimidin-4-yl)-6,7-dihydro-5<i>H</i>-pyrazolo[1,2-<i>a</i>]pyrazol-1-ones for control of inflammatory cytokines</span>. Patent WO 2003024971 A1 20030327,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=M.+P.+Clark&author=M.+J.+Laufersweiler&author=J.+F.+Djung&author=M.+G.+Natchus&author=B.+De&title=Preparation+of+3-%28pyrimidin-4-yl%29-6%2C7-dihydro-5H-pyrazolo%5B1%2C2-a%5Dpyrazol-1-ones+for+control+of+inflammatory+cytokines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DM.%2BP.%26atitle%3DPreparation%2520of%25203-%2528pyrimidin-4-yl%2529-6%252C7-dihydro-5H-pyrazolo%255B1%252C2-a%255Dpyrazol-1-ones%2520for%2520control%2520of%2520inflammatory%2520cytokines%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="ref15_4"><span> <span class="citation_source-journal">Chem Abst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">271694</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem+Abst.+2003%2C+138%2C+271694."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref15_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem%2520Abst.%26date%3D2003%26volume%3D138%26spage%3D271694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Daves, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baiocchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. C.</span><span> </span><span class="NLM_article-title">Pyrimidines. II. Orotic acid analogs</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2755</span><span class="NLM_x">–</span> <span class="NLM_lpage">2763</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01066a033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=2755-2763&author=G.+D.+Davesauthor=F.+Baiocchiauthor=R.+K.+Robinsauthor=C.+C.+Cheng&title=Pyrimidines.+II.+Orotic+acid+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjo01066a033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01066a033%26sid%3Dliteratum%253Aachs%26aulast%3DDaves%26aufirst%3DG.%2BD.%26aulast%3DBaiocchi%26aufirst%3DF.%26aulast%3DRobins%26aufirst%3DR.%2BK.%26aulast%3DCheng%26aufirst%3DC.%2BC.%26atitle%3DPyrimidines.%2520II.%2520Orotic%2520acid%2520analogs%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D2755%26epage%3D2763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Daves, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. C.</span><span> </span><span class="NLM_article-title">Pyrimidines. X111. 2- and 6-substituted 4-pyrimidinecarboxylic acids (1a)</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1964&pages=130-133&author=G.+D.+Davesauthor=D.+E.+O%E2%80%99Brienauthor=L.+R.+Lewisauthor=C.+C.+Cheng&title=Pyrimidines.+X111.+2-+and+6-substituted+4-pyrimidinecarboxylic+acids+%281a%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaves%26aufirst%3DG.%2BD.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DD.%2BE.%26aulast%3DLewis%26aufirst%3DL.%2BR.%26aulast%3DCheng%26aufirst%3DC.%2BC.%26atitle%3DPyrimidines.%2520X111.%25202-%2520and%25206-substituted%25204-pyrimidinecarboxylic%2520acids%2520%25281a%2529%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1964%26volume%3D1%26spage%3D130%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lok, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, A. J.</span><span> </span><span class="NLM_article-title">Facile rearrangements of alkynylamino heterocyles with noble metal cations</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3289</span><span class="NLM_x">–</span> <span class="NLM_lpage">3297</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo952101z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3289-3297&author=R.+Lokauthor=R.+E.+Leoneauthor=A.+J.+Williams&title=Facile+rearrangements+of+alkynylamino+heterocyles+with+noble+metal+cations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjo952101z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo952101z%26sid%3Dliteratum%253Aachs%26aulast%3DLok%26aufirst%3DR.%26aulast%3DLeone%26aufirst%3DR.%2BE.%26aulast%3DWilliams%26aufirst%3DA.%2BJ.%26atitle%3DFacile%2520rearrangements%2520of%2520alkynylamino%2520heterocyles%2520with%2520noble%2520metal%2520cations%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3289%26epage%3D3297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Edwards, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessinger, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presta, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodary, S. C.</span><span> </span><span class="NLM_article-title">Identification of amino acids in the CD11a I-domain important for binding of the leukocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">12635</span><span class="NLM_x">–</span> <span class="NLM_lpage">12640</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=12635-12640&author=C.+P.+Edwardsauthor=M.+Champeauthor=T.+Gonzalezauthor=M.+E.+Wessingerauthor=S.+A.+Spencerauthor=L.+G.+Prestaauthor=P.+W.+Bermanauthor=S.+C.+Bodary&title=Identification+of+amino+acids+in+the+CD11a+I-domain+important+for+binding+of+the+leukocyte+function-associated+antigen-1+%28LFA-1%29+to+intercellular+adhesion+molecule-1+%28ICAM-1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DC.%2BP.%26aulast%3DChampe%26aufirst%3DM.%26aulast%3DGonzalez%26aufirst%3DT.%26aulast%3DWessinger%26aufirst%3DM.%2BE.%26aulast%3DSpencer%26aufirst%3DS.%2BA.%26aulast%3DPresta%26aufirst%3DL.%2BG.%26aulast%3DBerman%26aufirst%3DP.%2BW.%26aulast%3DBodary%26aufirst%3DS.%2BC.%26atitle%3DIdentification%2520of%2520amino%2520acids%2520in%2520the%2520CD11a%2520I-domain%2520important%2520for%2520binding%2520of%2520the%2520leukocyte%2520function-associated%2520antigen-1%2520%2528LFA-1%2529%2520to%2520intercellular%2520adhesion%2520molecule-1%2520%2528ICAM-1%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D12635%26epage%3D12640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Otwinowski, Z.; Minor, W.</span> In  <span class="citation_source-book">Methods in Enzymology, Vol. 276: Macromolecular Crystallography Part A</span>; <span class="NLM_contrib-group">Abelson, J. N.; Simon, M. I.; Carter, C. W.,  Jr.; Sweet, R. M.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span><span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">307</span>− <span class="NLM_lpage">326</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=J.+N.+Abelson&author=M.+I.+Simon&author=C.+W.+Carter&author=R.+M.+Sweet&title=Methods+in+Enzymology%2C+Vol.+276%3A+Macromolecular+Crystallography+Part+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26btitle%3DMethods%2520in%2520Enzymology%252C%2520Vol.%2520276%253A%2520Macromolecular%2520Crystallography%2520Part%2520A%26aulast%3DAbelson%26aufirst%3DJ.%2BN.%26pub%3DAcademic%2520Press%26date%3D1997%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span> Collaborative Computational Project, Number 4. <span> </span><span class="NLM_article-title">The CCP4 Suite: programs for protein crystallography</span>.  <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span>− <span class="NLM_lpage">763</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=15299374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A280%3ADC%252BD2czpsV2gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Collaborative+Computational+Project%2C+Number+4.+The+CCP4+Suite%3A+programs+for+protein+crystallography.+Acta+Crystallogr.%2C+Sect.+D%3A+Biol.+Crystallogr.+1994%2C+50%2C+760%E2%88%92763."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">The CCP4 suite: programs for protein crystallography</span></div><div class="casAuthors">Anonymous</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">760-3</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The CCP4 (Collaborative Computational Project, number 4) program suite is a collection of programs and associated data and subroutine libraries which can be used for macromolecular structure determination by X-ray crystallography.  The suite is designed to be flexible, allowing users a number of methods of achieving their aims and so there may be more than one program to cover each function.  The programs are written mainly in standard Fortran77.  They are from a wide variety of sources but are connected by standard data file formats.  The package has been ported to all the major platforms under both Unix and VMS.  The suite is distributed by anonymous ftp from Daresbury Laboratory and is widely used throughout the world.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1Q-skJYIZ2IYPsCkJIw00fW6udTcc2eYI6yGKpDiWpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czpsV2gug%253D%253D&md5=92b759927d6071ea3f20c08b78ad1eb2</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520CCP4%2520Suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Navaza, J.</span><span> </span><span class="NLM_article-title">AMoRe: an automated package for molecular replacement</span>.  <span class="citation_source-journal">Acta Crystallogr., Sect. A: Found. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span>− <span class="NLM_lpage">163</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1107%2FS0108767393007597" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=157-163&author=J.+Navaza&title=AMoRe%3A+an+automated+package+for+molecular+replacement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1107%2FS0108767393007597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767393007597%26sid%3Dliteratum%253Aachs%26aulast%3DNavaza%26aufirst%3DJ.%26atitle%3DAMoRe%253A%2520an%2520automated%2520package%2520for%2520molecular%2520replacement%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D157%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span>CNX release 2002;, <span class="NLM_publisher-name">Accelrys, Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CNX+release+2002%3B%2C+Accelrys%2C+Inc.%3A+San+Diego%2C+CA%2C+2002."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCNX%2520release%25202002%26pub%3DAccelrys%252C%2520Inc%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span>QUANTA Modeling Environment release 2000; <span class="NLM_publisher-name">Accelrys Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=QUANTA+Modeling+Environment+release+2000%3B+Accelrys+Inc.%3A+San+Diego%2C+CA%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DQUANTA%2520Modeling%2520Environment%2520release%25202000%26pub%3DAccelrys%2520Inc%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b','cit2c','cit2d','cit2e'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c','cit4d'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e','cit7f'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11','ref11_2'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':['cit15a','cit15b','cit15c','ref15_4'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 36 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Bingsong Han, Francesco G. Salituro, <span class="NLM_string-name hlFld-ContribAuthor">Maria-Jesus Blanco</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1810-1819. <a href="https://doi.org/10.1021/acsmedchemlett.9b00655" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00655%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImpact%252Bof%252BAllosteric%252BModulation%252Bin%252BDrug%252BDiscovery%25253A%252BInnovation%252Bin%252BEmerging%252BChemical%252BModalities%26aulast%3DHan%26aufirst%3DBingsong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26122019%26date%3D10032020%26date%3D20032020%26date%3D10032020%26volume%3D11%26issue%3D10%26spage%3D1810%26epage%3D1819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yajun Zheng, <span class="NLM_string-name hlFld-ContribAuthor">Katerina Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into Protein–Ligand Interactions in Integrin Complexes: Advances in Structure Determinations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5675-5696. <a href="https://doi.org/10.1021/acs.jmedchem.9b01869" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01869</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01869%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInsights%252Binto%252BProtein%2525E2%252580%252593Ligand%252BInteractions%252Bin%252BIntegrin%252BComplexes%25253A%252BAdvances%252Bin%252BStructure%252BDeterminations%26aulast%3DZheng%26aufirst%3DYajun%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D11112019%26date%3D13022020%26date%3D30012020%26volume%3D63%26issue%3D11%26spage%3D5675%26epage%3D5696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dnyaneshwar
N. Garad, <span class="NLM_string-name hlFld-ContribAuthor">Santosh B. Mhaske</span>. </span><span class="cited-content_cbyCitation_article-title">Ru-Catalyzed Regioselective Cascade Annulation of Acrylamides with 2-Alkynoates for the Synthesis of Various 6-Oxo Nicotinic Acid Esters. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (4)
                                     , 1863-1870. <a href="https://doi.org/10.1021/acs.joc.8b02783" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02783%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRu-Catalyzed%252BRegioselective%252BCascade%252BAnnulation%252Bof%252BAcrylamides%252Bwith%252B2-Alkynoates%252Bfor%252Bthe%252BSynthesis%252Bof%252BVarious%252B6-Oxo%252BNicotinic%252BAcid%252BEsters%26aulast%3DGarad%26aufirst%3DDnyaneshwar%2BN.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D31102018%26date%3D30012019%26date%3D15012019%26volume%3D84%26issue%3D4%26spage%3D1863%26epage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laure  Konnert</span>, <span class="hlFld-ContribAuthor ">Frédéric  Lamaty</span>, <span class="hlFld-ContribAuthor ">Jean  Martinez</span>, and <span class="hlFld-ContribAuthor ">Evelina  Colacino</span>  . </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Synthesis of Hydantoins: The State of the Art of a Valuable Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2017,</strong> <em>117 </em>
                                    (23)
                                     , 13757-13809. <a href="https://doi.org/10.1021/acs.chemrev.7b00067" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00067%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BSynthesis%252Bof%252BHydantoins%25253A%252BThe%252BState%252Bof%252Bthe%252BArt%252Bof%252Ba%252BValuable%252BScaffold%26aulast%3DKonnert%26aufirst%3DLaure%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D30012017%26date%3D23062017%26date%3D13122017%26volume%3D117%26issue%3D23%26spage%3D13757%26epage%3D13809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Albert J.  DelMonte</span>, <span class="hlFld-ContribAuthor ">Yu  Fan</span>, <span class="hlFld-ContribAuthor ">Kevin P.  Girard</span>, <span class="hlFld-ContribAuthor ">Gregory S.  Jones</span>, <span class="hlFld-ContribAuthor ">Robert E.  Waltermire</span>, <span class="hlFld-ContribAuthor ">Victor  Rosso</span>, and <span class="hlFld-ContribAuthor ">Xuebao  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Kilogram Synthesis of a Second-Generation LFA-1/ICAM Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2011,</strong> <em>15 </em>
                                    (1)
                                     , 64-72. <a href="https://doi.org/10.1021/op100225g" title="DOI URL">https://doi.org/10.1021/op100225g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op100225g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop100225g%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DKilogram%252BSynthesis%252Bof%252Ba%252BSecond-Generation%252BLFA-1%25252FICAM%252BInhibitor%26aulast%3DDelMonte%26aufirst%3DAlbert%2BJ.%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D13%25208%25202010%26date%3D29112010%26date%3D21012011%26volume%3D15%26issue%3D1%26spage%3D64%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristina  Gak Simić</span>, <span class="hlFld-ContribAuthor ">Ivana  Đorđević</span>, <span class="hlFld-ContribAuthor ">Anita  Lazić</span>, <span class="hlFld-ContribAuthor ">Lidija  Radovanović</span>, <span class="hlFld-ContribAuthor ">Marija  Petković-Benazzouz</span>, <span class="hlFld-ContribAuthor ">Jelena  Rogan</span>, <span class="hlFld-ContribAuthor ">Nemanja  Trišović</span>, <span class="hlFld-ContribAuthor ">Goran  Janjić</span>. </span><span class="cited-content_cbyCitation_article-title">On the supramolecular outcomes of fluorination of cyclohexane-5-spirohydantoin derivatives. </span><span class="cited-content_cbyCitation_journal-name">CrystEngComm</span><span> <strong>2021,</strong> <em>23 </em>
                                    (13)
                                     , 2606-2622. <a href="https://doi.org/10.1039/D0CE01841D" title="DOI URL">https://doi.org/10.1039/D0CE01841D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CE01841D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CE01841D%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystEngComm%26atitle%3DOn%252Bthe%252Bsupramolecular%252Boutcomes%252Bof%252Bfluorination%252Bof%252Bcyclohexane-5-spirohydantoin%252Bderivatives%26aulast%3DGak%2BSimi%25C4%2587%26aufirst%3DKristina%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D13%26spage%3D2606%26epage%3D2622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuefei  Jin</span>, <span class="hlFld-ContribAuthor ">Wangquan  Ji</span>, <span class="hlFld-ContribAuthor ">Haiyan  Yang</span>, <span class="hlFld-ContribAuthor ">Shuaiyin  Chen</span>, <span class="hlFld-ContribAuthor ">Weiguo  Zhang</span>, <span class="hlFld-ContribAuthor ">Guangcai  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2020,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-020-00454-7" title="DOI URL">https://doi.org/10.1038/s41392-020-00454-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-020-00454-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-020-00454-7%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DEndothelial%252Bactivation%252Band%252Bdysfunction%252Bin%252BCOVID-19%25253A%252Bfrom%252Bbasic%252Bmechanisms%252Bto%252Bpotential%252Btherapeutic%252Bapproaches%26aulast%3DJin%26aufirst%3DYuefei%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Duan  Ni</span>, <span class="hlFld-ContribAuthor ">Shaoyong  Lu</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging roles of allosteric modulators in the regulation of protein‐protein interactions (PPIs): A new paradigm for PPI drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (6)
                                     , 2314-2342. <a href="https://doi.org/10.1002/med.21585" title="DOI URL">https://doi.org/10.1002/med.21585</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21585%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DEmerging%252Broles%252Bof%252Ballosteric%252Bmodulators%252Bin%252Bthe%252Bregulation%252Bof%252Bprotein%2525E2%252580%252590protein%252Binteractions%252B%252528PPIs%252529%25253A%252BA%252Bnew%252Bparadigm%252Bfor%252BPPI%252Bdrug%252Bdiscovery%26aulast%3DNi%26aufirst%3DDuan%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D2314%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Duan  Ni</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulators of Protein–Protein Interactions (PPIs). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 313-334. <a href="https://doi.org/10.1007/978-981-13-8719-7_13" title="DOI URL">https://doi.org/10.1007/978-981-13-8719-7_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-8719-7_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-8719-7_13%26sid%3Dliteratum%253Aachs%26atitle%3DAllosteric%252BModulators%252Bof%252BProtein%2525E2%252580%252593Protein%252BInteractions%252B%252528PPIs%252529%26aulast%3DNi%26aufirst%3DDuan%26date%3D2019%26date%3D2019%26spage%3D313%26epage%3D334%26pub%3DSpringer%2520Singapore%26atitle%3DProtein%252BAllostery%252Bin%252BDrug%252BDiscovery%26aulast%3DZhang%26aufirst%3DJian%26date%3D2019%26volume%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng  Xu</span>, <span class="hlFld-ContribAuthor ">Guo-Chun  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">A Convenient Synthesis of a Lymphocyte Function-Associated Antigen-1 (LFA-1) Antagonist of ‘Compound 4’. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2018,</strong> <em>42 </em>
                                    (5)
                                     , 280-284. <a href="https://doi.org/10.3184/174751918X15272594754006" title="DOI URL">https://doi.org/10.3184/174751918X15272594754006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3184/174751918X15272594754006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3184%2F174751918X15272594754006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DA%252BConvenient%252BSynthesis%252Bof%252Ba%252BLymphocyte%252BFunction-Associated%252BAntigen-1%252B%252528LFA-1%252529%252BAntagonist%252Bof%252B%2525E2%252580%252598Compound%252B4%2525E2%252580%252599%26aulast%3DXu%26aufirst%3DSheng%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D5%26spage%3D280%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanbasivarao  Kotha</span>, <span class="hlFld-ContribAuthor ">Gaddamedi  Sreevani</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of benzyl halide derivatives of spirohydantoins via [2+2+2] cyclotrimerization reaction. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (21)
                                     , 1996-1998. <a href="https://doi.org/10.1016/j.tetlet.2018.04.012" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.04.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.04.012%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bbenzyl%252Bhalide%252Bderivatives%252Bof%252Bspirohydantoins%252Bvia%252B%25255B2%25252B2%25252B2%25255D%252Bcyclotrimerization%252Breaction%26aulast%3DKotha%26aufirst%3DSanbasivarao%26date%3D2018%26volume%3D59%26issue%3D21%26spage%3D1996%26epage%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lesya M.  Saliyeva</span>, <span class="hlFld-ContribAuthor ">Nataliia Yu.  Slyvka</span>, <span class="hlFld-ContribAuthor ">Dmitro A.  Mel’nyk</span>, <span class="hlFld-ContribAuthor ">Eduard B.  Rusanov</span>, <span class="hlFld-ContribAuthor ">Ruslan I.  Vas’kevich</span>, <span class="hlFld-ContribAuthor ">Mikhailo V.  Vovk</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of spiro[imidazo[2,1-b][1,3]thiazole-6,3'-pyrrolidine] derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2018,</strong> <em>54 </em>
                                    (2)
                                     , 130-137. <a href="https://doi.org/10.1007/s10593-018-2244-8" title="DOI URL">https://doi.org/10.1007/s10593-018-2244-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-018-2244-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-018-2244-8%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Bof%252Bspiro%25255Bimidazo%25255B2%25252C1-b%25255D%25255B1%25252C3%25255Dthiazole-6%25252C3%252527-pyrrolidine%25255D%252Bderivatives%26aulast%3DSaliyeva%26aufirst%3DLesya%2BM.%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D2%26spage%3D130%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Protein-Protein Interactions and Small-Molecule Inhibitors Under Clinical Development. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 3-28. <a href="https://doi.org/10.1007/978-981-13-0773-7_1" title="DOI URL">https://doi.org/10.1007/978-981-13-0773-7_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-0773-7_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-0773-7_1%26sid%3Dliteratum%253Aachs%26atitle%3DOverview%252Bof%252BProtein-Protein%252BInteractions%252Band%252BSmall-Molecule%252BInhibitors%252BUnder%252BClinical%252BDevelopment%26aulast%3DDong%26aufirst%3DGuoqiang%26date%3D2018%26date%3D2018%26spage%3D3%26epage%3D28%26pub%3DSpringer%2520Singapore%26atitle%3DTargeting%252BProtein-Protein%252BInteractions%252Bby%252BSmall%252BMolecules%26aulast%3DSheng%26aufirst%3DChunquan%26date%3D2018%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abbas  Aminimanesh</span>, <span class="hlFld-ContribAuthor ">Safora  Shirian</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 5-Substituted Tetrazoles from Nitriles Catalyzed by Sulfamic Acid. </span><span class="cited-content_cbyCitation_journal-name">Organic Preparations and Procedures International</span><span> <strong>2017,</strong> <em>49 </em>
                                    (4)
                                     , 346-354. <a href="https://doi.org/10.1080/00304948.2017.1342510" title="DOI URL">https://doi.org/10.1080/00304948.2017.1342510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00304948.2017.1342510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00304948.2017.1342510%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Preparations%2520and%2520Procedures%2520International%26atitle%3DSynthesis%252Bof%252B5-Substituted%252BTetrazoles%252Bfrom%252BNitriles%252BCatalyzed%252Bby%252BSulfamic%252BAcid%26aulast%3DAminimanesh%26aufirst%3DAbbas%26date%3D2017%26date%3D2017%26volume%3D49%26issue%3D4%26spage%3D346%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jürgen  Bosch</span>. </span><span class="cited-content_cbyCitation_article-title">PPI inhibitor and stabilizer development in human diseases. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2017,</strong> <em>24 </em>, 3-9. <a href="https://doi.org/10.1016/j.ddtec.2017.10.004" title="DOI URL">https://doi.org/10.1016/j.ddtec.2017.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2017.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2017.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DPPI%252Binhibitor%252Band%252Bstabilizer%252Bdevelopment%252Bin%252Bhuman%252Bdiseases%26aulast%3DBosch%26aufirst%3DJ%25C3%25BCrgen%26date%3D2017%26volume%3D24%26spage%3D3%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Z.  Liu</span>, <span class="hlFld-ContribAuthor ">H.  Chen</span>, <span class="hlFld-ContribAuthor ">E.A.  Wold</span>, <span class="hlFld-ContribAuthor ">J.  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of Protein–Protein Interactions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 329-353. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12326-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12326-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12326-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12326-1%26sid%3Dliteratum%253Aachs%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252BProtein%2525E2%252580%252593Protein%252BInteractions%26aulast%3DLiu%26aufirst%3DZ.%26date%3D2017%26spage%3D329%26epage%3D353%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Faezeh  Taghavi</span>, <span class="hlFld-ContribAuthor ">Mostafa  Gholizadeh</span>, <span class="hlFld-ContribAuthor ">Amir Sh.  Saljooghi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Ramezani</span>. </span><span class="cited-content_cbyCitation_article-title">Cu(
              ii
              ) immobilized on Fe
              3
              O
              4
              @APTMS-DFX nanoparticles: an efficient catalyst for the synthesis of 5-substituted 1H-tetrazoles with cytotoxic activity. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 1953-1964. <a href="https://doi.org/10.1039/C7MD00302A" title="DOI URL">https://doi.org/10.1039/C7MD00302A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00302A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00302A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DCu%252528%252Bii%252B%252529%252Bimmobilized%252Bon%252BFe%252B3%252BO%252B4%252B%252540APTMS-DFX%252Bnanoparticles%25253A%252Ban%252Befficient%252Bcatalyst%252Bfor%252Bthe%252Bsynthesis%252Bof%252B5-substituted%252B1H-tetrazoles%252Bwith%252Bcytotoxic%252Bactivity%26aulast%3DTaghavi%26aufirst%3DFaezeh%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D10%26spage%3D1953%26epage%3D1964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tue Wenzel  Kragstrup</span>, <span class="hlFld-ContribAuthor ">Babak  Jalilian</span>, <span class="hlFld-ContribAuthor ">Kresten Krarup  Keller</span>, <span class="hlFld-ContribAuthor ">Xianwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Julie Kristine  Laustsen</span>, <span class="hlFld-ContribAuthor ">Kristian  Stengaard-Pedersen</span>, <span class="hlFld-ContribAuthor ">Merete Lund  Hetland</span>, <span class="hlFld-ContribAuthor ">Kim  Hørslev-Petersen</span>, <span class="hlFld-ContribAuthor ">Peter  Junker</span>, <span class="hlFld-ContribAuthor ">Mikkel  Østergaard</span>, <span class="hlFld-ContribAuthor ">Ellen-Margrethe  Hauge</span>, <span class="hlFld-ContribAuthor ">Malene  Hvid</span>, <span class="hlFld-ContribAuthor ">Thomas  Vorup-Jensen</span>, <span class="hlFld-ContribAuthor ">Bent  Deleuran</span>, . </span><span class="cited-content_cbyCitation_article-title">Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (2)
                                     , e0148486. <a href="https://doi.org/10.1371/journal.pone.0148486" title="DOI URL">https://doi.org/10.1371/journal.pone.0148486</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0148486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0148486%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DChanges%252Bin%252BSoluble%252BCD18%252Bin%252BMurine%252BAutoimmune%252BArthritis%252Band%252BRheumatoid%252BArthritis%252BReflect%252BDisease%252BEstablishment%252Band%252BTreatment%252BResponse%26aulast%3DKragstrup%26aufirst%3DTue%2BWenzel%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D2%26spage%3De0148486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malgorzata  Skwarczynska</span>, <span class="hlFld-ContribAuthor ">Christian  Ottmann</span>. </span><span class="cited-content_cbyCitation_article-title">Protein–protein interactions as drug targets. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (16)
                                     , 2195-2219. <a href="https://doi.org/10.4155/fmc.15.138" title="DOI URL">https://doi.org/10.4155/fmc.15.138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.15.138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.15.138%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DProtein%2525E2%252580%252593protein%252Binteractions%252Bas%252Bdrug%252Btargets%26aulast%3DSkwarczynska%26aufirst%3DMalgorzata%26date%3D2015%26volume%3D7%26issue%3D16%26spage%3D2195%26epage%3D2219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Cossins</span>, <span class="hlFld-ContribAuthor ">Alastair  Lawson</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Targeting of Protein–Protein Interactions through Allosteric Modulation of Dynamics. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (9)
                                     , 16435-16445. <a href="https://doi.org/10.3390/molecules200916435" title="DOI URL">https://doi.org/10.3390/molecules200916435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules200916435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules200916435%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSmall%252BMolecule%252BTargeting%252Bof%252BProtein%2525E2%252580%252593Protein%252BInteractions%252Bthrough%252BAllosteric%252BModulation%252Bof%252BDynamics%26aulast%3DCossins%26aufirst%3DBenjamin%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D9%26spage%3D16435%26epage%3D16445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nasrin  Razavi</span>, <span class="hlFld-ContribAuthor ">Batool  Akhlaghinia</span>. </span><span class="cited-content_cbyCitation_article-title">Cu(
              ii
              ) immobilized on aminated epichlorohydrin activated silica (CAES): as a new, green and efficient nanocatalyst for preparation of 5-substituted-1H-tetrazoles. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (16)
                                     , 12372-12381. <a href="https://doi.org/10.1039/C4RA15148H" title="DOI URL">https://doi.org/10.1039/C4RA15148H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA15148H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA15148H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCu%252528%252Bii%252B%252529%252Bimmobilized%252Bon%252Baminated%252Bepichlorohydrin%252Bactivated%252Bsilica%252B%252528CAES%252529%25253A%252Bas%252Ba%252Bnew%25252C%252Bgreen%252Band%252Befficient%252Bnanocatalyst%252Bfor%252Bpreparation%252Bof%252B5-substituted-1H-tetrazoles%26aulast%3DRazavi%26aufirst%3DNasrin%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D16%26spage%3D12372%26epage%3D12381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Orazio A.  Attanasi</span>, <span class="hlFld-ContribAuthor ">Lucia  De Crescentini</span>, <span class="hlFld-ContribAuthor ">Paolino  Filippone</span>, <span class="hlFld-ContribAuthor ">Gianluca  Giorgi</span>, <span class="hlFld-ContribAuthor ">Simona  Nicolini</span>, <span class="hlFld-ContribAuthor ">Francesca R.  Perrulli</span>, <span class="hlFld-ContribAuthor ">Stefania  Santeusanio</span>. </span><span class="cited-content_cbyCitation_article-title">From targeted aza-Michael addition to linked azaheterocyclic scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (40)
                                     , 7336-7343. <a href="https://doi.org/10.1016/j.tet.2014.07.038" title="DOI URL">https://doi.org/10.1016/j.tet.2014.07.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.07.038%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DFrom%252Btargeted%252Baza-Michael%252Baddition%252Bto%252Blinked%252Bazaheterocyclic%252Bscaffolds%26aulast%3DAttanasi%26aufirst%3DOrazio%2BA.%26date%3D2014%26volume%3D70%26issue%3D40%26spage%3D7336%26epage%3D7343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">The use of spirocyclic scaffolds in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 3673-3682. <a href="https://doi.org/10.1016/j.bmcl.2014.06.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.06.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.06.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Buse%252Bof%252Bspirocyclic%252Bscaffolds%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZheng%26aufirst%3DYajun%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3673%26epage%3D3682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh Kumar  Prajapti</span>, <span class="hlFld-ContribAuthor ">Atulya  Nagarsenkar</span>, <span class="hlFld-ContribAuthor ">Bathini Nagendra  Babu</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of 5-substituted 1H-tetrazoles via B(C6F5)3 catalyzed [3+2] cycloaddition of nitriles and sodium azide. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (24)
                                     , 3507-3510. <a href="https://doi.org/10.1016/j.tetlet.2014.04.089" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.04.089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.04.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.04.089%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252B5-substituted%252B1H-tetrazoles%252Bvia%252BB%252528C6F5%2525293%252Bcatalyzed%252B%25255B3%25252B2%25255D%252Bcycloaddition%252Bof%252Bnitriles%252Band%252Bsodium%252Bazide%26aulast%3DPrajapti%26aufirst%3DSantosh%2BKumar%26date%3D2014%26volume%3D55%26issue%3D24%26spage%3D3507%26epage%3D3510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marian  Brennan</span>, <span class="hlFld-ContribAuthor ">Dermot  Cox</span>. </span><span class="cited-content_cbyCitation_article-title">The Therapeutic Potential of I-Domain Integrins. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 157-178. <a href="https://doi.org/10.1007/978-94-017-9153-3_11" title="DOI URL">https://doi.org/10.1007/978-94-017-9153-3_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-94-017-9153-3_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-94-017-9153-3_11%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BTherapeutic%252BPotential%252Bof%252BI-Domain%252BIntegrins%26aulast%3DBrennan%26aufirst%3DMarian%26date%3D2014%26date%3D2014%26spage%3D157%26epage%3D178%26pub%3DSpringer%2520Netherlands%26atitle%3DI%252BDomain%252BIntegrins%26aulast%3DGullberg%26aufirst%3DDonald%26date%3D2014%26volume%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Ting-Ting  Yan</span>, <span class="hlFld-ContribAuthor ">Shan  Niu</span>, <span class="hlFld-ContribAuthor ">Yue-Tao  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiang-Bao  Meng</span>, <span class="hlFld-ContribAuthor ">Zhi-Hui  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhong-Jun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a series of multivalent homo-, and heteroglycosides and their anti-adhesion activities. </span><span class="cited-content_cbyCitation_journal-name">Carbohydrate Research</span><span> <strong>2013,</strong> <em>379 </em>, 78-94. <a href="https://doi.org/10.1016/j.carres.2013.06.011" title="DOI URL">https://doi.org/10.1016/j.carres.2013.06.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.carres.2013.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.carres.2013.06.011%26sid%3Dliteratum%253Aachs%26jtitle%3DCarbohydrate%2520Research%26atitle%3DSynthesis%252Bof%252Ba%252Bseries%252Bof%252Bmultivalent%252Bhomo-%25252C%252Band%252Bheteroglycosides%252Band%252Btheir%252Banti-adhesion%252Bactivities%26aulast%3DLi%26aufirst%3DQing%26date%3D2013%26volume%3D379%26spage%3D78%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin M.  Guckian</span>, <span class="hlFld-ContribAuthor ">Daniel M.  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of LFA-1/ICAM Interaction for the Treatment of Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 165-185. <a href="https://doi.org/10.1002/9783527648207.ch8" title="DOI URL">https://doi.org/10.1002/9783527648207.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527648207.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527648207.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DInhibition%252Bof%252BLFA-1%25252FICAM%252BInteraction%252Bfor%252Bthe%252BTreatment%252Bof%252BAutoimmune%252BDiseases%26aulast%3DGuckian%26aufirst%3DKevin%2BM.%26date%3D2013%26date%3D2013%26spage%3D165%26epage%3D185%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DProtein-Protein%252BInteractions%252Bin%252BDrug%252BDiscovery%26aulast%3DD%25C3%25B6mling%26aufirst%3DAlexander%26date%3D2013%26volume%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Jarmo  Käpylä</span>, <span class="hlFld-ContribAuthor ">Konstantin  Denessiouk</span>, <span class="hlFld-ContribAuthor ">Tomi  Airenne</span>, <span class="hlFld-ContribAuthor ">Bhanupratap Singh  Chouhan</span>, <span class="hlFld-ContribAuthor ">Jyrki  Heino</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of Cell Adhesion to Extracellular Matrix. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 243-283. <a href="https://doi.org/10.1007/978-3-642-36002-2_9" title="DOI URL">https://doi.org/10.1007/978-3-642-36002-2_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-642-36002-2_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-642-36002-2_9%26sid%3Dliteratum%253Aachs%26atitle%3DEvolution%252Bof%252BCell%252BAdhesion%252Bto%252BExtracellular%252BMatrix%26aulast%3DJohnson%26aufirst%3DMark%2BS.%26date%3D2013%26date%3D2013%26spage%3D243%26epage%3D283%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DEvolution%252Bof%252BExtracellular%252BMatrix%26aulast%3DKeeley%26aufirst%3DFred%2BW.%26date%3D2013%26volume%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sachin R.  Kandalkar</span>, <span class="hlFld-ContribAuthor ">Rahul D.  Kaduskar</span>, <span class="hlFld-ContribAuthor ">Parimi Atchuta  Ramaiah</span>, <span class="hlFld-ContribAuthor ">Dinesh A.  Barawkar</span>, <span class="hlFld-ContribAuthor ">Debnath  Bhuniya</span>, <span class="hlFld-ContribAuthor ">Anil M.  Deshpande</span>. </span><span class="cited-content_cbyCitation_article-title">Highly efficient one-pot amination of carboxylate-substituted nitrogen-containing heteroaryl chlorides via Staudinger reaction. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2013,</strong> <em>54 </em>
                                    (5)
                                     , 414-418. <a href="https://doi.org/10.1016/j.tetlet.2012.11.027" title="DOI URL">https://doi.org/10.1016/j.tetlet.2012.11.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2012.11.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2012.11.027%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DHighly%252Befficient%252Bone-pot%252Bamination%252Bof%252Bcarboxylate-substituted%252Bnitrogen-containing%252Bheteroaryl%252Bchlorides%252Bvia%252BStaudinger%252Breaction%26aulast%3DKandalkar%26aufirst%3DSachin%2BR.%26date%3D2013%26volume%3D54%26issue%3D5%26spage%3D414%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  Carballedo</span>, <span class="hlFld-ContribAuthor ">Danutia  Lisiecka</span>, <span class="hlFld-ContribAuthor ">Andrew  Fagan</span>, <span class="hlFld-ContribAuthor ">Karim  Saleh</span>, <span class="hlFld-ContribAuthor ">Yolande  Ferguson</span>, <span class="hlFld-ContribAuthor ">Gerard  Connolly</span>, <span class="hlFld-ContribAuthor ">James  Meaney</span>, <span class="hlFld-ContribAuthor ">Thomas  Frodl</span>. </span><span class="cited-content_cbyCitation_article-title">Early life adversity is associated with brain changes in subjects at family risk for depression. </span><span class="cited-content_cbyCitation_journal-name">The World Journal of Biological Psychiatry</span><span> <strong>2012,</strong> <em>13 </em>
                                    (8)
                                     , 569-578. <a href="https://doi.org/10.3109/15622975.2012.661079" title="DOI URL">https://doi.org/10.3109/15622975.2012.661079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/15622975.2012.661079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F15622975.2012.661079%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520World%2520Journal%2520of%2520Biological%2520Psychiatry%26atitle%3DEarly%252Blife%252Badversity%252Bis%252Bassociated%252Bwith%252Bbrain%252Bchanges%252Bin%252Bsubjects%252Bat%252Bfamily%252Brisk%252Bfor%252Bdepression%26aulast%3DCarballedo%26aufirst%3DAngela%26date%3D2012%26date%3D2012%26volume%3D13%26issue%3D8%26spage%3D569%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen W.  Wright</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of 2-, 4-, 5-, and 6-aminonicotinic acid tert-butyl esters. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2012,</strong> <em>49 </em>
                                    (2)
                                     , 442-445. <a href="https://doi.org/10.1002/jhet.799" title="DOI URL">https://doi.org/10.1002/jhet.799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.799%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DPreparation%252Bof%252B2-%25252C%252B4-%25252C%252B5-%25252C%252Band%252B6-aminonicotinic%252Bacid%252Btert-butyl%252Besters%26aulast%3DWright%26aufirst%3DStephen%2BW.%26date%3D2012%26date%3D2012%26volume%3D49%26issue%3D2%26spage%3D442%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Olimpieri</span>, <span class="hlFld-ContribAuthor ">Maria Cristina  Bellucci</span>, <span class="hlFld-ContribAuthor ">Tommaso  Marcelli</span>, <span class="hlFld-ContribAuthor ">Alessandro  Volonterio</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective multicomponent sequential synthesis of hydantoins. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2012,</strong> <em>10 </em>
                                    (48)
                                     , 9538. <a href="https://doi.org/10.1039/c2ob26498f" title="DOI URL">https://doi.org/10.1039/c2ob26498f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2ob26498f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2ob26498f%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRegioselective%252Bmulticomponent%252Bsequential%252Bsynthesis%252Bof%252Bhydantoins%26aulast%3DOlimpieri%26aufirst%3DFrancesca%26date%3D2012%26volume%3D10%26issue%3D48%26spage%3D9538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">New and unusual scaffolds in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2011,</strong> <em>40 </em>
                                    (11)
                                     , 5514. <a href="https://doi.org/10.1039/c1cs15119c" title="DOI URL">https://doi.org/10.1039/c1cs15119c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c1cs15119c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc1cs15119c%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DNew%252Band%252Bunusual%252Bscaffolds%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2011%26volume%3D40%26issue%3D11%26spage%3D5514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Cristina Bellucci</span>, <span class="hlFld-ContribAuthor ">Tommaso  Marcelli</span>, <span class="hlFld-ContribAuthor ">Leonardo  Scaglioni</span>, <span class="hlFld-ContribAuthor ">Alessandro  Volonterio</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of diverse spiroisoxazolidinohydantoins by totally regio- and diasteroselective 1,3-dipolar cycloadditions. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2011,</strong> <em>1 </em>
                                    (7)
                                     , 1250. <a href="https://doi.org/10.1039/c1ra00573a" title="DOI URL">https://doi.org/10.1039/c1ra00573a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c1ra00573a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc1ra00573a%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Bof%252Bdiverse%252Bspiroisoxazolidinohydantoins%252Bby%252Btotally%252Bregio-%252Band%252Bdiasteroselective%252B1%25252C3-dipolar%252Bcycloadditions%26aulast%3DCristina%2BBellucci%26aufirst%3DMaria%26date%3D2011%26volume%3D1%26issue%3D7%26spage%3D1250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dermot  Cox</span>, <span class="hlFld-ContribAuthor ">Marian  Brennan</span>, <span class="hlFld-ContribAuthor ">Niamh  Moran</span>. </span><span class="cited-content_cbyCitation_article-title">Integrins as therapeutic targets: lessons and opportunities. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2010,</strong> <em>9 </em>
                                    (10)
                                     , 804-820. <a href="https://doi.org/10.1038/nrd3266" title="DOI URL">https://doi.org/10.1038/nrd3266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd3266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd3266%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DIntegrins%252Bas%252Btherapeutic%252Btargets%25253A%252Blessons%252Band%252Bopportunities%26aulast%3DCox%26aufirst%3DDermot%26date%3D2010%26date%3D2010%26volume%3D9%26issue%3D10%26spage%3D804%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0017.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) sarcosine ethyl ester, NaOH, THF/H<sub>2</sub>O, 96%; (b) 4-cyanobenzaldehyde, β-alanine, AcOH, reflux, 35% or 4-cyanobenzaldehyde, pyrrolidine/EtOH, 78 °C 18 h, 85%; (c) <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzylamine, THF, TFA, 0 °C to RT, 18 h, 70%; (d) 1,2-dichloroethane, 1-chloroethyl chloroformate, 5 °C, to RT, 18 h, MeOH, reflux, 3 h, 50−85%; (e) Chiralpak-AD column, CO<sub>2</sub>/MeOH, ∼100% desired enantiomer (>99% ee).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 25%; (b) <b>6</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, biphenyl-2-yldicyclohexylphosphine, <i>t</i>-BuOK, DMA, 85 °C, 41%; (c) <b>6</b>, Cu(OAc)<sub>2</sub>, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 100 °C, 14%; (d) <b>6</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, biphenyl-2-yldicyclohexylphosphine, <i>t</i>-BuOK, DMA, 85 °C, 8%; (e) <b>6</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, DIPEA, 90 °C, 33%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SOCl<sub>2</sub>; <i>t</i>-BuOH, CH<sub>2</sub>Cl<sub>2</sub>, Et<sub>3</sub>N, DMAP, 70%; (b) <b>6</b>, DIPEA, DMA, 112 °C, 77%; (c) TFA, DCM, 86%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaN<sub>3</sub>, Et<sub>3</sub>N, AcOH, 130 °C, 30%; (b) Ph<sub>3</sub>CCl, NaOH, CHCl<sub>3</sub>, 39%; (c) <b>6</b>, DIPEA, 118 °C, 12%; (d) TFA, MeOH.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>6</b>, DIPEA, DMF, 100 °C, 86%; (b) 1 M aq KOH, 1,2-propanediol, THF, H<sub>2</sub>O, 28%.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>6</b>, DIPEA, DMF, 100 °C, 81%; (b) LiI, DMA, 140 °C, 42%.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>6</b>, neat, 96 °C, 37%; (b) LiI, DMA, 140 °C, 86%.</p></p></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) neat, 108 °C, 72%; (b) DMF, reflux, 55%; (c) POCl<sub>3</sub>, 128 °C; (d) NaOH (25% aq), 98%; (e) SOCl<sub>2</sub>; <i>t</i>-BuOH, DMAP, Et<sub>3</sub>N, 10% (f) <b>6</b>, DIPEA, DMA, 112 °C, 50%; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 76%.</p></p></figure><figure data-id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0009.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 9. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>SO<sub>4</sub>, MeOH, reflux; (b) POCl<sub>3</sub>; (c) urea, 100 °C, 40%; (d) <i>t</i>-BuONO, CuCl<sub>2</sub>, MeCN, 65 °C, 66%; (e) SOCl<sub>2</sub>, MeOH, 65%; (f) NaNO<sub>2</sub>, H<sub>2</sub>SO<sub>4</sub>, H<sub>2</sub>O, 71%; (g) POCl<sub>3</sub>, 110 °C; (h) <i>t</i>-butyl nitrite, CuBr<sub>2</sub>, MeCN.</p></p></figure><figure data-id="fig2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0018.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of compound <b>1</b> bound to the I-Domain of LFA-1. Also shown is the initial electron density prior to fitting the compound (magenta 2<i>F</i><sub>o</sub> − <i>F</i><sub>c</sub> contoured at 1σ and cyan: <i>F</i><sub>o</sub> − <i>F</i><sub>c</sub> contoured at 6σ, which indicates the positions of the chlorine atoms).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0019.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of compound <b>2e</b> bound to the I-Domain of LFA-1. Also shown is the initial electron density prior to fitting the compound (magenta 2<i>F</i><sub>o</sub> − <i>F</i><sub>c</sub> contoured at 1σ and cyan: <i>F</i><sub>o</sub> − <i>F</i><sub>c</sub> contoured at 6σ, which indicates the positions of the chlorine atoms).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/medium/jm-2010-00348u_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0020.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Efficacy of <b>2e</b> (1, 3, and 10 mg/kg) vs vehicle in a mouse allergic eosinophilic lung inflammation model. Mice (<i>n</i> = 8/group) were immunized with OVA IP on day 0, boosted on day 14, and challenged on day 28; <b>2e</b> was administered PO/BID for 3 days starting on day 28. Vehicle: PEG400/0.1 M phosphate buffer (80/20 v/v). M17 is an anti-LFA-1 monoclonal antibody. *<i>p</i> value <0.05 compared to vehicle treatment group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100348u/production/images/large/jm-2010-00348u_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100348u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76524" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76524" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hogg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitinger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, P.</span><span> </span><span class="NLM_article-title">Mechanisms contributing to the activity of integrins on leukocytes</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1034%2Fj.1600-065X.2002.18614.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=12234370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFeht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2002&pages=164-171&author=N.+Hoggauthor=R.+Hendersonauthor=B.+Leitingerauthor=A.+McDowallauthor=J.+Porterauthor=P.+Stanley&title=Mechanisms+contributing+to+the+activity+of+integrins+on+leukocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms contributing to the activity of integrins on leukocytes</span></div><div class="casAuthors">Hogg, Nancy; Henderson, Robert; Leitinger, Birgit; McDowall, Alison; Porter, Joanna; Stanley, Paula</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">A review.  Understanding how the integrins on leukocytes operate is important because these receptors control the activity of leukocytes in all phases of their lives.  Thus integrins control leukocyte development and maturation in bone marrow, the circulation of naive cells in secondary lymphoid tissue, e.g. the lymph nodes, and leukocyte responses to inflammatory signals emanating from injured tissues.  Using as an example LFA-1, which is expressed by all leukocytes, the authors outline how the activity of this integrin is modified to meet the challenges posed by these leukocyte activities.  Briefly, the authors discuss three means by which LFA-1 is adapted to bind more efficiently to its chief ligand, ICAM-1.  LFA-1 can undergo changes in conformation leading to increased affinity, can be clustered on the membrane and, finally, when activated can move into the lipid raft compartment of the membrane.  The study of humans with the β2 deficiency syndrome termed leukocyte adhesion deficiency (LAD)-1 and anal. of LFA-1 null mice has given further insight into integrin activation mechanisms and the in vivo roles of LFA-1 and other leukocyte integrins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZtQv56tpiurVg90H21EOLACvtfcHk0liNgxt3_N2V1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFeht7c%253D&md5=073ec79461608a7d57dee45331ade5c7</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-065X.2002.18614.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-065X.2002.18614.x%26sid%3Dliteratum%253Aachs%26aulast%3DHogg%26aufirst%3DN.%26aulast%3DHenderson%26aufirst%3DR.%26aulast%3DLeitinger%26aufirst%3DB.%26aulast%3DMcDowall%26aufirst%3DA.%26aulast%3DPorter%26aufirst%3DJ.%26aulast%3DStanley%26aufirst%3DP.%26atitle%3DMechanisms%2520contributing%2520to%2520the%2520activity%2520of%2520integrins%2520on%2520leukocytes%26jtitle%3DImmunol.%2520Rev.%26date%3D2002%26volume%3D186%26spage%3D164%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, N.</span><span> </span><span class="NLM_article-title">The role of the integrin LFA-1 in T-lymphocyte migration</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">218</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1111%2Fj.1600-065X.2007.00537.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=17624950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSiu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=2007&pages=135-146&author=A.+Smithauthor=P.+Stanleyauthor=K.+Jonesauthor=L.+Svenssonauthor=A.+McDowallauthor=N.+Hogg&title=The+role+of+the+integrin+LFA-1+in+T-lymphocyte+migration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the integrin LFA-1 in T-lymphocyte migration</span></div><div class="casAuthors">Smith, Andrew; Stanley, Paula; Jones, Kristian; Svensson, Lena; McDowall, Alison; Hogg, Nancy</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">135-146</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  A successful immune response depends on the migration of lymphocytes into lymph nodes or inflamed tissues where they make contact with antigen-presenting cells.  We are interested in how one member of the integrin family, leukocyte function-assocd. antigen-1 (LFA-1), controls the function and, in particular, the migration of immune cells.  We find that this integrin operates not only as an adhesion receptor for T lymphoblasts (T cells) but also induces their migration in vitro at approx. 15 μm/min.  Migration requires active myosin light chain kinase at the leading edge and Rho kinase at the trailing edge of the cell.  Two active conformations of LFA-1 are differently distributed on the T-cell membrane and regulate independent aspects of migration.  High-affinity LFA-1 is located in a midcell 'focal zone' and influences the speed of migration, whereas intermediate affinity LFA-1 controls leading edge adhesions.  Manipulating LFA-1 conformation in vivo can be performed, for example, by creating the active conformation in a transgenic mouse, and this model gives further insight into the role of LFA-1 in migration.  In humans, the beneficial effect of functioning CD 18 integrins in combating infections in vivo is illustrated by rare patients displaying two forms of leukocyte adhesion deficiency.  In summary, we speculate that T cells have evolved a mode of rapid migration that is of paramount importance in achieving the high-speed immune surveillance upon which depends the body's protection against diverse invaders from pathogens to cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_51XrMAHxlrVg90H21EOLACvtfcHk0liNgxt3_N2V1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSiu7zO&md5=812e99e2ba174b1c351160db13c46800</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2007.00537.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2007.00537.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DStanley%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DSvensson%26aufirst%3DL.%26aulast%3DMcDowall%26aufirst%3DA.%26aulast%3DHogg%26aufirst%3DN.%26atitle%3DThe%2520role%2520of%2520the%2520integrin%2520LFA-1%2520in%2520T-lymphocyte%2520migration%26jtitle%3DImmunol.%2520Rev.%26date%3D2007%26volume%3D218%26spage%3D135%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Welzenbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitz-Schmidt, G.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors induce conformational changes in the I Domain and the I-like domain of lymphocyte function-associated antigen-1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">10590</span><span class="NLM_x">–</span> <span class="NLM_lpage">10598</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=10590-10598&author=K.+Welzenbachauthor=U.+Hommelauthor=G.+Weitz-Schmidt&title=Small+molecule+inhibitors+induce+conformational+changes+in+the+I+Domain+and+the+I-like+domain+of+lymphocyte+function-associated+antigen-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWelzenbach%26aufirst%3DK.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DWeitz-Schmidt%26aufirst%3DG.%26atitle%3DSmall%2520molecule%2520inhibitors%2520induce%2520conformational%2520changes%2520in%2520the%2520I%2520Domain%2520and%2520the%2520I-like%2520domain%2520of%2520lymphocyte%2520function-associated%2520antigen-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D10590%26epage%3D10598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shimaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Therapeutic antagonists and the conformational regulation of the β<sub>2</sub> intergrins</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.2174%2F1568026043387575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=15544539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFakt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=1485-1495&author=M.+Shimaokaauthor=T.+A.+Springer&title=Therapeutic+antagonists+and+the+conformational+regulation+of+the+%CE%B22+intergrins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic antagonists and the conformational regulation of the β2 integrins</span></div><div class="casAuthors">Shimaoka, Motomu; Springer, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1485-1495</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The β2 integrins are validated therapeutic targets for inflammatory disorders.  Two distinct mechanistic classes of small mol. inhibitors, termed α I allosteric and α/β I-like allosteric antagonist, have recently been developed.  The α I allosteric antagonists bind underneath the C-terminal helix of the I domain and stabilize the I domain in the inactive closed conformation.  By contrast, the α/β I-like allosteric antagonists bind to the β2 I-like domain MIDAS and disrupt conformational signal transmission between the I and the I-like domain, leaving the I domain in a default inactive form.  Furthermore, the two classes of the antagonists have opposite effects on integrin conformation; the α I allosteric antagonists stabilize the bent conformation, whereas the α/β I-like allosteric antagonists induce the extended conformation with inactive I domain.  The small mol. antagonists to the β2 integrin highlight the importance of the structural linkages within and between integrin domains for transmission of the conformational signals and regulation of the overall conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqoL7f2YG1JrVg90H21EOLACvtfcHk0lhVVZBWOaAMuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFakt74%253D&md5=728aa985273c09d8b18b88e4d5e0f630</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.2174%2F1568026043387575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026043387575%26sid%3Dliteratum%253Aachs%26aulast%3DShimaoka%26aufirst%3DM.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DTherapeutic%2520antagonists%2520and%2520the%2520conformational%2520regulation%2520of%2520the%2520%25CE%25B22%2520intergrins%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D1485%26epage%3D1495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shimaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, C.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormiack, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Structures of the aL I Domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=99-111&author=M.+Shimaokaauthor=T.+Xiaoauthor=J.-H.+Liuauthor=Y.+Yangauthor=Y.+Dongauthor=C.-D.+Junauthor=A.+McCormiackauthor=R.+Zhangauthor=A.+Joachimakauthor=J.+Takagiauthor=J.-H.+Wangauthor=T.+A.+Springer&title=Structures+of+the+aL+I+Domain+and+its+complex+with+ICAM-1+reveal+a+shape-shifting+pathway+for+integrin+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimaoka%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.-H.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DJun%26aufirst%3DC.-D.%26aulast%3DMcCormiack%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DJoachimak%26aufirst%3DA.%26aulast%3DTakagi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.-H.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DStructures%2520of%2520the%2520aL%2520I%2520Domain%2520and%2520its%2520complex%2520with%2520ICAM-1%2520reveal%2520a%2520shape-shifting%2520pathway%2520for%2520integrin%2520regulation%26jtitle%3DCell%26date%3D2003%26volume%3D112%26spage%3D99%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carman, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Activation-induced conformational changes in the I Domain region of lymphocyte function-associated antigen-1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">10638</span><span class="NLM_x">–</span> <span class="NLM_lpage">10641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=10638-10641&author=Q.+Maauthor=M.+Shimaokaauthor=C.+Luauthor=H+Jingauthor=C.+V.+Carmanauthor=T.+A.+Springer&title=Activation-induced+conformational+changes+in+the+I+Domain+region+of+lymphocyte+function-associated+antigen-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DShimaoka%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DJing%26aufirst%3DH%26aulast%3DCarman%26aufirst%3DC.%2BV.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DActivation-induced%2520conformational%2520changes%2520in%2520the%2520I%2520Domain%2520region%2520of%2520lymphocyte%2520function-associated%2520antigen-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D10638%26epage%3D10641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Salas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimaoka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carman, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T.</span><span> </span><span class="NLM_article-title">Transition from rolling to firm adhesion is regulated by the conformation of the I Domain of the integrin lymphocyte function-associated antigen-1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">50255</span><span class="NLM_x">–</span> <span class="NLM_lpage">50262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=50255-50262&author=A.+Salasauthor=M.+Shimaokaauthor=S.+Chenauthor=C.+V.+Carmanauthor=T.+Springer&title=Transition+from+rolling+to+firm+adhesion+is+regulated+by+the+conformation+of+the+I+Domain+of+the+integrin+lymphocyte+function-associated+antigen-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalas%26aufirst%3DA.%26aulast%3DShimaoka%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DCarman%26aufirst%3DC.%2BV.%26aulast%3DSpringer%26aufirst%3DT.%26atitle%3DTransition%2520from%2520rolling%2520to%2520firm%2520adhesion%2520is%2520regulated%2520by%2520the%2520conformation%2520of%2520the%2520I%2520Domain%2520of%2520the%2520integrin%2520lymphocyte%2520function-associated%2520antigen-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D50255%26epage%3D50262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Takagi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Integrin activation and structural rearrangement</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1034%2Fj.1600-065X.2002.18613.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=12234369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2002&pages=141-163&author=J.+Takagiauthor=T.+A.+Springer&title=Integrin+activation+and+structural+rearrangement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2eR"><div class="casContent"><span class="casTitleNuber">2e</span><div class="casTitle"><span class="NLM_cas:atitle">Integrin activation and structural rearrangement</span></div><div class="casAuthors">Takagi, Junichi; Springer, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-163</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">A review.  Among adhesion receptor families, integrins are particularly important in biol. processes that require rapid modulation of adhesion and de-adhesion.  Activation on a timescale of <1s of β2 integrins on leukocytes and β3 integrins on platelets enables deposition of these cells at sites of inflammation or vessel wall injury.  Recent crystal, NMR, and electron microscope (EM) structures of integrins and their domains lead to a unifying mechanism of activation for both integrins that contain and those that lack an inserted (I) domain.  The I domain adopts two alternative conformations, termed open and closed.  In striking similarity to signaling G-proteins, rearrangement of a Mg2+-binding site is linked to large conformational movements in distant backbone regions.  Mutations that stabilize a particular conformation show that the open conformation has high affinity for ligand, whereas the closed conformation has low affinity.  Movement of the C-terminal α-helix 10 Å down the side of the domain in the open conformation is sufficient to increase affinity at the distal ligand-binding site 9000-fold.  This C-terminal "bell-rope" provides a mechanism for linkage to conformational movements in other domains.  Recent structures and functional studies reveal interactions between β-propeller, I, and I-like domains in the integrin headpiece, and a crit. role for integrin epidermal growth factor (EGF) domains in the stalk region.  The headpiece of the integrin faces down towards the membrane in the inactive conformation, and extends upward in a "switchblade"-like opening upon activation.  These long-range structural rearrangements of the entire integrin mol. involving interdomain contacts appear closely linked to conformational changes within the I and I-like domains, which result in increased affinity and competence for ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD_jVUWoex9bVg90H21EOLACvtfcHk0lhVVZBWOaAMuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFeht7Y%253D&md5=ed99d53bc5be08fa0119b0af20038900</span></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-065X.2002.18613.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-065X.2002.18613.x%26sid%3Dliteratum%253Aachs%26aulast%3DTakagi%26aufirst%3DJ.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DIntegrin%2520activation%2520and%2520structural%2520rearrangement%26jtitle%3DImmunol.%2520Rev.%26date%3D2002%26volume%3D186%26spage%3D141%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Berlin-Rufenach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathies, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, N.</span><span> </span><span class="NLM_article-title">Lymphocyte Migration in Lymphocyte Function-Associated Antigen (LFA)-1-deficient Mice</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">189</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=1999&pages=1467-1478&author=C.+Berlin-Rufenachauthor=F.+Ottoauthor=M.+Mathiesauthor=J.+Westermannauthor=M.+J.+Owenauthor=A.+Hamannauthor=N.+Hogg&title=Lymphocyte+Migration+in+Lymphocyte+Function-Associated+Antigen+%28LFA%29-1-deficient+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerlin-Rufenach%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DF.%26aulast%3DMathies%26aufirst%3DM.%26aulast%3DWestermann%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DM.%2BJ.%26aulast%3DHamann%26aufirst%3DA.%26aulast%3DHogg%26aufirst%3DN.%26atitle%3DLymphocyte%2520Migration%2520in%2520Lymphocyte%2520Function-Associated%2520Antigen%2520%2528LFA%2529-1-deficient%2520Mice%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1999%26volume%3D189%26spage%3D1467%26epage%3D1478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Selenko-Gebauer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlhofer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingl, G.</span><span> </span><span class="NLM_article-title">Efalizumab in routine use: a clinical experience</span> <span class="citation_source-journal">Br. J. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1111%2Fj.1365-2133.2007.07762.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=17371316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFehtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2007&pages=1-6&author=N.+Selenko-Gebauerauthor=F.+Karlhoferauthor=G.+Stingl&title=Efalizumab+in+routine+use%3A+a+clinical+experience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Efalizumab in routine use: a clinical experience</span></div><div class="casAuthors">Selenko-Gebauer, N.; Karlhofer, F.; Stingl, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology, Supplement</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">BJDSA9</span>;
        ISSN:<span class="NLM_cas:issn">0366-077X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  With the advent of biol. therapies, continuous long-term control of psoriasis is now becoming a reality.  We report our experience with biologics based on the treatment of more than 550 psoriatic patients with such compds. at our special outpatient care center of Bio-Immunotherapy at the Department of Dermatol. of the Medical University of Vienna.  Approx. 220 of these patients are currently receiving efalizumab.  In our hands, efalizumab was generally found to be safe and well tolerated and, after 12 wk of treatment, resulted in a PASI redn. of 50% or more in approx. two-thirds of patients treated.  In most of these 'early' responders, the therapeutic efficacy of efalizumab can be maintained for a prolonged period of time, in certain patients up to 36 mo.  Flares occurring during long-term therapy were rare and, in most instances, triggered by infections.  During such flares, we usually do not discontinue efalizumab therapy, but rather try to combat the infection by appropriate antibiotics and to control the activity of the cutaneous eruption by the addn. of topical (corticosteroids) and, when needed, systemic (e.g. methotrexate 15-20 mg week-1 for 8-10 wk) medication.  In such a situation, it is of utmost importance for the care-taking physician to closely communicate with the affected patients in a scientifically competent fashion and to have an open ear for their concerns.  This helps and improves patient compliance and minimizes the need for treatment discontinuation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmEkfXsWpUkrVg90H21EOLACvtfcHk0ljh7gq76LggGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFehtL4%253D&md5=6c9b4c757cbdf6a747c6c8adcbf3f0ad</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2007.07762.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2007.07762.x%26sid%3Dliteratum%253Aachs%26aulast%3DSelenko-Gebauer%26aufirst%3DN.%26aulast%3DKarlhofer%26aufirst%3DF.%26aulast%3DStingl%26aufirst%3DG.%26atitle%3DEfalizumab%2520in%2520routine%2520use%253A%2520a%2520clinical%2520experience%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2007%26volume%3D156%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lebwohl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyring, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glazer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawfik, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walicke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dummer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garovoy, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pariser, D.</span><span> </span><span class="NLM_article-title">A novel targeted T-cell modulator, Efalizumab, for plaque psoriasis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">2004</span><span class="NLM_x">–</span> <span class="NLM_lpage">2013</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1056%2FNEJMoa030002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=14627785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2003&pages=2004-2013&author=M.+Lebwohlauthor=S.+K.+Tyringauthor=T.+K.+Hamiltonauthor=D.+Tothauthor=S.+Glazerauthor=N.+H.+Tawfikauthor=P.+Walickeauthor=W.+Dummerauthor=X.+Wangauthor=M.+R.+Garovoyauthor=D.+Pariser&title=A+novel+targeted+T-cell+modulator%2C+Efalizumab%2C+for+plaque+psoriasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">A novel targeted T-cell modulator, efalizumab, for plaque psoriasis</span></div><div class="casAuthors">Lebwohl, Mark; Tyring, Stephen K.; Hamilton, Tiffani K.; Toth, Darryl; Glazer, Scott; Tawfik, Naji H.; Walicke, Patricia; Dummer, Wolfgang; Wang, Xiaolin; Garovoy, Marvin R.; Pariser, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2004-2013</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Interactions between leukocyte-function-assocd. antigen type 1 (LFA-1) and intercellular adhesion mols. are important in the pathogenesis of psoriasis.  Efalizumab, a humanized monoclonal antibody, binds to the a subunit (CD11a) of LFA-1 and inhibits the activation of T cells.  METHODS: In a phase 3, multicenter, randomized, placebo-controlled, double-blind study, we assign 597 subjects with psoriasis to receive s.c. efalizumab (1 or 2 mg per kg of body wt. per wk) or placebo for 12 wk.  Depending on the response after 12 wk, subjects received an addnl. 12 wk of treatment with efalizumab or placebo.  Study treatments were discontinued at week 24, and subjects were followed for an addnl. 12 wk.  RESULTS: At week 12, there was an improvement of 75 % or more in the psoriasis area-and-severity index in 22 % of the subjects who had received 1 mg of efalizumab per kg per wk and 28 % of those who had received 2 mg of efalizumab per kg per wk, as compared with 5 % of the subjects in the placebo group (P<0.001 for both comparisons).  Efalizumab-treated subjects had greater improvement than those in the placebo group as early as week 4(P<0.001).  Among the efalizumab-treated subjects who had an improvement of 75 % or more at week 12, improvement was maintained through week 23 in 77 % of those who continued to receive efalizumab, as compared with 20 % of those who were switched to placebo (P<0.001 for both comparisons).  After the discontinuation of efalizumab at week 24, an improvement of 50 % or more in the psoriasis area-and-severity index was maintained in approx. 30 % of subjects during the 12 wk of follow-up.  Efalizumab was well tolerated, and adverse events were generally mild to moderate.  CONCLUSIONS: Efalizumab therapy resulted in significant improvements in plaque psoriasis in subjects with moderate-to-severe disease.  Extending treatment from 12 to 24 wk resulted in both maintenance and improvement of responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz_2_0iKywCrVg90H21EOLACvtfcHk0ljh7gq76LggGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFGnsb8%253D&md5=b3565c9d9de945cd8c947039ef951803</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030002%26sid%3Dliteratum%253Aachs%26aulast%3DLebwohl%26aufirst%3DM.%26aulast%3DTyring%26aufirst%3DS.%2BK.%26aulast%3DHamilton%26aufirst%3DT.%2BK.%26aulast%3DToth%26aufirst%3DD.%26aulast%3DGlazer%26aufirst%3DS.%26aulast%3DTawfik%26aufirst%3DN.%2BH.%26aulast%3DWalicke%26aufirst%3DP.%26aulast%3DDummer%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGarovoy%26aufirst%3DM.%2BR.%26aulast%3DPariser%26aufirst%3DD.%26atitle%3DA%2520novel%2520targeted%2520T-cell%2520modulator%252C%2520Efalizumab%252C%2520for%2520plaque%2520psoriasis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D349%26spage%3D2004%26epage%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cather, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cather, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menter, A.</span><span> </span><span class="NLM_article-title">Modulating T cell responses for the treatment of psoriasis: a focus on Efalizumab</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1517%2F14712598.3.2.361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=12662148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitl2itLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=361-370&author=J.+C.+Catherauthor=J.+C.+Catherauthor=A.+Menter&title=Modulating+T+cell+responses+for+the+treatment+of+psoriasis%3A+a+focus+on+Efalizumab"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab</span></div><div class="casAuthors">Cather, Jennifer Clay; Cather, J. Christian; Menter, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">361-370</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">An improved understanding regarding the pathophysiol. of psoriasis, coupled with advances in mol. research, has prompted the development of targeted biol. treatments for patients with plaque psoriasis.  T lymphocytes play an important role in initiating the immune system and the inflammatory responses that result in the development and maintenance of psoriatic plaques.  Efalizumab (anti-CD11a, Raptiva; Genentech, Inc.) is a mAb that targets the T cell adhesion mol., leukocyte function-assocd. antigen-1 (LFA-1).  By binding to CD11a - the α-subunit of LFA-1 - LFA-1 is prevented from binding with its ligand, intercellular adhesion mol.-1 (ICAM-1).  This inhibits various T cell processes believed to be important in the pathogenesis of psoriasis, including T cell activation, T cell adhesion to endothelial cells and T cell migration.  Clin. trials demonstrate that efalizumab, given s.c. once-weekly, provides clin. benefit, including improved quality of life, in patients with moderate-to-severe plaque psoriasis.  Efalizumab is assocd. with an early onset of action, with improvement noted as early as 14 days.  Studies with extended treatment suggest that continuing efalizumab therapy is more beneficial in maintaining and improving responses.  Relapse of psoriasis is usually seen within 60-70 days after discontinuation of therapy, and rebound in ∼ 5% of patients (i.e., flare to > 125% of baseline) is noted.  Efalizumab is assocd. with acute adverse events during the first and second injections, which decrease in incidence with each subsequent injection.  Data indicate that efalizumab can be safely administered for extended periods of time.  Given the efficacy, early onset of clin. benefit, the safety profile and the convenience of once-weekly s.c. home dosing, efalizumab offers an interesting new therapeutic option for the treatment of psoriasis and the potential for improved and potentially safer long-term, continuous 'maintenance' therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYQBAncoXPx7Vg90H21EOLACvtfcHk0ljh7gq76LggGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitl2itLc%253D&md5=83f44740a5690138ce94bb1b0ded2f48</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1517%2F14712598.3.2.361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.3.2.361%26sid%3Dliteratum%253Aachs%26aulast%3DCather%26aufirst%3DJ.%2BC.%26aulast%3DCather%26aufirst%3DJ.%2BC.%26aulast%3DMenter%26aufirst%3DA.%26atitle%3DModulating%2520T%2520cell%2520responses%2520for%2520the%2520treatment%2520of%2520psoriasis%253A%2520a%2520focus%2520on%2520Efalizumab%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2003%26volume%3D3%26spage%3D361%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Dedrick, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walicke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garovoy, M.</span><span> </span><span class="NLM_article-title">Anti-adhesion antibodies Efalizumab, a humanized anti-CD11a monoclonal antibody</span> <span class="citation_source-journal">Transplant Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1016%2FS0966-3274%2802%2900029-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=12180828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlektLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=181-186&author=R.+L.+Dedrickauthor=P.+Walickeauthor=M.+Garovoy&title=Anti-adhesion+antibodies+Efalizumab%2C+a+humanized+anti-CD11a+monoclonal+antibody"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-adhesion antibodies efalizumab, a humanized anti-CD11a monoclonal antibody</span></div><div class="casAuthors">Dedrick, Russell L.; Walicke, Patricia; Garovoy, Marvin</div><div class="citationInfo"><span class="NLM_cas:title">Transplant Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2-4</span>),
    <span class="NLM_cas:pages">181-186</span>CODEN:
                <span class="NLM_cas:coden">TRIME2</span>;
        ISSN:<span class="NLM_cas:issn">0966-3274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The acquired immune response that leads to graft rejection depends on regulated adhesive interactions between T lymphocytes, endothelial cells, dendritic cells, graft tissue and the extracellular matrix to coordinate cellular trafficking and activation of antigen-reactive T lymphocytes.  Inhibiting the function of mols. involved in the adhesion processes offers the potential for interfering with the allograft response.  The leukocyte function assocd. antigen-1 mol. (LFA-1), a heterodimer of CD11a (αL) and CD18 (β2) integrin subunits, is an attractive therapeutic target because it plays an important role in key steps of inflammation and tissue rejection.  These include: (1) binding of leukocytes to endothelium; (2) trafficking through activated endothelium; and (3) costimulatory interactions between T lymphocytes and antigen presenting cells.  Clin. experience with efalizumab, a humanized anti-CD11a monoclonal antibody (mAb), in patients with chronic plaque psoriasis has shown that anti-CD11a therapy is well tolerated and effective at reducing the severity of the disease without depleting lymphocytes.  Initial results in renal transplant patients are also promising.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW06gOkUeKKLVg90H21EOLACvtfcHk0lgKwF-4979KLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlektLg%253D&md5=9d0aa0f994a35380cb68a28c6616e50b</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1016%2FS0966-3274%2802%2900029-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0966-3274%252802%252900029-1%26sid%3Dliteratum%253Aachs%26aulast%3DDedrick%26aufirst%3DR.%2BL.%26aulast%3DWalicke%26aufirst%3DP.%26aulast%3DGarovoy%26aufirst%3DM.%26atitle%3DAnti-adhesion%2520antibodies%2520Efalizumab%252C%2520a%2520humanized%2520anti-CD11a%2520monoclonal%2520antibody%26jtitle%3DTransplant%2520Immunol.%26date%3D2002%26volume%3D9%26spage%3D181%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Liu, G.</span><span> </span><span class="NLM_article-title">Inhibitors of LFA-1/ICAM-1 interaction: From monoclonal antibodies to small molecules</span>.  <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span>− <span class="NLM_lpage">778</span> and references cited therein.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1358%2Fdof.2001.026.08.858713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlGhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2001&pages=767-778&author=G.+Liu&title=Inhibitors+of+LFA-1%2FICAM-1+interaction%3A+From+monoclonal+antibodies+to+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of LFA-1/ICAM-1 interaction: from monoclonal antibodies to small molecules</span></div><div class="casAuthors">Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">767-778</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The interaction between leukocyte function-assocd. antigen-1 (LFA-1), a member of β2-integrin family, and intercellular adhesion mol.-1 (ICAM-1) plays a crit. role in mediating cell adhesion, leukocyte transmigration and augmentation of T-cell receptor signaling.  Inhibitors of LFA-1/ICAM-1 interaction represent a new therapeutic area for treatment of diseases such as rheumatoid arthritis, psoriasis and ischemic reperfusion injury, and have evolved from monoclonal antibodies (MAbs) to small mols. as potential therapeutic agents.  This review will summarize the MAbs that have been or are being evaluated in clin. trials and will examine the discovery of the small-mol. antagonists.  The SAR of several of the leading series and the mechanism of action for some of these mols. will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxq8Qv8kyc6LVg90H21EOLACvtfcHk0lgKwF-4979KLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlGhsL4%253D&md5=9bfe5cc765ec3cd25199c6b4d905f7a2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1358%2Fdof.2001.026.08.858713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2001.026.08.858713%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DInhibitors%2520of%2520LFA-1%252FICAM-1%2520interaction%253A%2520From%2520monoclonal%2520antibodies%2520to%2520small%2520molecules%26jtitle%3DDrugs%2520Future%26date%3D2001%26volume%3D26%26spage%3D767%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_contrib-group">Dodd, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheriff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetsko, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varcarro, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G. M.</span><span> </span><span class="NLM_article-title">Design of LFA-1 agonists based on a 2,3-dihydro-1<i>H</i>-pyrrolizin-5(7aH)-one scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1908</span><span class="NLM_x">–</span> <span class="NLM_lpage">1911</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1908-1911&author=D.+S.+Doddauthor=S.+Sheriffauthor=C.-Y.+J.+Changauthor=D.+K.+Stetskoauthor=L.+M.+Phillipsauthor=Y.+Zhangauthor=M.+Launayauthor=D.+Potinauthor=W.+Varcarroauthor=M.+A.+Possauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=S.+J.+Suchardauthor=T.+G.+M.+Dhar&title=Design+of+LFA-1+agonists+based+on+a+2%2C3-dihydro-1H-pyrrolizin-5%287aH%29-one+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDodd%26aufirst%3DD.%2BS.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DC.-Y.%2BJ.%26aulast%3DStetsko%26aufirst%3DD.%2BK.%26aulast%3DPhillips%26aufirst%3DL.%2BM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLaunay%26aufirst%3DM.%26aulast%3DPotin%26aufirst%3DD.%26aulast%3DVarcarro%26aufirst%3DW.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DSuchard%26aufirst%3DS.%2BJ.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26atitle%3DDesign%2520of%2520LFA-1%2520agonists%2520based%2520on%2520a%25202%252C3-dihydro-1H-pyrrolizin-5%25287aH%2529-one%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1908%26epage%3D1911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Potin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monatlik, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malabre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabreguette, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fouquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maillet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorgeret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevallier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufort, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caussade, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetsko, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balimane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postelneck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfarb, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherriff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einspahr, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMarco, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gougoutas, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadiyala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejwani, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traeger, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G. M.</span><span> </span><span class="NLM_article-title">Discovery and Development of 5-[(5<i>S</i>,9<i>R</i>)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro [4.4]non-7-yl]methyl]-3-thiophenecarboxylic acid (BMS-587101)—A small molecule antagonist of leukocyte function associated antigen-1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6946</span><span class="NLM_x">–</span> <span class="NLM_lpage">6949</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0610806" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6946-6949&author=D.+Potinauthor=M.+Launayauthor=F.+Monatlikauthor=P.+Malabreauthor=M+Fabreguetteauthor=A.+Fouquetauthor=M.+Mailletauthor=E.+Nicolaiauthor=L.+Dorgeretauthor=F.+Chevallierauthor=D.+Besseauthor=M.+Dufortauthor=F.+Caussadeauthor=S.+Z.+Ahmadauthor=D.+K.+Stetskoauthor=S.+Skalaauthor=P.+M.+Davisauthor=P.+Balimaneauthor=K.+Patelauthor=Z.+Yangauthor=P.+Maratheauthor=J.+Postelneckauthor=R.+M.+Townsendauthor=V.+Goldfarbauthor=S.+Sherriffauthor=H.+Einspahrauthor=K.+Kishauthor=M.+F.+Malleyauthor=J.+D.+DiMarcoauthor=J.+Z.+Gougoutasauthor=P.+Kadiyalaauthor=D.+L.+Cheneyauthor=R.+W.+Tejwaniauthor=D.+K.+Murphyauthor=K.+W.+McIntyreauthor=X.+Yangauthor=S.+Chaoauthor=L.+Leithauthor=Z.+Xiaoauthor=A.+Mathurauthor=B.-C.+Chenauthor=D.-R.+Wuauthor=S.+C.+Traegerauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=J.+A.+Roblauthor=E.+J.+Iwanowiczauthor=S.+J.+Suchardauthor=T.+G.+M.+Dhar&title=Discovery+and+Development+of+5-%5B%285S%2C9R%29-9-%284-Cyanophenyl%29-3-%283%2C5-dichlorophenyl%29-1-methyl-2%2C4-dioxo-1%2C3%2C7-triazaspiro+%5B4.4%5Dnon-7-yl%5Dmethyl%5D-3-thiophenecarboxylic+acid+%28BMS-587101%29%E2%80%94A+small+molecule+antagonist+of+leukocyte+function+associated+antigen-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm0610806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610806%26sid%3Dliteratum%253Aachs%26aulast%3DPotin%26aufirst%3DD.%26aulast%3DLaunay%26aufirst%3DM.%26aulast%3DMonatlik%26aufirst%3DF.%26aulast%3DMalabre%26aufirst%3DP.%26aulast%3DFabreguette%26aufirst%3DM%26aulast%3DFouquet%26aufirst%3DA.%26aulast%3DMaillet%26aufirst%3DM.%26aulast%3DNicolai%26aufirst%3DE.%26aulast%3DDorgeret%26aufirst%3DL.%26aulast%3DChevallier%26aufirst%3DF.%26aulast%3DBesse%26aufirst%3DD.%26aulast%3DDufort%26aufirst%3DM.%26aulast%3DCaussade%26aufirst%3DF.%26aulast%3DAhmad%26aufirst%3DS.%2BZ.%26aulast%3DStetsko%26aufirst%3DD.%2BK.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DP.%2BM.%26aulast%3DBalimane%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DPostelneck%26aufirst%3DJ.%26aulast%3DTownsend%26aufirst%3DR.%2BM.%26aulast%3DGoldfarb%26aufirst%3DV.%26aulast%3DSherriff%26aufirst%3DS.%26aulast%3DEinspahr%26aufirst%3DH.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DMalley%26aufirst%3DM.%2BF.%26aulast%3DDiMarco%26aufirst%3DJ.%2BD.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DKadiyala%26aufirst%3DP.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DTejwani%26aufirst%3DR.%2BW.%26aulast%3DMurphy%26aufirst%3DD.%2BK.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DLeith%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DWu%26aufirst%3DD.-R.%26aulast%3DTraeger%26aufirst%3DS.%2BC.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DSuchard%26aufirst%3DS.%2BJ.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26atitle%3DDiscovery%2520and%2520Development%2520of%25205-%255B%25285S%252C9R%2529-9-%25284-Cyanophenyl%2529-3-%25283%252C5-dichlorophenyl%2529-1-methyl-2%252C4-dioxo-1%252C3%252C7-triazaspiro%2520%255B4.4%255Dnon-7-yl%255Dmethyl%255D-3-thiophenecarboxylic%2520acid%2520%2528BMS-587101%2529%25E2%2580%2594A%2520small%2520molecule%2520antagonist%2520of%2520leukocyte%2520function%2520associated%2520antigen-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6946%26epage%3D6949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Potin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabreguette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malabre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caussade, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetsko, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todderud, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheriff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenbaugh, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G. M.</span><span> </span><span class="NLM_article-title">De novo design, synthesis and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold</span> <span class="citation_source-journal">Biorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1161</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1016%2Fj.bmcl.2004.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=15686933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1Cruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1161-1164&author=D.+Potinauthor=M.+Launayauthor=E.+Nicolaiauthor=M.+Fabreguetteauthor=P.+Malabreauthor=F.+Caussadeauthor=D.+Besseauthor=S.+Skalaauthor=D.+K.+Stetskoauthor=G.+Todderudauthor=B.+R.+Benoauthor=D.+L.+Cheneyauthor=C.+J.+Changauthor=S.+Sheriffauthor=D.+L.+Hollenbaughauthor=J.+C.+Barrishauthor=E.+J.+Iwanowiczauthor=S.+J.+Suchardauthor=T.+G.+M.+Dhar&title=De+novo+design%2C+synthesis+and+in+vitro+activity+of+LFA-1+antagonists+based+on+a+bicyclic%5B5.5%5Dhydantoin+scaffold"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic [5.5]hydantoin scaffold</span></div><div class="casAuthors">Potin, Dominique; Launay, Michele; Nicolai, Eric; Fabreguette, Maud; Malabre, Patrice; Caussade, Francois; Besse, Dominique; Skala, Stacey; Stetsko, Dawn K.; Todderud, Gordon; Beno, Brett R.; Cheney, Daniel L.; Chang, Chiehying J.; Sheriff, Steven; Hollenbaugh, Diane L.; Barrish, Joel C.; Iwanowicz, Edwin J.; Suchard, Suzanne J.; Dhar, T. G. Murali</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1161-1164</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">LFA-1 (leukocyte function-assocd. antigen-1), is a member of the β2-integrin family and is expressed on all leukocytes.  The LFA-1/ICAM interaction promotes tight adhesion between activated leukocytes and the endothelium, as well as between T cells and antigen-presenting cells.  Evidence from both animal models and clin. trials provides support for LFA-1 as a target in several different inflammatory diseases.  This paper describes the de novo design, synthesis and in vitro activity of LFA-1 antagonists I [X = O, OCH2, SCH2, NHCH2, NH(CH2)2, NMeCH2, NEtCH2; R = 4-BrC6H4, 3-BrC6H4, 4-NCC6H4, 4-ClC6H4, etc.] based on a bicyclic [5.5]hydantoin scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpMFNMv9bg97Vg90H21EOLACvtfcHk0lgRSosdFJiZSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1Cruw%253D%253D&md5=26f3ddbe2971e9c4a5a8b4278da733c1</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DPotin%26aufirst%3DD.%26aulast%3DLaunay%26aufirst%3DM.%26aulast%3DNicolai%26aufirst%3DE.%26aulast%3DFabreguette%26aufirst%3DM.%26aulast%3DMalabre%26aufirst%3DP.%26aulast%3DCaussade%26aufirst%3DF.%26aulast%3DBesse%26aufirst%3DD.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DStetsko%26aufirst%3DD.%2BK.%26aulast%3DTodderud%26aufirst%3DG.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DHollenbaugh%26aufirst%3DD.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DSuchard%26aufirst%3DS.%2BJ.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26atitle%3DDe%2520novo%2520design%252C%2520synthesis%2520and%2520in%2520vitro%2520activity%2520of%2520LFA-1%2520antagonists%2520based%2520on%2520a%2520bicyclic%255B5.5%255Dhydantoin%2520scaffold%26jtitle%3DBiorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1161%26epage%3D1164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wattanasin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weckbecker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzenbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitz-Schmidt, G.</span><span> </span><span class="NLM_article-title">1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1217-1220&author=S.+Wattanasinauthor=J.+Kallenauthor=S.+Myersauthor=Q.+Guoauthor=M.+Sabioauthor=C.+Ehrhardtauthor=R.+Albertauthor=U.+Hommelauthor=G.+Weckbeckerauthor=K.+Welzenbachauthor=G.+Weitz-Schmidt&title=1%2C4-Diazepane-2%2C5-diones+as+novel+inhibitors+of+LFA-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWattanasin%26aufirst%3DS.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DMyers%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DSabio%26aufirst%3DM.%26aulast%3DEhrhardt%26aufirst%3DC.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DWeckbecker%26aufirst%3DG.%26aulast%3DWelzenbach%26aufirst%3DK.%26aulast%3DWeitz-Schmidt%26aufirst%3DG.%26atitle%3D1%252C4-Diazepane-2%252C5-diones%2520as%2520novel%2520inhibitors%2520of%2520LFA-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1217%26epage%3D1220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wu, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emeigh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzmich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potocki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorcek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainolfi, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabozny, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothlein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woska, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T. A.</span><span> </span><span class="NLM_article-title">Second-generation lymphocyte function-associated antigen-1 inhibitors: 1<i>H</i>-Imidazo[1,2-a]imidazol-2-one derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5356</span><span class="NLM_x">–</span> <span class="NLM_lpage">5366</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049657b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5356-5366&author=J.-P.+Wuauthor=J.+Emeighauthor=A.+A.+Gaoauthor=D.+R.+Goldbergauthor=D.+Kuzmichauthor=C.+Miaoauthor=I.+Potockiauthor=K.+C.+Qianauthor=R.+J.+Sorcekauthor=D.+D.+Jeanfavreauthor=K.+Kishimotoauthor=E.+A.+Mainolfiauthor=G.+Naboznyauthor=C.+Pengauthor=P.+Reillyauthor=R.+Rothleinauthor=R.+H.+Sellatiauthor=J.+R.+Woskaauthor=S.+Chenauthor=J.+A.+Gunnauthor=D.+O%E2%80%99Brienauthor=S.+H.+Norrisauthor=T.+A.+Kelly&title=Second-generation+lymphocyte+function-associated+antigen-1+inhibitors%3A+1H-Imidazo%5B1%2C2-a%5Dimidazol-2-one+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Fjm049657b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049657b%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-P.%26aulast%3DEmeigh%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DA.%2BA.%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DKuzmich%26aufirst%3DD.%26aulast%3DMiao%26aufirst%3DC.%26aulast%3DPotocki%26aufirst%3DI.%26aulast%3DQian%26aufirst%3DK.%2BC.%26aulast%3DSorcek%26aufirst%3DR.%2BJ.%26aulast%3DJeanfavre%26aufirst%3DD.%2BD.%26aulast%3DKishimoto%26aufirst%3DK.%26aulast%3DMainolfi%26aufirst%3DE.%2BA.%26aulast%3DNabozny%26aufirst%3DG.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DReilly%26aufirst%3DP.%26aulast%3DRothlein%26aufirst%3DR.%26aulast%3DSellati%26aufirst%3DR.%2BH.%26aulast%3DWoska%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DGunn%26aufirst%3DJ.%2BA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DD.%26aulast%3DNorris%26aufirst%3DS.%2BH.%26aulast%3DKelly%26aufirst%3DT.%2BA.%26atitle%3DSecond-generation%2520lymphocyte%2520function-associated%2520antigen-1%2520inhibitors%253A%25201H-Imidazo%255B1%252C2-a%255Dimidazol-2-one%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5356%26epage%3D5366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gadek, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsters, J. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paris, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oare, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zioncheck, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumas, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claark, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilley, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presta, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodary, S. C.</span><span> </span><span class="NLM_article-title">Generation of an LFA-1 antagonist by the transfer of ICAM-1 immunoregulatory epitope to a small molecule</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1089</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2002&pages=1086-1089&author=T.+R.+Gadekauthor=D.+J.+Burdickauthor=R.+S.+McDowellauthor=M.+S.+Stanleyauthor=J.+C.+Marstersauthor=K.+J.+Parisauthor=D.+A.+Oareauthor=M.+E.+Reynoldsauthor=C.+Ladnerauthor=K.+A.+Zioncheckauthor=W.+P.+Leeauthor=P.+Griblingauthor=M.+S.+Dennisauthor=N.+J.+Skeltonauthor=D.+B.+Tumasauthor=K.+R.+Claarkauthor=S.+M.+Keatingauthor=M.+H.+Beresiniauthor=J.+W.+Tilleyauthor=L.+G.+Prestaauthor=S.+C.+Bodary&title=Generation+of+an+LFA-1+antagonist+by+the+transfer+of+ICAM-1+immunoregulatory+epitope+to+a+small+molecule"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGadek%26aufirst%3DT.%2BR.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DMcDowell%26aufirst%3DR.%2BS.%26aulast%3DStanley%26aufirst%3DM.%2BS.%26aulast%3DMarsters%26aufirst%3DJ.%2BC.%26aulast%3DParis%26aufirst%3DK.%2BJ.%26aulast%3DOare%26aufirst%3DD.%2BA.%26aulast%3DReynolds%26aufirst%3DM.%2BE.%26aulast%3DLadner%26aufirst%3DC.%26aulast%3DZioncheck%26aufirst%3DK.%2BA.%26aulast%3DLee%26aufirst%3DW.%2BP.%26aulast%3DGribling%26aufirst%3DP.%26aulast%3DDennis%26aufirst%3DM.%2BS.%26aulast%3DSkelton%26aufirst%3DN.%2BJ.%26aulast%3DTumas%26aufirst%3DD.%2BB.%26aulast%3DClaark%26aufirst%3DK.%2BR.%26aulast%3DKeating%26aufirst%3DS.%2BM.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DTilley%26aufirst%3DJ.%2BW.%26aulast%3DPresta%26aufirst%3DL.%2BG.%26aulast%3DBodary%26aufirst%3DS.%2BC.%26atitle%3DGeneration%2520of%2520an%2520LFA-1%2520antagonist%2520by%2520the%2520transfer%2520of%2520ICAM-1%2520immunoregulatory%2520epitope%2520to%2520a%2520small%2520molecule%26jtitle%3DScience%26date%3D2002%26volume%3D295%26spage%3D1086%26epage%3D1089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sircar, I.; Furth, P.; Teegarden, B. R.; Morningstar, M.; Smith, N.; Griffith, R.</span> Patent WO 0130781 (Tanabe Seiyaku)<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sircar%2C+I.%3B+Furth%2C+P.%3B+Teegarden%2C+B.+R.%3B+Morningstar%2C+M.%3B+Smith%2C+N.%3B+Griffith%2C+R.+Patent+WO+0130781+%28Tanabe+Seiyaku%29+2001."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSircar%26aufirst%3DI.%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Weitz-Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzenbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommel, U.</span><span> </span><span class="NLM_article-title">Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1038%2F89058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=11385505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlGkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=687-692&author=G.+Weitz-Schmidtauthor=K.+Welzenbachauthor=V.+Brinkmannauthor=T.+Kamataauthor=J.+Kallenauthor=C.+Brunsauthor=S.+Cottensauthor=Y.+Takadaauthor=U.+Hommel&title=Statins+selectively+inhibit+leukocyte+function+antigen-1+by+binding+to+a+novel+regulatory+integrin+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site</span></div><div class="casAuthors">Weitz-Schmidt, Gabriele; Welzenbach, Karl; Brinkmann, Volker; Kamata, Tetsji; Kallen, Joerg; Bruns, Christian; Cottens, Sylvain; Takada, Yoshikazu; Hommel, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">687-692</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The β2 integrin leukocyte function antigen-1 (LFA-1) has an important role in the pathophysiol. of inflammatory and autoimmune diseases.  Here we report that statin compds. commonly used for the treatment of hypercholesterolemia selectively blocked LFA-1-mediated adhesion and costimulation of lymphocytes.  This effect was unrelated to the statins' inhibition of 3-hydroxy-3-methylglutaryl coenzyme-A reductase; instead it occurred via binding to a novel allosteric site within LFA-1.  Subsequent optimization of the statins for LFA-1 binding resulted in potent, selective and orally active LFA-1 inhibitors that suppress the inflammatory response in a murine model of peritonitis.  Targeting of the statin-binding site of LFA-1 could be used to treat diseases such as psoriasis, rheumatoid arthritis, ischemia/reperfusion injury and transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_fuB_LsBXg7Vg90H21EOLACvtfcHk0ljMVYAcXAjtOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlGkurc%253D&md5=74f1565e9ec7a8561b9ccfdd27782c66</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1038%2F89058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F89058%26sid%3Dliteratum%253Aachs%26aulast%3DWeitz-Schmidt%26aufirst%3DG.%26aulast%3DWelzenbach%26aufirst%3DK.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DKamata%26aufirst%3DT.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DHommel%26aufirst%3DU.%26atitle%3DStatins%2520selectively%2520inhibit%2520leukocyte%2520function%2520antigen-1%2520by%2520binding%2520to%2520a%2520novel%2520regulatory%2520integrin%2520site%26jtitle%3DNat.%2520Med.%26date%3D2001%26volume%3D7%26spage%3D687%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Kelly, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woska, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainolfi, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabozny, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothlein, R.</span><span> </span><span class="NLM_article-title">Cutting edge: A small molecule antagonist of LFA-1 mediated cell adhesion</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">5173</span><span class="NLM_x">–</span> <span class="NLM_lpage">5177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1999&pages=5173-5177&author=T.+A.+Kellyauthor=D.+D.+Jeanfavreauthor=D.+W.+McNeilauthor=R.+J.+Woskaauthor=L.+P.+Reillyauthor=E.+A.+Mainolfiauthor=K.+M.+Kishimotoauthor=G.+H.+Naboznyauthor=R.+Zinterauthor=B.+Bormannauthor=R.+Rothlein&title=Cutting+edge%3A+A+small+molecule+antagonist+of+LFA-1+mediated+cell+adhesion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DT.%2BA.%26aulast%3DJeanfavre%26aufirst%3DD.%2BD.%26aulast%3DMcNeil%26aufirst%3DD.%2BW.%26aulast%3DWoska%26aufirst%3DR.%2BJ.%26aulast%3DReilly%26aufirst%3DL.%2BP.%26aulast%3DMainolfi%26aufirst%3DE.%2BA.%26aulast%3DKishimoto%26aufirst%3DK.%2BM.%26aulast%3DNabozny%26aufirst%3DG.%2BH.%26aulast%3DZinter%26aufirst%3DR.%26aulast%3DBormann%26aufirst%3DB.%26aulast%3DRothlein%26aufirst%3DR.%26atitle%3DCutting%2520edge%253A%2520A%2520small%2520molecule%2520antagonist%2520of%2520LFA-1%2520mediated%2520cell%2520adhesion%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D163%26spage%3D5173%26epage%3D5177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Last-Barney, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grygon, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zindell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T. A.</span><span> </span><span class="NLM_article-title">Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary techniques: Evidence for the allosteric inhibition of a protein−protein interaction</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">5643</span><span class="NLM_x">–</span> <span class="NLM_lpage">5650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2001&pages=5643-5650&author=K.+Last-Barneyauthor=W.+Davidsonauthor=M.+Cardozoauthor=L.+L.+Fryeauthor=C.+A.+Grygonauthor=J.+L.+Hopkinsauthor=D.+D.+Jeanfavreauthor=S.+Pavauthor=C.+Qianauthor=J.+M.+Stevensonauthor=L.+Tongauthor=R.+Zindellauthor=T.+A.+Kelly&title=Binding+site+elucidation+of+hydantoin-based+antagonists+of+LFA-1+using+multidisciplinary+techniques%3A+Evidence+for+the+allosteric+inhibition+of+a+protein%E2%88%92protein+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLast-Barney%26aufirst%3DK.%26aulast%3DDavidson%26aufirst%3DW.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGrygon%26aufirst%3DC.%2BA.%26aulast%3DHopkins%26aufirst%3DJ.%2BL.%26aulast%3DJeanfavre%26aufirst%3DD.%2BD.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DStevenson%26aufirst%3DJ.%2BM.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DZindell%26aufirst%3DR.%26aulast%3DKelly%26aufirst%3DT.%2BA.%26atitle%3DBinding%2520site%2520elucidation%2520of%2520hydantoin-based%2520antagonists%2520of%2520LFA-1%2520using%2520multidisciplinary%2520techniques%253A%2520Evidence%2520for%2520the%2520allosteric%2520inhibition%2520of%2520a%2520protein%25E2%2588%2592protein%2520interaction%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D125%26spage%3D5643%26epage%3D5650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="note"><p class="first last">Similar results were seen with a Boehringer−Igelheim series of LFA-1 antagonists.</p></div><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Winquist, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabozny, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzenbeck, M.</span><span> </span><span class="NLM_article-title">The role of leukocyte function-associated antigen-1 in animal models of inflammation</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">429</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1016%2FS0014-2999%2801%2901328-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=11698049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFWitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=429&publication_year=2001&pages=297-302&author=R.+J.+Winquistauthor=S.+Desaiauthor=S.+Fogalauthor=N.+A.+Haynesauthor=G.+H.+Naboznyauthor=P.+L.+Reillyauthor=D.+Souzaauthor=M.+Panzenbeck&title=The+role+of+leukocyte+function-associated+antigen-1+in+animal+models+of+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of leukocyte function-associated antigen-1 in animal models of inflammation</span></div><div class="casAuthors">Winquist, Raymond J.; Desai, Sudha; Fogal, Stephen; Haynes, Nancy A.; Nabozny, Gerald H.; Reilly, Patricia L.; Souza, Donald; Panzenbeck, Maret</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">429</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">297-302</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Both preclin. and clin. data have identified leukocyte function-assocd. antigen-1 (LFA-1) as an important component of inflammatory disease states.  The authors evaluated small mol. inhibitors of this glycoprotein in several animal models in which the inflammatory process is dependent on human or non-human primate LFA-1. (R)-5(4-bromobenzyl)-3(3,5-dichlorophenyl)-1,5-dimethylimidazolidine-2,4-dione, BIRT 377, effectively suppressed the prodn. of human Ig (IgG) following reconstitution of severe combined immunodeficient (SCID) mice with human peripheral blood mononuclear cells.  The BIRT 377 analog, BIX 642, inhibited the cellular infiltrate and increase in skin thickness assocd. with the delayed-type hypersensitivity reaction in previously immunized squirrel monkeys challenged with antigen.  BIX 642 also inhibited the trans-vivo delayed-type hypersensitivity response in the footpads of SCID mice injected with human peripheral blood mononuclear cells and donor-sensitive antigen.  These results demonstrate the efficacy of small mol. inhibitors of LFA-1 in preclin. models of inflammation dependent on human or non-human primate LFA-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0Qvv4aTLgobVg90H21EOLACvtfcHk0liLcEkfxlPn7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFWitLw%253D&md5=d0251932ab9bd1d8d9284c069812bbfb</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2901328-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252901328-0%26sid%3Dliteratum%253Aachs%26aulast%3DWinquist%26aufirst%3DR.%2BJ.%26aulast%3DDesai%26aufirst%3DS.%26aulast%3DFogal%26aufirst%3DS.%26aulast%3DHaynes%26aufirst%3DN.%2BA.%26aulast%3DNabozny%26aufirst%3DG.%2BH.%26aulast%3DReilly%26aufirst%3DP.%2BL.%26aulast%3DSouza%26aufirst%3DD.%26aulast%3DPanzenbeck%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520leukocyte%2520function-associated%2520antigen-1%2520in%2520animal%2520models%2520of%2520inflammation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D429%26spage%3D297%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Panzenbeck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanfavre, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabozny, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, S.</span><span> </span><span class="NLM_article-title">An orally active, primate selective antagonist of LFA-1 inhibits delayed-type hypersensitivity in a humanized-mouse model</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">534</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1016%2Fj.ejphar.2006.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=16487962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit12jtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=534&publication_year=2006&pages=233-240&author=M.+J.+Panzenbeckauthor=D.+D.+Jeanfavreauthor=T.+A.+Kellyauthor=R.+Lemieuxauthor=G.+Naboznyauthor=P.+L.+Reillyauthor=S.+Desai&title=An+orally+active%2C+primate+selective+antagonist+of+LFA-1+inhibits+delayed-type+hypersensitivity+in+a+humanized-mouse+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">An orally active, primate selective antagonist of LFA-1 inhibits delayed-type hypersensitivity in a humanized-mouse model</span></div><div class="casAuthors">Panzenbeck, Maret J.; Jeanfavre, Deborah D.; Kelly, Terence A.; Lemieux, Rene; Nabozny, Gerald; Reilly, Patricia L.; Desai, Sudha</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">534</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">233-240</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Compd. I, a novel small mol. antagonist (Kd = 6 nM) of human lymphocyte function-assocd. antigen-1 (LFA-1, CD11a/CD18) was tested for activity in a humanized mouse model of delayed-type hypersensitivity (trans vivo delayed-type hypersensitivity).  Trans vivo delayed-type hypersensitivity is a model for testing compds. with human targets in mice.  Tetanus toxoid and 7-10 × 106 human peripheral blood mononuclear cells from tetanus-sensitized donors were coinjected into footpads of naive mice.  Footpads were measured before and 24 h later.  Injection of peripheral blood mononuclear cells plus antigen resulted in swelling of 0.178-0.254 mm, significantly greater than peripheral blood mononuclear cells or tetanus toxoid alone (P < 0.05).  Preincubation of peripheral blood mononuclear cells with anti-human major histocompatibility complex class II (MHCII) or anti-human LFA-1 monoclonal antibody (mAb), but not anti-mouse MHCII or anti-mouse LFA-1 mAb, significantly inhibited the response.  Compd. I inhibited footpad swelling in a dose related manner (0.1-100 mg/kg, p.o.; ED50 ∼ 1 mg/kg), whereas its enantiomer had no effect.  These data demonstrate the oral efficacy of a novel antagonist of LFA-1 in trans vivo delayed-type hypersensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD6dwX49BszrVg90H21EOLACvtfcHk0liLcEkfxlPn7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit12jtLo%253D&md5=ffff54b30a9738bfcab4c892c03580f6</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DPanzenbeck%26aufirst%3DM.%2BJ.%26aulast%3DJeanfavre%26aufirst%3DD.%2BD.%26aulast%3DKelly%26aufirst%3DT.%2BA.%26aulast%3DLemieux%26aufirst%3DR.%26aulast%3DNabozny%26aufirst%3DG.%26aulast%3DReilly%26aufirst%3DP.%2BL.%26aulast%3DDesai%26aufirst%3DS.%26atitle%3DAn%2520orally%2520active%252C%2520primate%2520selective%2520antagonist%2520of%2520LFA-1%2520inhibits%2520delayed-type%2520hypersensitivity%2520in%2520a%2520humanized-mouse%2520model%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D534%26spage%3D233%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Sushard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetsko, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Launay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Susulic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter-Cid, L.</span><span> </span><span class="NLM_article-title">An LFA-1 (a<sub>L</sub>,b<sub>2</sub>) small-modecule antagonist reduces inflammation and joint destruction in murine models of arthritis</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">3917</span><span class="NLM_x">–</span> <span class="NLM_lpage">3926</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2010&pages=3917-3926&author=S.+J.+Sushardauthor=D.+K.+Stetskoauthor=P.+M.+Davisauthor=S.+Skalaauthor=D.+Potinauthor=M.+Launayauthor=T.+G.+M.+Dharauthor=J.+C.+Barrishauthor=V.+Susulicauthor=D.+J.+Shusterauthor=K.+W.+McIntyreauthor=M.+McKinnonauthor=L.+Salter-Cid&title=An+LFA-1+%28aL%2Cb2%29+small-modecule+antagonist+reduces+inflammation+and+joint+destruction+in+murine+models+of+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSushard%26aufirst%3DS.%2BJ.%26aulast%3DStetsko%26aufirst%3DD.%2BK.%26aulast%3DDavis%26aufirst%3DP.%2BM.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DPotin%26aufirst%3DD.%26aulast%3DLaunay%26aufirst%3DM.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DSusulic%26aufirst%3DV.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DSalter-Cid%26aufirst%3DL.%26atitle%3DAn%2520LFA-1%2520%2528aL%252Cb2%2529%2520small-modecule%2520antagonist%2520reduces%2520inflammation%2520and%2520joint%2520destruction%2520in%2520murine%2520models%2520of%2520arthritis%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D184%26spage%3D3917%26epage%3D3926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Dhar, T. G. M.; Launay, M.; Potin, D; Watterson, S. H.; Xiao, Z.</span><span> </span><span class="NLM_article-title">Pyridyl-substituted spiro-hydantoin compounds and their preparation, pharmaceutical compositions and use for treatment of immune and inflammatory diseases</span>. US 7186727 2007; </span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dhar%2C+T.+G.+M.%3B+Launay%2C+M.%3B+Potin%2C+D%3B+Watterson%2C+S.+H.%3B+Xiao%2C+Z.+Pyridyl-substituted+spiro-hydantoin+compounds+and+their+preparation%2C+pharmaceutical+compositions+and+use+for+treatment+of+immune+and+inflammatory+diseases.+US+7186727+2007%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26atitle%3DPyridyl-substituted%2520spiro-hydantoin%2520compounds%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520for%2520treatment%2520of%2520immune%2520and%2520inflammatory%2520diseases" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-ref11_2"><span> <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">83333</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem.+Abstr.+2006%2C+145%2C+83333."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref11_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2006%26volume%3D145%26spage%3D83333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Jiang, L.; Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Palladium catalyzed aromatic carbon-nitrogen bond formation</span>. In  <span class="citation_source-book">Metal-Catalyzed Cross-Coupling Reactions</span>, <span class="NLM_edition">2nd</span> ed.: <span class="NLM_contrib-group">De Meijere, A.; Diederich, F.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">699</span>− <span class="NLM_lpage">760</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1002%2F9783527619535.ch13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=699-760&author=L.+Jiang&author=S.+L.+Buchwaldauthor=A.+De+Meijere&author=F.+Diederich&title=Metal-Catalyzed+Cross-Coupling+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2F9783527619535.ch13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527619535.ch13%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26atitle%3DPalladium%2520catalyzed%2520aromatic%2520carbon-nitrogen%2520bond%2520formation%26btitle%3DMetal-Catalyzed%2520Cross-Coupling%2520Reactions%26aulast%3DDe%2BMeijere%26aufirst%3DA.%26pub%3DWiley-VCH%26date%3D2004%26spage%3D699%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Chan, D. M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaco, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, P. Y. S.</span><span> </span><span class="NLM_article-title">Copper promoted C−N and C−O bond cross-coupling with phenyl and pryidylboronates</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3863</span><span class="NLM_x">–</span> <span class="NLM_lpage">3865</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=3863-3865&author=D.+M.+T.+Chanauthor=K.+L.+Monacoauthor=R.+Liauthor=D.+Bonneauthor=C.+G.+Clarkauthor=P.+Y.+S.+Lam&title=Copper+promoted+C%E2%88%92N+and+C%E2%88%92O+bond+cross-coupling+with+phenyl+and+pryidylboronates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BM.%2BT.%26aulast%3DMonaco%26aufirst%3DK.%2BL.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DBonne%26aufirst%3DD.%26aulast%3DClark%26aufirst%3DC.%2BG.%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26atitle%3DCopper%2520promoted%2520C%25E2%2588%2592N%2520and%2520C%25E2%2588%2592O%2520bond%2520cross-coupling%2520with%2520phenyl%2520and%2520pryidylboronates%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D3863%26epage%3D3865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ohta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawachi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagechika, H.</span><span> </span><span class="NLM_article-title">Retinoidal pyrimidinecarboxylic acids. Unexpected diaza-substituent effects in retinobenzoic acids</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1504</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2000&pages=1504-1513&author=K.+Ohtaauthor=E.+Kawachiauthor=N.+Inoueauthor=H.+Fukasawaauthor=Y.+Hashimotoauthor=A.+Itaiauthor=H.+Kagechika&title=Retinoidal+pyrimidinecarboxylic+acids.+Unexpected+diaza-substituent+effects+in+retinobenzoic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhta%26aufirst%3DK.%26aulast%3DKawachi%26aufirst%3DE.%26aulast%3DInoue%26aufirst%3DN.%26aulast%3DFukasawa%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DItai%26aufirst%3DA.%26aulast%3DKagechika%26aufirst%3DH.%26atitle%3DRetinoidal%2520pyrimidinecarboxylic%2520acids.%2520Unexpected%2520diaza-substituent%2520effects%2520in%2520retinobenzoic%2520acids%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2000%26volume%3D48%26spage%3D1504%26epage%3D1513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Takamizawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, K.</span><span> </span><span class="NLM_article-title">Pyrimidine derivatives, XXX1. Reactions of ethyl 2-methoxy-methylene-3-ethoxypropionate with ureas</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1964&pages=804-808&author=A.+Takamizawaauthor=K.+Hirai&title=Pyrimidine+derivatives%2C+XXX1.+Reactions+of+ethyl+2-methoxy-methylene-3-ethoxypropionate+with+ureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakamizawa%26aufirst%3DA.%26aulast%3DHirai%26aufirst%3DK.%26atitle%3DPyrimidine%2520derivatives%252C%2520XXX1.%2520Reactions%2520of%2520ethyl%25202-methoxy-methylene-3-ethoxypropionate%2520with%2520ureas%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1964%26volume%3D12%26spage%3D804%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McOmie, J. F. W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, I. M.</span><span> </span><span class="NLM_article-title">Pyrimidines. Part VI. 5-Bromopyrimidine</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_fpage">3129</span><span class="NLM_x">–</span> <span class="NLM_lpage">3131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1953&pages=3129-3131&author=J.+F.+W+McOmieauthor=I.+M.+White&title=Pyrimidines.+Part+VI.+5-Bromopyrimidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcOmie%26aufirst%3DJ.%2BF.%2BW%26aulast%3DWhite%26aufirst%3DI.%2BM.%26atitle%3DPyrimidines.%2520Part%2520VI.%25205-Bromopyrimidine%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1953%26spage%3D3129%26epage%3D3131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kim, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haines, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, J. J.</span><span> </span><span class="NLM_article-title">Synthesis of pyrimidine-2-one nuclorsides as acid-stable inhibitors of cytidine deaminase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1374</span><span class="NLM_x">–</span> <span class="NLM_lpage">1380</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00158a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=1374-1380&author=C.-H.+Kimauthor=V.+E.+Marquezauthor=D.+T.+Maoauthor=D.+R.+Hainesauthor=J.+J.+McCormack&title=Synthesis+of+pyrimidine-2-one+nuclorsides+as+acid-stable+inhibitors+of+cytidine+deaminase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fjm00158a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00158a009%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DC.-H.%26aulast%3DMarquez%26aufirst%3DV.%2BE.%26aulast%3DMao%26aufirst%3DD.%2BT.%26aulast%3DHaines%26aufirst%3DD.%2BR.%26aulast%3DMcCormack%26aufirst%3DJ.%2BJ.%26atitle%3DSynthesis%2520of%2520pyrimidine-2-one%2520nuclorsides%2520as%2520acid-stable%2520inhibitors%2520of%2520cytidine%2520deaminase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D1374%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Clark, M. P.; Laufersweiler, M. J.; Djung, J. F.; Natchus, M. G.; De, B.</span><span> </span><span class="NLM_article-title">Preparation of 3-(pyrimidin-4-yl)-6,7-dihydro-5<i>H</i>-pyrazolo[1,2-<i>a</i>]pyrazol-1-ones for control of inflammatory cytokines</span>. Patent WO 2003024971 A1 20030327,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=M.+P.+Clark&author=M.+J.+Laufersweiler&author=J.+F.+Djung&author=M.+G.+Natchus&author=B.+De&title=Preparation+of+3-%28pyrimidin-4-yl%29-6%2C7-dihydro-5H-pyrazolo%5B1%2C2-a%5Dpyrazol-1-ones+for+control+of+inflammatory+cytokines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DM.%2BP.%26atitle%3DPreparation%2520of%25203-%2528pyrimidin-4-yl%2529-6%252C7-dihydro-5H-pyrazolo%255B1%252C2-a%255Dpyrazol-1-ones%2520for%2520control%2520of%2520inflammatory%2520cytokines%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-ref15_4"><span> <span class="citation_source-journal">Chem Abst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">271694</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem+Abst.+2003%2C+138%2C+271694."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref15_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem%2520Abst.%26date%3D2003%26volume%3D138%26spage%3D271694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Daves, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baiocchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. C.</span><span> </span><span class="NLM_article-title">Pyrimidines. II. Orotic acid analogs</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2755</span><span class="NLM_x">–</span> <span class="NLM_lpage">2763</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01066a033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=2755-2763&author=G.+D.+Davesauthor=F.+Baiocchiauthor=R.+K.+Robinsauthor=C.+C.+Cheng&title=Pyrimidines.+II.+Orotic+acid+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjo01066a033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01066a033%26sid%3Dliteratum%253Aachs%26aulast%3DDaves%26aufirst%3DG.%2BD.%26aulast%3DBaiocchi%26aufirst%3DF.%26aulast%3DRobins%26aufirst%3DR.%2BK.%26aulast%3DCheng%26aufirst%3DC.%2BC.%26atitle%3DPyrimidines.%2520II.%2520Orotic%2520acid%2520analogs%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D2755%26epage%3D2763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Daves, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. C.</span><span> </span><span class="NLM_article-title">Pyrimidines. X111. 2- and 6-substituted 4-pyrimidinecarboxylic acids (1a)</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1964&pages=130-133&author=G.+D.+Davesauthor=D.+E.+O%E2%80%99Brienauthor=L.+R.+Lewisauthor=C.+C.+Cheng&title=Pyrimidines.+X111.+2-+and+6-substituted+4-pyrimidinecarboxylic+acids+%281a%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaves%26aufirst%3DG.%2BD.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DD.%2BE.%26aulast%3DLewis%26aufirst%3DL.%2BR.%26aulast%3DCheng%26aufirst%3DC.%2BC.%26atitle%3DPyrimidines.%2520X111.%25202-%2520and%25206-substituted%25204-pyrimidinecarboxylic%2520acids%2520%25281a%2529%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1964%26volume%3D1%26spage%3D130%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lok, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, A. J.</span><span> </span><span class="NLM_article-title">Facile rearrangements of alkynylamino heterocyles with noble metal cations</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3289</span><span class="NLM_x">–</span> <span class="NLM_lpage">3297</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo952101z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3289-3297&author=R.+Lokauthor=R.+E.+Leoneauthor=A.+J.+Williams&title=Facile+rearrangements+of+alkynylamino+heterocyles+with+noble+metal+cations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjo952101z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo952101z%26sid%3Dliteratum%253Aachs%26aulast%3DLok%26aufirst%3DR.%26aulast%3DLeone%26aufirst%3DR.%2BE.%26aulast%3DWilliams%26aufirst%3DA.%2BJ.%26atitle%3DFacile%2520rearrangements%2520of%2520alkynylamino%2520heterocyles%2520with%2520noble%2520metal%2520cations%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3289%26epage%3D3297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Edwards, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessinger, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presta, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodary, S. C.</span><span> </span><span class="NLM_article-title">Identification of amino acids in the CD11a I-domain important for binding of the leukocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">12635</span><span class="NLM_x">–</span> <span class="NLM_lpage">12640</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=12635-12640&author=C.+P.+Edwardsauthor=M.+Champeauthor=T.+Gonzalezauthor=M.+E.+Wessingerauthor=S.+A.+Spencerauthor=L.+G.+Prestaauthor=P.+W.+Bermanauthor=S.+C.+Bodary&title=Identification+of+amino+acids+in+the+CD11a+I-domain+important+for+binding+of+the+leukocyte+function-associated+antigen-1+%28LFA-1%29+to+intercellular+adhesion+molecule-1+%28ICAM-1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DC.%2BP.%26aulast%3DChampe%26aufirst%3DM.%26aulast%3DGonzalez%26aufirst%3DT.%26aulast%3DWessinger%26aufirst%3DM.%2BE.%26aulast%3DSpencer%26aufirst%3DS.%2BA.%26aulast%3DPresta%26aufirst%3DL.%2BG.%26aulast%3DBerman%26aufirst%3DP.%2BW.%26aulast%3DBodary%26aufirst%3DS.%2BC.%26atitle%3DIdentification%2520of%2520amino%2520acids%2520in%2520the%2520CD11a%2520I-domain%2520important%2520for%2520binding%2520of%2520the%2520leukocyte%2520function-associated%2520antigen-1%2520%2528LFA-1%2529%2520to%2520intercellular%2520adhesion%2520molecule-1%2520%2528ICAM-1%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D12635%26epage%3D12640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Otwinowski, Z.; Minor, W.</span> In  <span class="citation_source-book">Methods in Enzymology, Vol. 276: Macromolecular Crystallography Part A</span>; <span class="NLM_contrib-group">Abelson, J. N.; Simon, M. I.; Carter, C. W.,  Jr.; Sweet, R. M.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span><span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">307</span>− <span class="NLM_lpage">326</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=J.+N.+Abelson&author=M.+I.+Simon&author=C.+W.+Carter&author=R.+M.+Sweet&title=Methods+in+Enzymology%2C+Vol.+276%3A+Macromolecular+Crystallography+Part+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26btitle%3DMethods%2520in%2520Enzymology%252C%2520Vol.%2520276%253A%2520Macromolecular%2520Crystallography%2520Part%2520A%26aulast%3DAbelson%26aufirst%3DJ.%2BN.%26pub%3DAcademic%2520Press%26date%3D1997%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span> Collaborative Computational Project, Number 4. <span> </span><span class="NLM_article-title">The CCP4 Suite: programs for protein crystallography</span>.  <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span>− <span class="NLM_lpage">763</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm100348u&amp;key=15299374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm100348u&amp;key=1%3ACAS%3A280%3ADC%252BD2czpsV2gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Collaborative+Computational+Project%2C+Number+4.+The+CCP4+Suite%3A+programs+for+protein+crystallography.+Acta+Crystallogr.%2C+Sect.+D%3A+Biol.+Crystallogr.+1994%2C+50%2C+760%E2%88%92763."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">The CCP4 suite: programs for protein crystallography</span></div><div class="casAuthors">Anonymous</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">760-3</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The CCP4 (Collaborative Computational Project, number 4) program suite is a collection of programs and associated data and subroutine libraries which can be used for macromolecular structure determination by X-ray crystallography.  The suite is designed to be flexible, allowing users a number of methods of achieving their aims and so there may be more than one program to cover each function.  The programs are written mainly in standard Fortran77.  They are from a wide variety of sources but are connected by standard data file formats.  The package has been ported to all the major platforms under both Unix and VMS.  The suite is distributed by anonymous ftp from Daresbury Laboratory and is widely used throughout the world.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1Q-skJYIZ2IYPsCkJIw00fW6udTcc2eZsJAgR-xKpzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czpsV2gug%253D%253D&md5=92b759927d6071ea3f20c08b78ad1eb2</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520CCP4%2520Suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Navaza, J.</span><span> </span><span class="NLM_article-title">AMoRe: an automated package for molecular replacement</span>.  <span class="citation_source-journal">Acta Crystallogr., Sect. A: Found. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span>− <span class="NLM_lpage">163</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm100348u&amp;key=10.1107%2FS0108767393007597" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=157-163&author=J.+Navaza&title=AMoRe%3A+an+automated+package+for+molecular+replacement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1107%2FS0108767393007597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767393007597%26sid%3Dliteratum%253Aachs%26aulast%3DNavaza%26aufirst%3DJ.%26atitle%3DAMoRe%253A%2520an%2520automated%2520package%2520for%2520molecular%2520replacement%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D157%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span>CNX release 2002;, <span class="NLM_publisher-name">Accelrys, Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CNX+release+2002%3B%2C+Accelrys%2C+Inc.%3A+San+Diego%2C+CA%2C+2002."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCNX%2520release%25202002%26pub%3DAccelrys%252C%2520Inc%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span>QUANTA Modeling Environment release 2000; <span class="NLM_publisher-name">Accelrys Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=QUANTA+Modeling+Environment+release+2000%3B+Accelrys+Inc.%3A+San+Diego%2C+CA%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DQUANTA%2520Modeling%2520Environment%2520release%25202000%26pub%3DAccelrys%2520Inc%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100348u&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-9%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm100348u%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100348u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a9300dff61985","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
